<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN">
<html>
<head>
<title>Promethease is-a-medicine</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" >
<style type="text/css">
body {
font-family: arial, helvetica, sans-serif;
color: black;
}
button {
border: 1px solid #000000;
padding: 0px;
font-size: 4px;
margin-left: 1px;
}
button:hover {
cursor: pointer;
color: #ffffff;
}
#navmenu {
background-color: #F0F0F0;
position:fixed;
right:5px;
top:5px;
border:1px solid black;
z-index:2;
}
#navbox {
border:1px solid black;
padding-left: 170px;
float: right;
clear: none;
padding: 0px;
min-width: 50%;
max-width: 69%;
}
#treeDiv1 {
max-height:300px;
overflow: auto;
background-color: #F0F0F0;
float:left;
right:5px;
top:5px;
border:1px solid black;
clear: none;
min-width: 20%;
max-width: 30%;
padding: 0px;
}
#expandcontractdiv {
border:1px dotted #dedede;
background-color:#EBE4F2;
margin:0 0 .5em 0;
padding:0.4em;
}
.majorsection {
float:left;
width:95%;
border:1px solid black;
clear:both;
margin: 5px 0px;
padding: 0px 10px;
}
.sectiontext {
clear:both;
font-size: x-large;
}
.boxresult {
width: inherit;
margin: 10px auto;
border: 2px solid grey;
}
.boxgoodresult {
width: inherit;
margin: 10px auto;
border: 2px solid #80FF90;
}
.boxbadresult {
width: inherit;
margin: 10px auto;
border: 2px solid #FF8080;
}
.boxresultcol1 {
background-color: #FFFFFF;
float: left;
width: 190px;
margin: 0;
word-wrap: break-word;
}
.boxresultcol2 {
margin-left: 190px;
}
.boxlink {
float:left;
width:130px;
}
.boxfreq {
float:left;
width:170px;
clear:both;
}
.boxmag {
float:left;
width:170px;
clear:both;
}
.boxrep {
float:left;
width:170px;
clear:both;
}
.boxeffect {
float:left;
}
.gsboxeffect {
float:left;
clear: none;
}
.boxshow {
float:left;
width:100px;
}
.rstext {
float:left;
clear: left;
background-color: #D0D0FF;
}
.diseasebutton {
margin-left: 20px;
float:left;
clear: both;
}
.member-Topic {
margin-left: 40px;
border:1px solid black;
clear: both;
}
.member-is-a-medical-condition {
margin-left: 40px;
border:1px solid black;
clear: both;
}
.member-is-a-medicine {
margin-left: 40px;
border:1px solid black;
clear: both;
}
.adiseasebox {
width: 90%;
float:left;
margin-left: 40px;
clear: both;
}
.diseaselink {
margin-left: 240px;
FONT-SIZE: 18pt;
}
.diseaseinfo {
margin-left: 650px;
}
.boxfooter {
clear: both;
margin: 0;
border-top: 1px solid gray;
}
.majorboxfooter {
clear: both;
margin: 0;
border-top: 1px solid gray;
}
</style>

<script type="text/javascript">
function toggle(element) {
if (document.getElementById(element).style.display == "none") {
   document.getElementById(element).style.display = "";
} else {
   document.getElementById(element).style.display = "none";
}
}
function toggle2(element) {
if (document.getElementById(element).style.display == "none") {
   document.getElementById(element).style.display = "";
   document.getElementById('show-'+element).style.display = "none";
} else {
   document.getElementById(element).style.display = "none";
   document.getElementById('show-'+element).style.display = "";
}
}
function toggle3(name) {
var e=getElementsByClassName(name);
for ( var i=0; i < e.length; i++ ) {
   if (e[i].style.display == "none") {
       e[i].style.display = "";
       document.getElementById('show-'+e[i].id).style.display = "none";
   } else {
       e[i].style.display = "none";
       document.getElementById('show-'+e[i].id).style.display = "";
   }
}
}

/*

Need to switch to this cleaner method
Crockford walkTheDOM http://javascript.crockford.com/hackday.ppt

function walkTheDOM(node, func) {

func(node);
node = node.firstChild;
while (node) {
    walkTheDOM(node, func);
    node = node.nextSibling;
}

}


function getElementsByClassName(className, node) {
 var results = [];
 walkTheDOM(node || document.body, function (node) {
     var a, c = node.className, i;
     if (c) {
         a = c.split(' ');
         for (i = 0; i < a.length; i += 1) {
             if (a[i] === className) {
                  results.push(node);
                  break;
              }
         }
     }
 });
 return results;
}


By now there is a more efficient method, but once upon a time this javascript served well enough

    BEGIN:http://www.robertnyman.com
    http://www.robertnyman.com/2008/05/27/the-ultimate-getelementsbyclassname-anno-2008/
    cross platform 'getElementsByClassName'
    Developed by Robert Nyman, http://www.robertnyman.com
    Code/licensing: http://code.google.com/p/getelementsbyclassname/
*/
var getElementsByClassName = function (className, tag, elm){
    if (document.getElementsByClassName) {
            getElementsByClassName = function (className, tag, elm) {
                    elm = elm || document;
                    var elements = elm.getElementsByClassName(className),
                            nodeName = (tag)? new RegExp("\b" + tag + "\b", "i") : null,
                            returnElements = [],
                            current;
                    for(var i=0, il=elements.length; i<il; i+=1){
                            current = elements[i];
                            if(!nodeName || nodeName.test(current.nodeName)) {
                                    returnElements.push(current);
                            }
                    }
                    return returnElements;
            };
    }
    else if (document.evaluate) {
            getElementsByClassName = function (className, tag, elm) {
                    tag = tag || "*";
                    elm = elm || document;
                    var classes = className.split(" "),
                            classesToCheck = "",
                            xhtmlNamespace = "http://www.w3.org/1999/xhtml",
                            namespaceResolver = (document.documentElement.namespaceURI === xhtmlNamespace)? xhtmlNamespace : null,
                            returnElements = [],
                            elements,
                            node;
                    for(var j=0, jl=classes.length; j<jl; j+=1){
                            classesToCheck += "[contains(concat(' ', @class, ' '), ' " + classes[j] + " ')]";
                    }
                    try     {
                            elements = document.evaluate(".//" + tag + classesToCheck, elm, namespaceResolver, 0, null);
                    }
                    catch (e) {
                            elements = document.evaluate(".//" + tag + classesToCheck, elm, null, 0, null);
                    }
                    while ((node = elements.iterateNext())) {
                            returnElements.push(node);
                    }
                    return returnElements;
            };
    }
    else {
            getElementsByClassName = function (className, tag, elm) {
                    tag = tag || "*";
                    elm = elm || document;
                    var classes = className.split(" "),
                            classesToCheck = [],
                            elements = (tag === "*" && elm.all)? elm.all : elm.getElementsByTagName(tag),
                            current,
                            returnElements = [],
                            match;
                    for(var k=0, kl=classes.length; k<kl; k+=1){
                            classesToCheck.push(new RegExp("(^|\s)" + classes[k] + "(\s|$)"));
                    }
                    for(var l=0, ll=elements.length; l<ll; l+=1){
                            current = elements[l];
                            match = false;
                            for(var m=0, ml=classesToCheck.length; m<ml; m+=1){
                                    match = classesToCheck[
                                        m].test(current.className);
                                    if (!match) {
                                            break;
                                    }
                            }
                            if (match) {
                                    returnElements.push(current);
                            }
                    }
                    return returnElements;
            };
    }
    return getElementsByClassName(className, tag, elm);
};
/*      END:http://www.robertnyman.com */

function ShowEverything(){//we open all of them

var sections = new Array('diseasebox',
                     'member-is-a-Topic',
                     'member-is-a-medical-condition',
                     'member-is-a-medicine',
                     'rstext',
                     'boxrstext',
                     'boxshow',
                     'boxsection'
                     );

for ( var i_sect=0; i_sect < sections.length; i_sect++ ) {
    var e=getElementsByClassName(sections[i_sect]);
    for ( var i=0; i < e.length; i++ ) {
        e[i].style.display = '';
    }
}

}
</script>
</head>
<body><p>
<a href="../report.html">main page</a><a name='top'></a>
<div id='header'>
<h1><a href='http://www.promethease.com'>Promethease</a> Report</h1>
<h2>Version: 0.1.163</h2>
<h2>Generated: 2015-08-03 15:41</h2>
<h3>Infile: genome_Stuart_Lynn_Full_20150803082101.txt <br>infiles /tmp/tmpb1LT3a</h3><h3>Reference Population CEU</h3><h3>19053 genotypes annotated</h3></div>
<div id='navmenu'>
<h3><a href='http://www.snpedia.com/index.php?title=Promethease/results'>Help</a> interpreting your results.</h3>
<a href="javascript:ShowEverything()">Show Everything</a>
</div>
    <div class="majorsection">
     <div class='sectiontext'>Medicines</div>

        <div class='boxshow' id="show-is-a-medicine" style="display: none;"><a href="javascript:toggle2('is-a-medicine')">...more...</a></div>
        <div class="boxsection" id="is-a-medicine" style="display: inline;"><a href="javascript:toggle2('is-a-medicine')">(hide)</a>
<div id="block-is-a-medicine" class="diseasebox" style="display: inline;">
<a href="javascript:toggle3('member-is-a-medicine')">(toggle all)</a>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|40|0">17 alpha-hydroxyprogesterone caproate</a>

        <div class='boxshow' id="show-disease-1750757322750066841" style="display: inline;"><a href="javascript:toggle2('disease-1750757322750066841')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-1750757322750066841" style="display: none;"><a href="javascript:toggle2('disease-1750757322750066841')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=17%20alpha-hydroxyprogesterone%20caproate">17 alpha-hydroxyprogesterone caproate</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs578029'>rs578029</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs578029(A;T)'>(A;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDCDC;'>46.7%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.462572533406" style="display: inline;"><a href="javascript:toggle2('sec-0.462572533406')">...more...</a></div>
        <div class='boxrstext' id="sec-0.462572533406" style="display: none;"><a href="javascript:toggle2('sec-0.462572533406')">(hide)</a>
        <div class='rstext'>news The effectiveness of 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth is influenced by SNPs. Black women *rs471767 homozygous for the major allele treatment significantly reduced the rate of preterm birth. *rs578029 who had a least one copy of the major allele, treatment significantly reduced in preterm birth non-black women *a least one copy of the minor allele of rs503362 had a significant reduction with treatment *with at least one copy of the minor allele of rs666553 had a significant reduction in very preterm birth</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs666553'>rs666553</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs666553(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFF0F0;'>73.8%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.362916992452" style="display: inline;"><a href="javascript:toggle2('sec-0.362916992452')">...more...</a></div>
        <div class='boxrstext' id="sec-0.362916992452" style="display: none;"><a href="javascript:toggle2('sec-0.362916992452')">(hide)</a>
        <div class='rstext'>news The effectiveness of 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth is influenced by SNPs. Black women *rs471767 homozygous for the major allele treatment significantly reduced the rate of preterm birth. *rs578029 who had a least one copy of the major allele, treatment significantly reduced in preterm birth non-black women *a least one copy of the minor allele of rs503362 had a significant reduction with treatment *with at least one copy of the minor allele of rs666553 had a significant reduction in very preterm birth</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs503362'>rs503362</a><a href='http://www.snpedia.com/index.php/rs503362(C;G)'>(C;G)</a></div>
        <div class='boxmag'>Magnitude: 0.1<br/>Frequency: <span style='background-color: #FFD9D9;'>43.8%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.849387689428" style="display: inline;"><a href="javascript:toggle2('sec-0.849387689428')">...more...</a></div>
        <div class='boxrstext' id="sec-0.849387689428" style="display: none;"><a href="javascript:toggle2('sec-0.849387689428')">(hide)</a>
        <div class='rstext'>news The effectiveness of 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth is influenced by SNPs. Black women *rs471767 homozygous for the major allele treatment significantly reduced the rate of preterm birth. *rs578029 who had a least one copy of the major allele, treatment significantly reduced in preterm birth non-black women *a least one copy of the minor allele of rs503362 had a significant reduction with treatment *with at least one copy of the minor allele of rs666553 had a significant reduction in very preterm birth</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs471767'>rs471767</a><a href='http://www.snpedia.com/index.php/rs471767(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Magnitude: 0.1<br/>Frequency: <span style='background-color: #FFDADA;'>45.1%</span><br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.409000345464" style="display: inline;"><a href="javascript:toggle2('sec-0.409000345464')">...more...</a></div>
        <div class='boxrstext' id="sec-0.409000345464" style="display: none;"><a href="javascript:toggle2('sec-0.409000345464')">(hide)</a>
        <div class='rstext'>news The effectiveness of 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth is influenced by SNPs. Black women *rs471767 homozygous for the major allele treatment significantly reduced the rate of preterm birth. *rs578029 who had a least one copy of the major allele, treatment significantly reduced in preterm birth non-black women *a least one copy of the minor allele of rs503362 had a significant reduction with treatment *with at least one copy of the minor allele of rs666553 had a significant reduction in very preterm birth</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">5-fluorouracil</a>

        <div class='boxshow' id="show-disease-6658741684999238227" style="display: inline;"><a href="javascript:toggle2('disease-6658741684999238227')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-6658741684999238227" style="display: none;"><a href="javascript:toggle2('disease-6658741684999238227')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=5-fluorouracil">5-fluorouracil</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3918290'>rs3918290</a><a href='http://www.snpedia.com/index.php/rs3918290(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFEFE;'>99.1%</span><br/>Repute:Good<br/>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.734412242669" style="display: inline;"><a href="javascript:toggle2('sec-0.734412242669')">...more...</a></div>
        <div class='boxrstext' id="sec-0.734412242669" style="display: none;"><a href="javascript:toggle2('sec-0.734412242669')">(hide)</a>
        <div class='rstext'>23andMe reports that the A allele of rs3918290 is associated with the rare recessive disorder dihydropyrimidine dehydrogenase deficiency (DPD), also known as hereditary thymine-uraciluria or familial pyrimidinemia. Note that the terms used in the literature for this gene can be confusing, since the gene is in reverse orientation to the chromosome strand on the reference genome. pharmgkb - defines *2A allele, which has a significantly higher chance of 5-fluorouracil toxicity Fluorouracil Toxicity  [PharmGKB:In-Depth Heterozygosity for the A allele of this SNP is associated with mucositis and leukopenia drug toxicity in cancer patients treated with fluorouracil. Heterozygous males were more likely than heterozygous females to develop severe toxicity. In this study, no A/A homozygotes were ob...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:50|0|0">6-Mercaptopurine</a>

        <div class='boxshow' id="show-disease8996008578807157405" style="display: inline;"><a href="javascript:toggle2('disease8996008578807157405')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease8996008578807157405" style="display: none;"><a href="javascript:toggle2('disease8996008578807157405')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=6-Mercaptopurine">6-Mercaptopurine</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1127354'>rs1127354</a><a href='http://www.snpedia.com/index.php/rs1127354(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF6F6;'>83.3%</span><br/>Repute:Good<br/>References:35<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in clinvar</div>
        <div class='boxshow' id="show-sec-0.900492255886" style="display: inline;"><a href="javascript:toggle2('sec-0.900492255886')">...more...</a></div>
        <div class='boxrstext' id="sec-0.900492255886" style="display: none;"><a href="javascript:toggle2('sec-0.900492255886')">(hide)</a>
        <div class='rstext'>rs1127354 (Pro32Thr/P32T, 94C&gt;A) is a SNP within the ITPA (Inosine triphosphate pyrophosphatase) gene. (note: rs1127354 supersedes rs41320251) abolishes IPTA activity in homozygous individuals and reduces the activity to 25% in heterozygous subjects, mercaptopurine metabolism (sig. higher methyl mercaptopurine nucleotides levels + higher probability of severe febrile neutropenia in A carriers treated with mercaptopurine) Mutations in the gene encoding the Wnt-signaling component R-spondin 4 (RSPO4) cause autosomal recessive anonychia. Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine. Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate. Variants in the ITPA gene protect a...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1142345'>rs1142345</a><a href='http://www.snpedia.com/index.php/rs1142345(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFCFC;'>94.7%</span><br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in clinvar</div>
        <div class='boxshow' id="show-sec-0.7731810594" style="display: inline;"><a href="javascript:toggle2('sec-0.7731810594')">...more...</a></div>
        <div class='boxrstext' id="sec-0.7731810594" style="display: none;"><a href="javascript:toggle2('sec-0.7731810594')">(hide)</a>
        <div class='rstext'>rs1142345 is a SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs. In general, individuals must have two nonfunctioning TPMT alleles for the toxicity to be pronounced. The risk allele for this SNP is rs1142345(G), and when it is the only variant in the TPMT gene, it encodes the TPMT*3C allele. While still rare, it is more common in African-Americans (2.4% of all alleles) than in Caucasians. Note that if the same allele also carries the rs1800460(A) SNP, the allele is actually a TPMT*3A allele (OMIM). The medicine 6-Mercaptopurine is metabolized by TPMT. Individual differences in TPMT activity associated with this SNP are now used to determine appropriate dosage range and interval for treatment. 23an...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1800584'>rs1800584</a><a href='http://www.snpedia.com/index.php/rs1800584(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFEFE;'>98.2%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.942863625562" style="display: inline;"><a href="javascript:toggle2('sec-0.942863625562')">...more...</a></div>
        <div class='boxrstext' id="sec-0.942863625562" style="display: none;"><a href="javascript:toggle2('sec-0.942863625562')">(hide)</a>
        <div class='rstext'>rs1800584 is a rare SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs. In general, individuals must have two nonfunctioning TPMT alleles for the toxicity to be pronounced. The rs1800584(A) SNP defines the TPMT*4A allele (OMIM). wikipedia thiopurine drugs metabolized by TPMT include azathioprine, mercaptopurine, and thioguanine  [PharmGKB:In-Depth This splicing variant results in very low TPMT activity and risk for hematologic toxicity as a result of treatment with thiopurines.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1800460'>rs1800460</a><a href='http://www.snpedia.com/index.php/rs1800460(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.104141773042" style="display: inline;"><a href="javascript:toggle2('sec-0.104141773042')">...more...</a></div>
        <div class='boxrstext' id="sec-0.104141773042" style="display: none;"><a href="javascript:toggle2('sec-0.104141773042')">(hide)</a>
        <div class='rstext'>rs1800460 is a SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs. In general, individuals must have two nonfunctioning TPMT alleles for the toxicity to be pronounced. The risk allele for this SNP is rs1800460(A), and when it is the only variation in the TPMT gene, it encodes the TPMT*3B allele. While still rare, it is more common in Caucasians (4.5% of all alleles) than in African-Americans (0.8%). Note that if the same allele also carries the rs1142345(G) SNP, the allele is actually a TPMT*3A allele (OMIM). The medicine 6-Mercaptopurine is metabolized by TPMT. Individual differences in TPMT activity associated with this SNP are now used to determine appropriate dosage range and interval for treatm...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1800462'>rs1800462</a><a href='http://www.snpedia.com/index.php/rs1800462(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:8<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal for 23andMe  appears common for 23andMe users</div>
        <div class='boxshow' id="show-sec-0.46594215295" style="display: inline;"><a href="javascript:toggle2('sec-0.46594215295')">...more...</a></div>
        <div class='boxrstext' id="sec-0.46594215295" style="display: none;"><a href="javascript:toggle2('sec-0.46594215295')">(hide)</a>
        <div class='rstext'>rs1800462, also known as A80P, is a rare SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs. In general, individuals must have two nonfunctioning TPMT alleles for the toxicity to be pronounced. The risk allele for this SNP (in orientation to the dbSNP entry) is rs1800462(C), and it encodes the TPMT*2 allele. It may occur at a frequency of 1 in 200 alleles among Caucasians. wikipedia thiopurine drugs metabolized by TPMT include azathioprine, mercaptopurine, and thioguanine  [PharmGKB:In-Depth The TPMT:238G&gt;C SNP was cloned from a patient with severe mercaptopurine toxicity. It results in a non-synonymous protein change TPMT:Ala80Pro that has a 100-fold reduction in catalytic activity compared to w...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">5 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Abacavir</a>

        <div class='boxshow' id="show-disease-7349187530932319411" style="display: inline;"><a href="javascript:toggle2('disease-7349187530932319411')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-7349187530932319411" style="display: none;"><a href="javascript:toggle2('disease-7349187530932319411')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Abacavir">Abacavir</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2395029'>rs2395029</a><a href='http://www.snpedia.com/index.php/rs2395029(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF9F9;'>88.5%</span><br/>Repute:Good<br/>References:32<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common  The rs2395029(T;T) genotype is the common genotype for this SNP, against which the rs2395029(T;G) and rs2395029(G;G) genotypes that are associated with reduced HIV viral load in HIV carriers are compared. See also rs9264942 and HIV.</div>
        <div class='boxshow' id="show-sec-0.15110006931" style="display: inline;"><a href="javascript:toggle2('sec-0.15110006931')">...more...</a></div>
        <div class='boxrstext' id="sec-0.15110006931" style="display: none;"><a href="javascript:toggle2('sec-0.15110006931')">(hide)</a>
        <div class='rstext'>rs2395029 is a SNP in the major histocompatibility complex (MHC) region, and several studies have shown that the rs2395029(G) allele is 99.9% predictive of the presence of an HLA-B*5701 allele. This HLA allele, in turn, has been associated with several conditions. A study of 51 cases of flucloxacillin drug-induced liver injury (DILI), an important cause of serious liver disease, along with a replication study of another 23 cases, found that the rs2395029(G) carriers were at highly increased risk (odds ratio 80, p=8.7x10(-33)). * see also: 23andMe blog rs2395029(G;G) increases the odds of drug-induced liver injury in response to flucloxacillin by 45x This SNP is thought to be involved in determining the HIV viral load set point during the asymptomatic period of infection. This SNP is estima...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">ACE Inhibitors</a>

        <div class='boxshow' id="show-disease4924815747612765316" style="display: inline;"><a href="javascript:toggle2('disease4924815747612765316')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease4924815747612765316" style="display: none;"><a href="javascript:toggle2('disease4924815747612765316')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=ACE%20Inhibitors">ACE Inhibitors</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3788853'>rs3788853</a><a href='http://www.snpedia.com/index.php/rs3788853(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFB5B5;'>17.0%</span><br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal  This genotype is susceptible to skin swelling when taking medicines called ACE Inhibitors . for more information visit rs3788853</div>
        <div class='boxshow' id="show-sec-0.823729944688" style="display: inline;"><a href="javascript:toggle2('sec-0.823729944688')">...more...</a></div>
        <div class='boxrstext' id="sec-0.823729944688" style="display: none;"><a href="javascript:toggle2('sec-0.823729944688')">(hide)</a>
        <div class='rstext'>A form of this snp, located upstream of the XPNPEP2 gene on the X chromosome, may cause susceptibility to skin swelling when taking medicines called ACE Inhibitors. Also known as -2399C/A in the literature; however in SNPedia, where the orientation of the corresponding dbSNP entry is recognized as primary, this is G/T. After noticing the association of this SNP with the phenotype, the authors genotyped 20 independent AE-ACEi cases and 60 unrelated, matching controls for this SNP. The T allele was present in 8 of the 20 AE patients; and by allele counting, the T allele was found at a frequency of 11.1% in the control population and 27.3% in their AE-ACEi cases. *See also OMIM 300145  [OMIM:?]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Acetaminophen</a>

        <div class='boxshow' id="show-disease5996838818512756375" style="display: inline;"><a href="javascript:toggle2('disease5996838818512756375')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease5996838818512756375" style="display: none;"><a href="javascript:toggle2('disease5996838818512756375')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Acetaminophen">Acetaminophen</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1467558'>rs1467558</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1467558(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCCCC;'>31.9%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.740428854708" style="display: inline;"><a href="javascript:toggle2('sec-0.740428854708')">...more...</a></div>
        <div class='boxrstext' id="sec-0.740428854708" style="display: none;"><a href="javascript:toggle2('sec-0.740428854708')">(hide)</a>
        <div class='rstext'>After taking Acetaminophen (Tylenol&#174;), rs1467558(A;G) individuals have higher alanine aminotransferase (ALT) levels, a sign of liver toxicity, than do (G;G) homozygotes. More studies are needed; there was only 1 (A;A) individual, and he didn't show elevated ALT levels; furthermore, the ALT increases were 'modest' anyway for (A;G) individuals compared to (G;G). see also: 23andMe blog '''Note:''' the orientation of this SNP in SNPedia is as detailed in dbSNP, but in publications (including 23andMe's blog) the orientation is 'flipped', so what's (A;A) in dbSNP is (T;T) as discussed by the 23andMe blog.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|0|10">Allegra</a>

        <div class='boxshow' id="show-disease3743416292249058401" style="display: inline;"><a href="javascript:toggle2('disease3743416292249058401')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease3743416292249058401" style="display: none;"><a href="javascript:toggle2('disease3743416292249058401')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Allegra">Allegra</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1045642'>rs1045642</a><a href='http://www.snpedia.com/index.php/rs1045642(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFE4E4;'>55.8%</span><br/>Repute:Bad<br/>References:100<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Slower metaboliser for some drugs</div>
        <div class='boxshow' id="show-sec-0.979007390579" style="display: inline;"><a href="javascript:toggle2('sec-0.979007390579')">...more...</a></div>
        <div class='boxrstext' id="sec-0.979007390579" style="display: none;"><a href="javascript:toggle2('sec-0.979007390579')">(hide)</a>
        <div class='rstext'>rs1045642, also known as C3435T, is a SNP located in the ABCB1 gene. It is often studied in conjunction with rs2032582. C3435T has been mentioned by: * A 'Silent' Polymorphism in the MDR1 Gene Changes Substrate Specificity (for example, to verapamil) * (R)-lansoprazole (Prevacid) concentrations are significantly increased in CYP2C19 extensive metabolizers with ABCB1 C3435T C allele. * In a Korean population, plasma concentrations of fexofenadine (Allegra) were 17% lower in 2677AA/3435CC subjects and 47% higher in the 2677TT/3435TT subjects compared to 2677GG/3435CC subjects. * In contrast, in this study no association was observed between the C3435T polymorphism and fexofenadine plasma or urine concentrations in a German Caucasian population. * A meta-analysis including 9 case-control stud...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Allopurinol</a>

        <div class='boxshow' id="show-disease-6039078024333398318" style="display: inline;"><a href="javascript:toggle2('disease-6039078024333398318')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-6039078024333398318" style="display: none;"><a href="javascript:toggle2('disease-6039078024333398318')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Allopurinol">Allopurinol</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3117583'>rs3117583</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs3117583(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFF3F3;'>77.9%</span><br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.0954016726309" style="display: inline;"><a href="javascript:toggle2('sec-0.0954016726309')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0954016726309" style="display: none;"><a href="javascript:toggle2('sec-0.0954016726309')">(hide)</a>
        <div class='rstext'>HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. 'In particular, three SNPs in the MHC class III region have P values &lt;10-7 (-log10 P value &gt; 7, Fig. 1). These SNPs were rs3117583 of BAT3 (encoding for HLA-B associated transcript 3), rs1150793 of MSH5 (encoding mutS homolog), and rs2855804 of MICB (encoding MHC class I polypeptide-related sequence).'</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:40|0|0">Amitriptyline</a>

        <div class='boxshow' id="show-disease-2255996137269908968" style="display: inline;"><a href="javascript:toggle2('disease-2255996137269908968')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-2255996137269908968" style="display: none;"><a href="javascript:toggle2('disease-2255996137269908968')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Amitriptyline">Amitriptyline</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.60296385217" style="display: inline;"><a href="javascript:toggle2('sec-0.60296385217')">...more...</a></div>
        <div class='boxrstext' id="sec-0.60296385217" style="display: none;"><a href="javascript:toggle2('sec-0.60296385217')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs12720067'>rs12720067</a><a href='http://www.snpedia.com/index.php/rs12720067(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.300430874824" style="display: inline;"><a href="javascript:toggle2('sec-0.300430874824')">...more...</a></div>
        <div class='boxrstext' id="sec-0.300430874824" style="display: none;"><a href="javascript:toggle2('sec-0.300430874824')">(hide)</a>
        <div class='rstext'>rs12720067 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs12720067 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are kn...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2235040'>rs2235040</a><a href='http://www.snpedia.com/index.php/rs2235040(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Magnitude: 1<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.716031939167" style="display: inline;"><a href="javascript:toggle2('sec-0.716031939167')">...more...</a></div>
        <div class='boxrstext' id="sec-0.716031939167" style="display: none;"><a href="javascript:toggle2('sec-0.716031939167')">(hide)</a>
        <div class='rstext'>rs2235040 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2235040 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7787082'>rs7787082</a><a href='http://www.snpedia.com/index.php/rs7787082(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCDCD;'>32.3%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.759748875886" style="display: inline;"><a href="javascript:toggle2('sec-0.759748875886')">...more...</a></div>
        <div class='boxrstext' id="sec-0.759748875886" style="display: none;"><a href="javascript:toggle2('sec-0.759748875886')">(hide)</a>
        <div class='rstext'>rs7787082 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs7787082 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|10|0">Amlodipine</a>

        <div class='boxshow' id="show-disease-1207201887806592592" style="display: inline;"><a href="javascript:toggle2('disease-1207201887806592592')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-1207201887806592592" style="display: none;"><a href="javascript:toggle2('disease-1207201887806592592')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Amlodipine">Amlodipine</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5065'>rs5065</a><a href='http://www.snpedia.com/index.php/rs5065(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC5C5;'>26.5%</span><br/>References:21<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal risk</div>
        <div class='boxshow' id="show-sec-0.220974754138" style="display: inline;"><a href="javascript:toggle2('sec-0.220974754138')">...more...</a></div>
        <div class='boxrstext' id="sec-0.220974754138" style="display: none;"><a href="javascript:toggle2('sec-0.220974754138')">(hide)</a>
        <div class='rstext'>rs5065, also known as T2238C, is a SNP in the atrial natriuretic precursor A NPPA gene. A large study has been conducted in which 42,418 hypertensive participants 55 or older were followed for several years while on one of four medications: a diuretic, a calcium antagonist, an angiotensin-converting enzyme inhibitor, or an alpha-blocker. The primary endpoint was either fatal heart disease or a heart attack. The blood pressure after six months of rs5065(G;G) patients (note: genotype is in dbSNP orientation, not as published) was lower if the patients were treated with diuretics compared to other medications, with smaller variation seen for (A;A) genotypes. The authors noted that none of the findings retained statistical significance after correction for multiple comparisons, but since the t...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3774426'>rs3774426</a><a href='http://www.snpedia.com/index.php/rs3774426(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD1D1;'>35.4%</span><br/>Repute:Good<br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>better response to certain calcium channel blockers</div>
        <div class='boxshow' id="show-sec-0.0807613524805" style="display: inline;"><a href="javascript:toggle2('sec-0.0807613524805')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0807613524805" style="display: none;"><a href="javascript:toggle2('sec-0.0807613524805')">(hide)</a>
        <div class='rstext'>rs3774426 is a SNP in the calcium channel, voltage-dependent, L type, alpha 1D subunit CACNA1D gene. A study of 161 Japanese patients (85 men, 76 women) being treated for hypertension with L-type dCCBs (calcium channel blockers) concluded that individuals with rs3774426(C;C) genotypes responded better, as measured by lowered systolic and diastolic blood pressure readings.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs312481'>rs312481</a><a href='http://www.snpedia.com/index.php/rs312481(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFE2E2;'>54.0%</span><br/>Repute:Good<br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>better response to certain calcium channel blockers</div>
        <div class='boxshow' id="show-sec-0.0394550226162" style="display: inline;"><a href="javascript:toggle2('sec-0.0394550226162')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0394550226162" style="display: none;"><a href="javascript:toggle2('sec-0.0394550226162')">(hide)</a>
        <div class='rstext'>rs312481 is a SNP in the calcium channel, voltage-dependent, L type, alpha 1D subunit CACNA1D gene. A study of 161 Japanese patients (85 men, 76 women) being treated for hypertension with L-type dCCBs (calcium channel blockers) concluded that individuals with rs312481(C;C) genotypes responded better, as measured by lowered systolic and diastolic blood pressure readings.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Anafranil</a>

        <div class='boxshow' id="show-disease1276768011606429481" style="display: inline;"><a href="javascript:toggle2('disease1276768011606429481')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease1276768011606429481" style="display: none;"><a href="javascript:toggle2('disease1276768011606429481')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Anafranil">Anafranil</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.299507700584" style="display: inline;"><a href="javascript:toggle2('sec-0.299507700584')">...more...</a></div>
        <div class='boxrstext' id="sec-0.299507700584" style="display: none;"><a href="javascript:toggle2('sec-0.299507700584')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:60|10|20">Antidepressants</a>

        <div class='boxshow' id="show-disease-1345160398688564353" style="display: inline;"><a href="javascript:toggle2('disease-1345160398688564353')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-1345160398688564353" style="display: none;"><a href="javascript:toggle2('disease-1345160398688564353')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Antidepressants">Antidepressants</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1360780'>rs1360780</a><a href='http://www.snpedia.com/index.php/rs1360780(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 2.1<br/>Frequency: <span style='background-color: #FF9696;'>6.2%</span><br/>Repute:Bad<br/>References:39<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>1.3x increased risk for depression</div>
        <div class='boxshow' id="show-sec-0.232053815684" style="display: inline;"><a href="javascript:toggle2('sec-0.232053815684')">...more...</a></div>
        <div class='boxrstext' id="sec-0.232053815684" style="display: none;"><a href="javascript:toggle2('sec-0.232053815684')">(hide)</a>
        <div class='rstext'>In Caucasian non-Hispanics, the rs1360780(T) allele is associated with increased risk for depression, with an odds ratio of 1.39 (CI: 1.14-1.70, p=0.046). This same SNP, which is in the FKBP5 gene, may influence how patients respond to antidepressants including citalopram. rs1360780(T;T) homozgyotes tend to report more depressive episodes, but they also respond better to treatment with antidepressants. rs9296158 rs3800373 rs1360780 rs9470080 linked with the severity of child abuse to predict level of adult PTSD symptoms after correcting for multiple testing.  [PharmGKB:Curated This variant is associated with higher chance of response to anti-depressant drugs.] [OMIM:FK506-BINDING PROTEIN 5; FKBP5]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.7447812189" style="display: inline;"><a href="javascript:toggle2('sec-0.7447812189')">...more...</a></div>
        <div class='boxrstext' id="sec-0.7447812189" style="display: none;"><a href="javascript:toggle2('sec-0.7447812189')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs12720067'>rs12720067</a><a href='http://www.snpedia.com/index.php/rs12720067(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.385012705788" style="display: inline;"><a href="javascript:toggle2('sec-0.385012705788')">...more...</a></div>
        <div class='boxrstext' id="sec-0.385012705788" style="display: none;"><a href="javascript:toggle2('sec-0.385012705788')">(hide)</a>
        <div class='rstext'>rs12720067 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs12720067 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are kn...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2235040'>rs2235040</a><a href='http://www.snpedia.com/index.php/rs2235040(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Magnitude: 1<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.646759316674" style="display: inline;"><a href="javascript:toggle2('sec-0.646759316674')">...more...</a></div>
        <div class='boxrstext' id="sec-0.646759316674" style="display: none;"><a href="javascript:toggle2('sec-0.646759316674')">(hide)</a>
        <div class='rstext'>rs2235040 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2235040 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7787082'>rs7787082</a><a href='http://www.snpedia.com/index.php/rs7787082(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCDCD;'>32.3%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.0842370677554" style="display: inline;"><a href="javascript:toggle2('sec-0.0842370677554')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0842370677554" style="display: none;"><a href="javascript:toggle2('sec-0.0842370677554')">(hide)</a>
        <div class='rstext'>rs7787082 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs7787082 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7997012'>rs7997012</a><a href='http://www.snpedia.com/index.php/rs7997012(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD4D4;'>38.7%</span><br/>Repute:Bad<br/>References:22<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>~18% less likely to respond to citalopram</div>
        <div class='boxshow' id="show-sec-0.0325641281079" style="display: inline;"><a href="javascript:toggle2('sec-0.0325641281079')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0325641281079" style="display: none;"><a href="javascript:toggle2('sec-0.0325641281079')">(hide)</a>
        <div class='rstext'>rs7997012, located in an intron of the HTR2A gene, was found to be associated with a somewhat increased rate of successful response to treatment of depression with the drug citalopram. From this article : 'HTR2A encodes the serotonin 2A receptor, which is downregulated by citalopram. Participants who were homozygous for the A allele had an 18% reduction in absolute risk of having no response to treatment, compared with those homozygous for the other allele.' * See also Anxiety Blog posting  [PharmGKB:Curated Risk or phenotype-associated allele: A. Phenotype: Patients with the 5-HTR2A intron 2 (rs7997012) AA genotype suffered from more pronounced side effects compared to carriers of the GA or GG genotype. Study size: 124. Study population/ethnicity: Caucasian; Patients with psychiatric diso...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1532701'>rs1532701</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1532701(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFE1E1;'>53.1%</span><br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.31185477342" style="display: inline;"><a href="javascript:toggle2('sec-0.31185477342')">...more...</a></div>
        <div class='boxrstext' id="sec-0.31185477342" style="display: none;"><a href="javascript:toggle2('sec-0.31185477342')">(hide)</a>
        <div class='rstext'>Trajectories of change in depression severity during treatment with antidepressants. Pharmacogenomics of antidepressant drugs.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs908867'>rs908867</a><a href='http://www.snpedia.com/index.php/rs908867(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF1F1;'>76.1%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.655537290191" style="display: inline;"><a href="javascript:toggle2('sec-0.655537290191')">...more...</a></div>
        <div class='boxrstext' id="sec-0.655537290191" style="display: none;"><a href="javascript:toggle2('sec-0.655537290191')">(hide)</a>
        <div class='rstext'>rs908867 is a SNP near the brain-derived neurotrophic factor BDNF gene. In a study of , the rs908867 was associated with antidepressant response, with heterozygote carriers showing a better response than homozygotes. However, a critique of this study was published , indicating that this finding should be viewed as preliminary until more research is conducted for several reasons, to wit, 'First, the study included not only major depression but also bipolar disorder patients; second, various antidepressants were used in this study, which could affect patients' responses; third, the frequency of the haplotype associated with treatment response is rare; and fourth, previous studies of the effects of single BDNF polymorphisms on antidepressant action have reported conflicting findings.' A brain...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.237380770742" style="display: inline;"><a href="javascript:toggle2('sec-0.237380770742')">...more...</a></div>
        <div class='boxrstext' id="sec-0.237380770742" style="display: none;"><a href="javascript:toggle2('sec-0.237380770742')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">9 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:43|37|18">Aspirin</a>

        <div class='boxshow' id="show-disease1920194393697703455" style="display: inline;"><a href="javascript:toggle2('disease1920194393697703455')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease1920194393697703455" style="display: none;"><a href="javascript:toggle2('disease1920194393697703455')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Aspirin">Aspirin</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6983267'>rs6983267</a><a href='http://www.snpedia.com/index.php/rs6983267(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 3.2<br/>Frequency: <span style='background-color: #FFBDBD;'>21.2%</span><br/>Repute:Bad<br/>References:148<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>1.6x increased risk for prostate cancer; also other cancers  1.4 times as likely to develop colorectal cancer</div>
        <div class='boxshow' id="show-sec-0.547844297044" style="display: inline;"><a href="javascript:toggle2('sec-0.547844297044')">...more...</a></div>
        <div class='boxrstext' id="sec-0.547844297044" style="display: none;"><a href="javascript:toggle2('sec-0.547844297044')">(hide)</a>
        <div class='rstext'>rs6983267 is a SNP on chromosome 8q24, associated with increased risk for several cancers, particularly prostate cancer. In studies dividing the 8q24 region, this SNP falls in region 3. This SNP has also been reported to influence the cancer-risk-decreasing effect of aspirin. In a study of over 3,600 Caucasians with prostate cancer, rs6983267 is one of five SNPs used (with family history as a sixth factor) to cumulatively predict overall risk. On their own, the rs6983267(G;G) and (G;T) risk genotypes yield an odds ratio for developing prostate cancer of 1.37 (CI: 1.18-1.59, p=3.4-10e-5) and may account for 22.2% of population attributable risk. The increased risk of developing prostate cancer associated with rs6983267 now appears to be independent of the risk associated with its close neig...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>


  <div id="gs161"  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs161'>gs161</a></div></div>
        <div class='boxmag'>Magnitude: 2.5</div>
        <div class='boxrep'></div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>CYP2C9 Intermediate Metabolizers</div>
        <div class='gsboxeffect'>CYP2C9 intermediate metabolizers are 30% of the population. May require slightly different dosages for drugs such as tamoxifen, warfarin, fluvastin, and many nonsteroidal anti-inflammatory agents such as aspirin, ibuprofen and naproxen.</div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5918'>rs5918</a><a href='http://www.snpedia.com/index.php/rs5918(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FF7777;'>1.8%</span><br/>Repute:Bad<br/>References:26<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>MI risk, aspirin resistance  23andMe blog lower odds of early stent thrombosis</div>
        <div class='boxshow' id="show-sec-0.53753534954" style="display: inline;"><a href="javascript:toggle2('sec-0.53753534954')">...more...</a></div>
        <div class='boxrstext' id="sec-0.53753534954" style="display: none;"><a href="javascript:toggle2('sec-0.53753534954')">(hide)</a>
        <div class='rstext'>The 'A2' allele of the platelet specific alloantigen system is encoded by rs5918(C), and it has been implicated as increasing the risk of myocardial infarctions, heart disease, and resistance to blood-thinning benefits of aspirin. On its own, the A2 allele is implicated especially in early onset heart disease ; in combination with the 4G allele of the PAI1 gene, rs1799889, the increased risk of myocardial infarction in a Finnish study population was 4 fold higher (odds ratio = 4.5, p=0.001), particularly in males (odds ratio = 6.4, p=0.0005) . Olympic skater Sergei Grinkov, who had this risk factor, died of a heart attack at age 28. A2 allele carriers also appear to be relatively resistant to the anti-thrombotic (i.e. anti-clotting) actions normally associated with aspirin] use. A protecti...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3842787'>rs3842787</a><a href='http://www.snpedia.com/index.php/rs3842787(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFB3B3;'>15.9%</span><br/>Repute:Bad<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Higher risk of bleeding during coronary angiography</div>
        <div class='boxshow' id="show-sec-0.436242640256" style="display: inline;"><a href="javascript:toggle2('sec-0.436242640256')">...more...</a></div>
        <div class='boxrstext' id="sec-0.436242640256" style="display: none;"><a href="javascript:toggle2('sec-0.436242640256')">(hide)</a>
        <div class='rstext'>rs3842787, also known as 50C&gt;T, is a SNP in the signal peptide region of the cyclooxygenase-1 PTGS1 gene. A study of 696 European patients undergoing elective diagnostic coronary angiographies (CAGs) because of suspected or proven stable coronary artery disease found that 23 experienced bleeding, perhaps the most common complication of this type of invasive coronary procedure. After controlling for various variables (especially gender), two co-inherited SNPs, rs10306114 and rs3842787, were found to be associated with higher risk for bleeding in otherwise low risk patients who (i) did undergo percutaneous coronary intervention and (ii) did not take clopidogrel. Having the less common haplotype (rs10306114(G) and/or rs3842787(T)) increases the bleeding risk upon CAG ~12 fold (p = 0.012). ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4794067'>rs4794067</a><a href='http://www.snpedia.com/index.php/rs4794067(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFD4D4;'>38.9%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>2.1x risk for Aspirin Induced Asthma. But possibly lower risk of intractible Grave's disease.  Only tested in Japanese people. Might not be true for other races. May also be slightly protective against lupus (in Chinese people).</div>
        <div class='boxshow' id="show-sec-0.585629815144" style="display: inline;"><a href="javascript:toggle2('sec-0.585629815144')">...more...</a></div>
        <div class='boxrstext' id="sec-0.585629815144" style="display: none;"><a href="javascript:toggle2('sec-0.585629815144')">(hide)</a>
        <div class='rstext'>rs4794067(C;C) and rs4794067(C;T) genotypes for the TBX21 gene are calculated to be at 2.15 fold higher risk (CI: 1.26-3.64) for aspirin-induced asthma (AIA) compared to rs4794067(T;T) homozygotes, based on a study of 72 patients vs 640 controls in a study of a Japanese population. Note that in this population, but perhaps not others, linkage disequilibrium exists between this SNP located upstream of the gene, rs4794067, and a common synonymous SNP located in the first exon, rs2074190, with a predictive accuracy of 92%. On the other hand, rs4794067(C;C) may greatly decrease the risk of lupus if rs17250932(C;C) is also present (at least in Chinese people). And those 2 SNPs also reduce the risk of intractable Graves' disease (at least in Japanese people).</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1799853'>rs1799853</a><a href='http://www.snpedia.com/index.php/rs1799853(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFB9B9;'>19.0%</span><br/>References:22<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>CYP2C9*2 carrier; average 20% reduction in warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.96387733961" style="display: inline;"><a href="javascript:toggle2('sec-0.96387733961')">...more...</a></div>
        <div class='boxrstext' id="sec-0.96387733961" style="display: none;"><a href="javascript:toggle2('sec-0.96387733961')">(hide)</a>
        <div class='rstext'>rs1799853 is a SNP in the CYP2C9 gene and is linked to poor warfarin metabolism. Advanced knowledge of this may influence initial warfarin dosing by physicians. Warfarin is monitored through INR (international normalized ratio) and proper dosing is influenced by a variety of factors including warfarin metabolism and diet. rs1799853 is a SNP in the CYP2C9 gene. The rs1799853(T) allele encodes a variant amino acid, cysteine, which has been linked to poor metabolism of warfarin and thus sensitivity . The common nomenclature for this polymorphism is CYP2C9*2 (Cys amino acid, T allele; the SNP is also known as C430T or Cys144Arg). The CYP2C9*2 allele is also associated with higher sensitivity to the anti-epileptic drug phenytoin. The effect of CYP2C9 variants on drug metabolism should not be pr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2070959'>rs2070959</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs2070959(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDADA;'>45.1%</span><br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.914573254643" style="display: inline;"><a href="javascript:toggle2('sec-0.914573254643')">...more...</a></div>
        <div class='boxrstext' id="sec-0.914573254643" style="display: none;"><a href="javascript:toggle2('sec-0.914573254643')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1105879'>rs1105879</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1105879(G;T)'>(G;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDBDB;'>45.5%</span><br/>References:9<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.937928640715" style="display: inline;"><a href="javascript:toggle2('sec-0.937928640715')">...more...</a></div>
        <div class='boxrstext' id="sec-0.937928640715" style="display: none;"><a href="javascript:toggle2('sec-0.937928640715')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6759892'>rs6759892</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs6759892(G;T)'>(G;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFE2E2;'>54.0%</span><br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.569412999167" style="display: inline;"><a href="javascript:toggle2('sec-0.569412999167')">...more...</a></div>
        <div class='boxrstext' id="sec-0.569412999167" style="display: none;"><a href="javascript:toggle2('sec-0.569412999167')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1057910'>rs1057910</a><a href='http://www.snpedia.com/index.php/rs1057910(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0.1<br/>Frequency: <span style='background-color: #FFF9F9;'>88.5%</span><br/>Repute:Good<br/>References:65<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal; no effect on warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.0872080388982" style="display: inline;"><a href="javascript:toggle2('sec-0.0872080388982')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0872080388982" style="display: none;"><a href="javascript:toggle2('sec-0.0872080388982')">(hide)</a>
        <div class='rstext'>SNP rs1057910(A), located in the cytochrome p450 CYP2C9 gene, most commonly encodes the amino acid isoleucine at position 359, and the resulting allele is also known as CYP2C9*1. rs1057910(C) encodes a leucine at this same position, and the resulting allele is called CYP2C9*3. This SNP is also known as Ile359Leu or A1075C. The effect of CYP2C9 variants on drug metabolism should not be predicted without also considering CYP2C9*2, defined as the common loss of function variant rs1799853(T) (NM_000771:c.430C&gt;T, NP_000762:p.144R&gt;C) Studies of the effects of these alleles include: * rs1057910(C;C)] genotypes may clear drugs like celecoxib (trade name Celebrex) twice as slowly as rs1057910(A;A) genotypes; the rs1057910(A;C) genotypes are in-between clearance rates. Lower clearance rates wi...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs9332131'>rs9332131</a><a href='http://www.snpedia.com/index.php/rs9332131(I;I)'>(I;I)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:5<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.421339932752" style="display: inline;"><a href="javascript:toggle2('sec-0.421339932752')">...more...</a></div>
        <div class='boxrstext' id="sec-0.421339932752" style="display: none;"><a href="javascript:toggle2('sec-0.421339932752')">(hide)</a>
        <div class='rstext'>rs9332131, also known as 818delA, 10601delA or 273Frame shift, is a SNP in the CYP2C9 gene. The rs9332131(-) allele defines the CYP2C9*6 variant, which is inactive.  [PharmGKB:Curated Phenotype: In African Americans patients, weekly warfarin dose requirements were lower in those with the CYP2C9*8 allele (34 (30-47) mg; P = 0.023) and the CYP2C9 *2, *3, *5, *6, or *11 allele (33(28-40 mg); P &lt; 0.001) as compared with those with the CYP2C9*1/*1 genotype (43 (35-56) mg). Adding the *5,*6,*8 and *11 alleles to a model containing the *2 and *3 alleles plus the VKORC1 -1639 G&gt;A allele (along with clinical variables) explained 36% vs. 30% of the variability in dose requirements. Study size: 226 . Study population/ethnicity: African-American . Type of association: PD;GN;CO]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5789'>rs5789</a><a href='http://www.snpedia.com/index.php/rs5789(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFBFB;'>93.8%</span><br/>Repute:Good<br/>References:6<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.672987197226" style="display: inline;"><a href="javascript:toggle2('sec-0.672987197226')">...more...</a></div>
        <div class='boxrstext' id="sec-0.672987197226" style="display: none;"><a href="javascript:toggle2('sec-0.672987197226')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3798220'>rs3798220</a><a href='http://www.snpedia.com/index.php/rs3798220(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFFFF;'>100.0%</span><br/>Repute:Good<br/>References:20<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.94826469076" style="display: inline;"><a href="javascript:toggle2('sec-0.94826469076')">...more...</a></div>
        <div class='boxrstext' id="sec-0.94826469076" style="display: none;"><a href="javascript:toggle2('sec-0.94826469076')">(hide)</a>
        <div class='rstext'>rs3798220, also known as I4399M or Ile4399Met, is a SNP in the apolipoprotein(A) LPA gene that has been reported to be associated with elevated plasma lipoprotein(a) [Lp(a)] and increased cardiovascular risk, and in particular, coronary artery disease. In one study, 25,131 initially healthy Caucasian participants in the Women's Health Study were followed for ~10 years. rs3798220(C) allele carriers (3.7%) in the placebo (i.e. not receiving aspirin) group had a 2x higher risk of major cardiovascular events than non-carriers (age-adjusted hazard ratio (HR) of 2.21, CI: 1.39-3.52). Among rs3798220(C) carriers, the risk was reduced more than twofold by aspirin: for aspirin compared with placebo the age-adjusted HR was 0.44 (CI: 0.20-0.94). The risk was not significantly reduced among non-carrie...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3842792'>rs3842792</a><a href='http://www.snpedia.com/index.php/rs3842792(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFFFF;'>100.0%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.175586546851" style="display: inline;"><a href="javascript:toggle2('sec-0.175586546851')">...more...</a></div>
        <div class='boxrstext' id="sec-0.175586546851" style="display: none;"><a href="javascript:toggle2('sec-0.175586546851')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs28371685'>rs28371685</a><a href='http://www.snpedia.com/index.php/rs28371685(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:5<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.796419958884" style="display: inline;"><a href="javascript:toggle2('sec-0.796419958884')">...more...</a></div>
        <div class='boxrstext' id="sec-0.796419958884" style="display: none;"><a href="javascript:toggle2('sec-0.796419958884')">(hide)</a>
        <div class='rstext'>rs28371685, also known as 1003C&gt;T, 42542C&gt;T or R335W is a SNP in the CYP2C9 gene. The rs28371685(T) allele defines the CYP2C9*11 variant, which has decreased activity. According to a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504.  [PharmGKB:Curated Phenotype: In African Americans patients, weekly warfarin dose requirements were lower in those with the CYP2C9*8 allele (34 (30-47) mg; P = 0.023) and the CYP2C9 *2, *3, *5, *6, or *11 allele (33(28-40 mg); P &lt; 0.001) as compared with those with the CYP2C9*1/*1 genotype (43 (35-56) mg). Adding the *5,*6,*8 and *11 alleles to a...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs28371686'>rs28371686</a><a href='http://www.snpedia.com/index.php/rs28371686(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:5<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal  common for Caucasians on the 23andme platform</div>
        <div class='boxshow' id="show-sec-0.0554234062734" style="display: inline;"><a href="javascript:toggle2('sec-0.0554234062734')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0554234062734" style="display: none;"><a href="javascript:toggle2('sec-0.0554234062734')">(hide)</a>
        <div class='rstext'>rs28371686, also known as 1080C&gt;G, 42619C&gt;G or D360E, is a SNP in the CYP2C9 gene. The rs28371686(G) allele defines the CYP2C9*5 variant, which appears to have decreased activity.  [PharmGKB:Curated Phenotype: In African Americans patients, weekly warfarin dose requirements were lower in those with the CYP2C9*8 allele (34 (30-47) mg; P = 0.023) and the CYP2C9 *2, *3, *5, *6, or *11 allele (33(28-40 mg); P &lt; 0.001) as compared with those with the CYP2C9*1/*1 genotype (43 (35-56) mg). Adding the *5,*6,*8 and *11 alleles to a model containing the *2 and *3 alleles plus the VKORC1 -1639 G&gt;A allele (along with clinical variables) explained 36% vs. 30% of the variability in dose requirements. Study size: 226 . Study population/ethnicity: African-American . Type of association: PD;GN;...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 genoset 15 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|20|0">Atomoxetine</a>

        <div class='boxshow' id="show-disease-3915863198216828342" style="display: inline;"><a href="javascript:toggle2('disease-3915863198216828342')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-3915863198216828342" style="display: none;"><a href="javascript:toggle2('disease-3915863198216828342')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Atomoxetine">Atomoxetine</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1566652'>rs1566652</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1566652(G;T)'>(G;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDADA;'>45.1%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.0360122972965" style="display: inline;"><a href="javascript:toggle2('sec-0.0360122972965')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0360122972965" style="display: none;"><a href="javascript:toggle2('sec-0.0360122972965')">(hide)</a>
        <div class='rstext'>G allele associated with better response to treatment of ADHD with atomoxetine.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5568'>rs5568</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs5568(A;C)'>(A;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDADA;'>45.1%</span><br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.702262353133" style="display: inline;"><a href="javascript:toggle2('sec-0.702262353133')">...more...</a></div>
        <div class='boxrstext' id="sec-0.702262353133" style="display: none;"><a href="javascript:toggle2('sec-0.702262353133')">(hide)</a>
        <div class='rstext'>A allele associated with better response to treatment of ADHD with atomoxetine.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs734980'>rs734980</a><a href='http://www.snpedia.com/index.php/rs734980(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEDED;'>69.0%</span><br/>Repute:Good<br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.516822134895" style="display: inline;"><a href="javascript:toggle2('sec-0.516822134895')">...more...</a></div>
        <div class='boxrstext' id="sec-0.516822134895" style="display: none;"><a href="javascript:toggle2('sec-0.516822134895')">(hide)</a>
        <div class='rstext'>G allele associated with better response to treatment of ADHD with atomoxetine.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3785152'>rs3785152</a><a href='http://www.snpedia.com/index.php/rs3785152(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF7F7;'>85.8%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.210930377716" style="display: inline;"><a href="javascript:toggle2('sec-0.210930377716')">...more...</a></div>
        <div class='boxrstext' id="sec-0.210930377716" style="display: none;"><a href="javascript:toggle2('sec-0.210930377716')">(hide)</a>
        <div class='rstext'>T allele associated with better response to treatment of ADHD with atomoxetine.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1065852'>rs1065852</a><a href='http://www.snpedia.com/index.php/rs1065852(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.031146110769" style="display: inline;"><a href="javascript:toggle2('sec-0.031146110769')">...more...</a></div>
        <div class='boxrstext' id="sec-0.031146110769" style="display: none;"><a href="javascript:toggle2('sec-0.031146110769')">(hide)</a>
        <div class='rstext'>The wild type (normal) allele at this SNP is (C). The (T) variant indicates the presence of a non-wild type CYP2D6 variant, but it appears in many different variants so it can not be used to determine the presence of any particular variant. The most common variants it appears in are CYP2D6*10 and CYP2D6*4, but these are not the only ones. While this is the defining mutation for CYP2D6*10, it is not possible by itself for this mutation to determine a particular variant. In addition, the CYP2D6*4 variant includes this mutation, but the defining mutation 1846G&gt;A SNP is not available in the common direct to consumer testing services. While it is not possible for this mutation to identify one particular variant, all the variants in which it appears have reduced or no CYP2D6 activity. If two ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">5 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Atorvastatin</a>

        <div class='boxshow' id="show-disease-6404456171598810888" style="display: inline;"><a href="javascript:toggle2('disease-6404456171598810888')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-6404456171598810888" style="display: none;"><a href="javascript:toggle2('disease-6404456171598810888')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Atorvastatin">Atorvastatin</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs20455'>rs20455</a><a href='http://www.snpedia.com/index.php/rs20455(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD3D3;'>37.2%</span><br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.768034802822" style="display: inline;"><a href="javascript:toggle2('sec-0.768034802822')">...more...</a></div>
        <div class='boxrstext' id="sec-0.768034802822" style="display: none;"><a href="javascript:toggle2('sec-0.768034802822')">(hide)</a>
        <div class='rstext'>rs20455, often called Arg719 or 719Arg, is a reasonably well studied SNP in the KIF6 gene. The risk allele (encoding the arginine at position 719) is rs20455(C). An extensive 2010 meta-analysis, including over 17,000 patients, suggests this variant does not significantly influence coronary artery disease risk. This SNP is one of the 5 used by Celera's genetic risk score (GRS) for coronary heart disease (CHD). *rs20455, in the KIF6 gene *rs3900940, in the MYH15 gene *rs7439293, in the PALLD gene *rs2298566, in the SNX19 gene *rs1010, in the VAMP8 gene For each of the five variants, the GRS was increased by 1 if the subject was homozygous for the risk variant, unchanged if heterozygous, and decreased by 1 if the individual did not carry the variant. Therefore, individuals carrying all 10 pos...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Aventyl</a>

        <div class='boxshow' id="show-disease5468588504915792708" style="display: inline;"><a href="javascript:toggle2('disease5468588504915792708')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease5468588504915792708" style="display: none;"><a href="javascript:toggle2('disease5468588504915792708')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Aventyl">Aventyl</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.898282385501" style="display: inline;"><a href="javascript:toggle2('sec-0.898282385501')">...more...</a></div>
        <div class='boxrstext' id="sec-0.898282385501" style="display: none;"><a href="javascript:toggle2('sec-0.898282385501')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:40|0|0">Azathioprine</a>

        <div class='boxshow' id="show-disease-7571916016641701406" style="display: inline;"><a href="javascript:toggle2('disease-7571916016641701406')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-7571916016641701406" style="display: none;"><a href="javascript:toggle2('disease-7571916016641701406')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Azathioprine">Azathioprine</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1142345'>rs1142345</a><a href='http://www.snpedia.com/index.php/rs1142345(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFCFC;'>94.7%</span><br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in clinvar</div>
        <div class='boxshow' id="show-sec-0.539116494412" style="display: inline;"><a href="javascript:toggle2('sec-0.539116494412')">...more...</a></div>
        <div class='boxrstext' id="sec-0.539116494412" style="display: none;"><a href="javascript:toggle2('sec-0.539116494412')">(hide)</a>
        <div class='rstext'>rs1142345 is a SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs. In general, individuals must have two nonfunctioning TPMT alleles for the toxicity to be pronounced. The risk allele for this SNP is rs1142345(G), and when it is the only variant in the TPMT gene, it encodes the TPMT*3C allele. While still rare, it is more common in African-Americans (2.4% of all alleles) than in Caucasians. Note that if the same allele also carries the rs1800460(A) SNP, the allele is actually a TPMT*3A allele (OMIM). The medicine 6-Mercaptopurine is metabolized by TPMT. Individual differences in TPMT activity associated with this SNP are now used to determine appropriate dosage range and interval for treatment. 23an...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1800584'>rs1800584</a><a href='http://www.snpedia.com/index.php/rs1800584(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFEFE;'>98.2%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.310239775783" style="display: inline;"><a href="javascript:toggle2('sec-0.310239775783')">...more...</a></div>
        <div class='boxrstext' id="sec-0.310239775783" style="display: none;"><a href="javascript:toggle2('sec-0.310239775783')">(hide)</a>
        <div class='rstext'>rs1800584 is a rare SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs. In general, individuals must have two nonfunctioning TPMT alleles for the toxicity to be pronounced. The rs1800584(A) SNP defines the TPMT*4A allele (OMIM). wikipedia thiopurine drugs metabolized by TPMT include azathioprine, mercaptopurine, and thioguanine  [PharmGKB:In-Depth This splicing variant results in very low TPMT activity and risk for hematologic toxicity as a result of treatment with thiopurines.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1800460'>rs1800460</a><a href='http://www.snpedia.com/index.php/rs1800460(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.803138637838" style="display: inline;"><a href="javascript:toggle2('sec-0.803138637838')">...more...</a></div>
        <div class='boxrstext' id="sec-0.803138637838" style="display: none;"><a href="javascript:toggle2('sec-0.803138637838')">(hide)</a>
        <div class='rstext'>rs1800460 is a SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs. In general, individuals must have two nonfunctioning TPMT alleles for the toxicity to be pronounced. The risk allele for this SNP is rs1800460(A), and when it is the only variation in the TPMT gene, it encodes the TPMT*3B allele. While still rare, it is more common in Caucasians (4.5% of all alleles) than in African-Americans (0.8%). Note that if the same allele also carries the rs1142345(G) SNP, the allele is actually a TPMT*3A allele (OMIM). The medicine 6-Mercaptopurine is metabolized by TPMT. Individual differences in TPMT activity associated with this SNP are now used to determine appropriate dosage range and interval for treatm...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1800462'>rs1800462</a><a href='http://www.snpedia.com/index.php/rs1800462(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:8<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal for 23andMe  appears common for 23andMe users</div>
        <div class='boxshow' id="show-sec-0.923851354195" style="display: inline;"><a href="javascript:toggle2('sec-0.923851354195')">...more...</a></div>
        <div class='boxrstext' id="sec-0.923851354195" style="display: none;"><a href="javascript:toggle2('sec-0.923851354195')">(hide)</a>
        <div class='rstext'>rs1800462, also known as A80P, is a rare SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs. In general, individuals must have two nonfunctioning TPMT alleles for the toxicity to be pronounced. The risk allele for this SNP (in orientation to the dbSNP entry) is rs1800462(C), and it encodes the TPMT*2 allele. It may occur at a frequency of 1 in 200 alleles among Caucasians. wikipedia thiopurine drugs metabolized by TPMT include azathioprine, mercaptopurine, and thioguanine  [PharmGKB:In-Depth The TPMT:238G&gt;C SNP was cloned from a patient with severe mercaptopurine toxicity. It results in a non-synonymous protein change TPMT:Ala80Pro that has a 100-fold reduction in catalytic activity compared to w...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|10|0">Beta blocker</a>

        <div class='boxshow' id="show-disease-6729566028159086868" style="display: inline;"><a href="javascript:toggle2('disease-6729566028159086868')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-6729566028159086868" style="display: none;"><a href="javascript:toggle2('disease-6729566028159086868')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Beta%20blocker">Beta blocker</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801253'>rs1801253</a><a href='http://www.snpedia.com/index.php/rs1801253(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 1.1<br/>Frequency: <span style='background-color: #F0D4F0;'>50.8%</span><br/>References:28<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>responds well to bucindolol; may also depend on rs1801252</div>
        <div class='boxshow' id="show-sec-0.263180732348" style="display: inline;"><a href="javascript:toggle2('sec-0.263180732348')">...more...</a></div>
        <div class='boxrstext' id="sec-0.263180732348" style="display: none;"><a href="javascript:toggle2('sec-0.263180732348')">(hide)</a>
        <div class='rstext'>Also known as Arg389, variation at this SNP, located in the ADRB1 gene, may encode either the amino acid glycine or arginine at amino acid position 389 of the corresponding protein, the beta-1 adrenergic receptor (hence why it is frequently called Arg389Gly). This protein is the target of beta blocker drugs, and so how well the drug works to help lower a patients high blood pressure depends in part on this SNP. The status of this SNP is often reported together with the status of SNP rs1801252, which encodes an amino acid variant at position 49 of the same (ADRB1) protein. The rs1801253(G) allele encodes the glycine. One of the best known studies of the effects of these 2 separate SNPs on the average efficacy of the beta blocker metoprolol in lowering blood pressure (BP) can be summarized f...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.547138177191" style="display: inline;"><a href="javascript:toggle2('sec-0.547138177191')">...more...</a></div>
        <div class='boxrstext' id="sec-0.547138177191" style="display: none;"><a href="javascript:toggle2('sec-0.547138177191')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Bleomycin</a>

        <div class='boxshow' id="show-disease7022538026382611491" style="display: inline;"><a href="javascript:toggle2('disease7022538026382611491')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease7022538026382611491" style="display: none;"><a href="javascript:toggle2('disease7022538026382611491')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Bleomycin">Bleomycin</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1050565'>rs1050565</a><a href='http://www.snpedia.com/index.php/rs1050565(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFDDDD;'>47.8%</span><br/>References:5<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.211758461001" style="display: inline;"><a href="javascript:toggle2('sec-0.211758461001')">...more...</a></div>
        <div class='boxrstext' id="sec-0.211758461001" style="display: none;"><a href="javascript:toggle2('sec-0.211758461001')">(hide)</a>
        <div class='rstext'>Testicular cancer patients may be treated with bleomycin, a cytotoxic drug that is essential component of chemotherapy regimens for this cancer, officially known as disseminated testicular germ-cell cancer (TC). rs1050565 is a SNP in the BLMH gene. This gene encodes a protein that can inactivate bleomycin. Based on a study of 300 TC patients treated with bleomycin, a testicular cancer patient with a rs1050565(G;G) genotype has an odds ratio of 4.97 (CI: 2.17 - 11.39) for TC-related death compared to (A;G) or (A;A) genotypes. The rs1050565(G;G) genotype also shows a higher prevalence of early relapses.  [PharmGKB:Curated Testicular germ cell cancer patients carrying the homozygous G/G allele of this variant showed reduced survival and higher prevalence of early relapses after treatment with...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Bucindolol</a>

        <div class='boxshow' id="show-disease-4702859872857996265" style="display: inline;"><a href="javascript:toggle2('disease-4702859872857996265')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-4702859872857996265" style="display: none;"><a href="javascript:toggle2('disease-4702859872857996265')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Bucindolol">Bucindolol</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801253'>rs1801253</a><a href='http://www.snpedia.com/index.php/rs1801253(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 1.1<br/>Frequency: <span style='background-color: #F0D4F0;'>50.8%</span><br/>References:28<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>responds well to bucindolol; may also depend on rs1801252</div>
        <div class='boxshow' id="show-sec-0.436887947679" style="display: inline;"><a href="javascript:toggle2('sec-0.436887947679')">...more...</a></div>
        <div class='boxrstext' id="sec-0.436887947679" style="display: none;"><a href="javascript:toggle2('sec-0.436887947679')">(hide)</a>
        <div class='rstext'>Also known as Arg389, variation at this SNP, located in the ADRB1 gene, may encode either the amino acid glycine or arginine at amino acid position 389 of the corresponding protein, the beta-1 adrenergic receptor (hence why it is frequently called Arg389Gly). This protein is the target of beta blocker drugs, and so how well the drug works to help lower a patients high blood pressure depends in part on this SNP. The status of this SNP is often reported together with the status of SNP rs1801252, which encodes an amino acid variant at position 49 of the same (ADRB1) protein. The rs1801253(G) allele encodes the glycine. One of the best known studies of the effects of these 2 separate SNPs on the average efficacy of the beta blocker metoprolol in lowering blood pressure (BP) can be summarized f...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|10|0">Budesonide</a>

        <div class='boxshow' id="show-disease-3641203478756911576" style="display: inline;"><a href="javascript:toggle2('disease-3641203478756911576')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-3641203478756911576" style="display: none;"><a href="javascript:toggle2('disease-3641203478756911576')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Budesonide">Budesonide</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2240017'>rs2240017</a><a href='http://www.snpedia.com/index.php/rs2240017(C;G)'>(C;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FF0A0A;'>0.0%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>respond better to steroids</div>
        <div class='boxshow' id="show-sec-0.713593829721" style="display: inline;"><a href="javascript:toggle2('sec-0.713593829721')">...more...</a></div>
        <div class='boxrstext' id="sec-0.713593829721" style="display: none;"><a href="javascript:toggle2('sec-0.713593829721')">(hide)</a>
        <div class='rstext'>This SNP encodes a variation in the 33rd amino acid of the protein encoded by the TBX21 gene. Although 95% or so of all Caucasians carry two copies of the rs2240017(G) allele, as oriented in dbSNP orientation, and are thus rs2240017(G;G) homozygotes, a few individuals are rs2240017(C;G) heterozygotes. These heterozgotes are reported to improve better over time in response to corticosteroid treatment for asthma than the rs2240017(G;G) homozygotes. So far, studies have not linked, however, this SNP to any change in the overall risk of asthma itself. Although the effect observed was strong, in that treating rs2240017(C;G) heterozygotes ultimately (over 4 years) yields average airway responsiveness in the normal range (i.e. in the same range as for nonasthmatics), the authors point out that th...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs37973'>rs37973</a><a href='http://www.snpedia.com/index.php/rs37973(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFC7C7;'>27.7%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.814041607795" style="display: inline;"><a href="javascript:toggle2('sec-0.814041607795')">...more...</a></div>
        <div class='boxrstext' id="sec-0.814041607795" style="display: none;"><a href="javascript:toggle2('sec-0.814041607795')">(hide)</a>
        <div class='rstext'>rs37973 is a SNP in the promoter region of the glucocorticoid induced transcript 1 GLCCI1 gene on chromosome 7. Based on 4 populations totaling 900+ asthma patients, the rs37973(G) allele was associated (p = 0.0007, pooled data) with lower amounts of improvement of lung function in response to inhaled glucocorticoids such as budesonide. The mean (&#177;SE) increase in forced expiratory volume in 1 second (FEV1) in treated rs37973(G;G) patients was about one third of that seen in rs37973(A;A) patients (3.2&#177;1.6% vs. 9.4&#177;1.1%). Based on dividing the response into highest vs lowest quartiles of response, the allelic odds ratio of falling into the lowest responding quartile based on an additive genetic model was calculated to be 1.52 (CI: 1.13 - 2.03). Genotype accounted for about 7% ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|10">Bupropion</a>

        <div class='boxshow' id="show-disease2217220720937277407" style="display: inline;"><a href="javascript:toggle2('disease2217220720937277407')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease2217220720937277407" style="display: none;"><a href="javascript:toggle2('disease2217220720937277407')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Bupropion">Bupropion</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1800497'>rs1800497</a><a href='http://www.snpedia.com/index.php/rs1800497(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2.9<br/>Frequency: <span style='background-color: #FFC8C8;'>28.3%</span><br/>Repute:Bad<br/>References:110<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>A1/A2: Bad at avoidance of errors. 0.5x lower OCD risk, 0.87x lower Tardive Diskinesia risk, higher ADHD risk. More Alcohol Dependence. Lower risk of Postoperative Nausea. Increased obesity. Bupropion is not effective.  The DRD2 TaqIA A1/A2 version causes less dopamine receptors. Doesn't learn from mistakes well. Reduced response to errors and increased addictive behavior Men may have half the risk of Obsessive Compulsive Disorder but higher risk of ADHD. Women have lower Persistence. 0.87x reduced risk of Tardive Diskinesia when taking dopamine receptor antagonists. Slightly increased risk of alcoholism and smoking addiction. Slower recovery from traumatic brain injury. Lower risk of postoperative nausea within 6 hours of surgery. Bupropion (Wellbutrin, Budeprion, Prexaton, Elontril, Aple...</div>
        <div class='boxshow' id="show-sec-0.31570226851" style="display: inline;"><a href="javascript:toggle2('sec-0.31570226851')">...more...</a></div>
        <div class='boxrstext' id="sec-0.31570226851" style="display: none;"><a href="javascript:toggle2('sec-0.31570226851')">(hide)</a>
        <div class='rstext'>rs1800497, a SNP also known as the TaqIA (or Taq1A) polymorphism of the dopamine D2 receptor DRD2 gene (even though it is actually located over 10,000bp downstream of the gene), gives rise to the DRD2*A1 allele. This allele (rs1800497(T)) is associated with a reduced number of dopamine binding sites in the brain . Reduced response to errors and increased addictive behavior It has been postulated to play a role in alcoholism, smoking, and certain neuropsychiatric disorders. The reduced number of dopamine binding sites may play a role in nicotine addiction by causing an 'understimulated' state that can be relieved by smoking (and/or use of other drugs). A wide variety of reports have been published over more than ten years either linking rs1800497 to aspects of nicotine use and smoking cessa...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs737865'>rs737865</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs737865(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDADA;'>44.6%</span><br/>References:46<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.429934428648" style="display: inline;"><a href="javascript:toggle2('sec-0.429934428648')">...more...</a></div>
        <div class='boxrstext' id="sec-0.429934428648" style="display: none;"><a href="javascript:toggle2('sec-0.429934428648')">(hide)</a>
        <div class='rstext'>part of a three marker haplotype rs737865-rs4680-rs165599 COMT haplotypes at rs737865 and rs165599 may predict a favorable outcome for bupropion treatment for smoking cessation. We have typed the IVS 1 rs737865 and 3' rs615599 sites and also included a novel IVS 1 indel polymorphism. We report that the schizophrenia-associated haplotype is significantly heterogeneous in populations worldwide. may affect non-Hodgkin lymphoma, anxiety-related personality traits Also mentioned in these PMIDs * * * * * *  [PharmGKB:Curated This variant may predict a favorable outcome for bupropion treatment for smoking cessation] [OMIM:CATECHOL-O-METHYLTRANSFERASE; COMT]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|30|20">Caffeine</a>

        <div class='boxshow' id="show-disease-3678286444329713651" style="display: inline;"><a href="javascript:toggle2('disease-3678286444329713651')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-3678286444329713651" style="display: none;"><a href="javascript:toggle2('disease-3678286444329713651')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Caffeine">Caffeine</a>
  <div id="gs140"  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs140'>gs140</a></div></div>
        <div class='boxmag'>Magnitude: 2</div>
        <div class='boxrep'>Repute: Bad</div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>NAT2 slow metabolizer</div>
        <div class='gsboxeffect'>Most non-Scandinavian Caucasians and approximately half of African-Americans are slow metabolizers. This variation is important because of its primary role in the deactivation of many chemicals in the body's environment, including those produced by caffeine and cigarettes as well as aromatic amine and hydrazine drugs used medicinally. In general, slow metabolizers have higher rates of certain types of cancer and are more susceptible to side effects from chemicals metabolized by NAT2. According to this source 6 snps determine NAT2 metabolism. The way their genotypes interact is very complex, which makes this one of the largest genosets in SNPedia. The SNPs are: *rs1208 *rs1041983 *rs1799929 *rs1799930 *rs1799931 *rs1801280</div>
      </div>
      <div class="boxfooter"></div>
  </div>


  <div id="gs154"  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs154'>gs154</a></div></div>
        <div class='boxmag'>Magnitude: 2</div>
        <div class='boxrep'>Repute: Bad</div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>NAT2 Slow metabolizer</div>
        <div class='gsboxeffect'>Most non-Scandinavian Caucasians and approximately half of African-Americans are slow metabolizers. This variation is important because of its primary role in the deactivation of many chemicals in the body's environment, including those produced by caffeine and cigarettes as well as aromatic amine and hydrazine drugs used medicinally. In general, slow metabolizers have higher rates of certain types of cancer and are more susceptible to side effects from chemicals metabolized by NAT2. This prediction and that of gs156 of NAT2 metabolizer phenotype is based on using 2 SNPs, rs1041983 and rs1801280. An alternative prediction of NAT2 metabolizer status based on using more SNPs (6) is used by genosets gs138, gs139, and gs140.</div>
      </div>
      <div class="boxfooter"></div>
  </div>


  <div id="gs159"  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs159'>gs159</a></div></div>
        <div class='boxmag'>Magnitude: 2</div>
        <div class='boxrep'>Repute: Good</div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>CYP1A2 fast metabolizer</div>
        <div class='gsboxeffect'>Your CYP1A2 fast metabolizer status means that you are less stimulated by caffeine. Ciprofloxacin is also metabolized by CYP1A2, but is unclear if your genotype should influence its effect.</div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4410790'>rs4410790</a><a href='http://www.snpedia.com/index.php/rs4410790(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFB7B7;'>17.7%</span><br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>drank about a third of a cup of coffee less each day than those without any copies.</div>
        <div class='boxshow' id="show-sec-0.764429493354" style="display: inline;"><a href="javascript:toggle2('sec-0.764429493354')">...more...</a></div>
        <div class='boxrstext' id="sec-0.764429493354" style="display: none;"><a href="javascript:toggle2('sec-0.764429493354')">(hide)</a>
        <div class='rstext'>rs4410790 and rs2470893 influences habitual caffeine consumption  [GWAS:None]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs762551'>rs762551</a><a href='http://www.snpedia.com/index.php/rs762551(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFE1E1;'>53.1%</span><br/>References:38<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Fast Caffeine Metabolizer.  Unlike the majority of people, caffeine is broken down faster in your liver, so it has less effect on you. Supposedly this decreases heart attack risk, although other studies show caffeine is generally good for the heart. Caffeine will be less effective at preventing Breast Cancer, Alzheimer's Disease, and Parkinson's disease. Caffeine will not make your breasts smaller.</div>
        <div class='boxshow' id="show-sec-0.892239159418" style="display: inline;"><a href="javascript:toggle2('sec-0.892239159418')">...more...</a></div>
        <div class='boxrstext' id="sec-0.892239159418" style="display: none;"><a href="javascript:toggle2('sec-0.892239159418')">(hide)</a>
        <div class='rstext'>rs762551, also known as -164A&gt;C or -163C&gt;A, is a SNP encoding the CYP1A2*1F allele of the CYP1A2 gene. For historic reasons, the rs762551(C) allele is considered the wild-type, even though it is the rarer allele in most populations. The rs762551(A) allele is the 'fast metabolizer' allele known as CYP1A2*1F; the (C) allele is by comparison a slower metabolizer of certain substrates (including caffeine). In terms of genotypes, only rs762551(A;A) individuals are considered fast metabolizers. Individuals who are rs762551(A;C) heterozygotes or rs762551(C;C) homozygotes are both considered slow metabolizers. The CYP1A2 gene encodes a member of the cytochrome p450 family of proteins, which metabolize nutrients and drugs. One well known substrate of CYP1A2 is caffeine; individuals who are ca...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2470893'>rs2470893</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs2470893(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDFDF;'>50.4%</span><br/>References:5<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.021749367653" style="display: inline;"><a href="javascript:toggle2('sec-0.021749367653')">...more...</a></div>
        <div class='boxrstext' id="sec-0.021749367653" style="display: none;"><a href="javascript:toggle2('sec-0.021749367653')">(hide)</a>
        <div class='rstext'>rs4410790 and rs2470893 influence habitual caffeine consumption Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.  [GWAS:None]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5751876'>rs5751876</a><a href='http://www.snpedia.com/index.php/rs5751876(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>None</div>
        <div class='boxshow' id="show-sec-0.960763401273" style="display: inline;"><a href="javascript:toggle2('sec-0.960763401273')">...more...</a></div>
        <div class='boxrstext' id="sec-0.960763401273" style="display: none;"><a href="javascript:toggle2('sec-0.960763401273')">(hide)</a>
        <div class='rstext'>Variation at this SNP, rs5751876, also referred to as 1976C&gt;T or 1976T&gt;C, appears to influence how an individual responds to moderate levels (150mg) of caffeine. T/T carriers displaying significantly increased subjective levels of anxiety after consumption. However a PharmGKB variant annotation suggests it is (C;C) genotypes who are more sensitive to caffeine. rs5751876 is not associated with how much coffee one drinks, though, nor with risk for Parkinson's disease, based on a study of 1,200 subjects. 'rs2298383 shows functional potential based on in silico analyses and might therefore represent the true underlying causal variant'</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 genosets 4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|20|0">Camptosar</a>

        <div class='boxshow' id="show-disease-3956067607430505841" style="display: inline;"><a href="javascript:toggle2('disease-3956067607430505841')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-3956067607430505841" style="display: none;"><a href="javascript:toggle2('disease-3956067607430505841')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Camptosar">Camptosar</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs34983651'>rs34983651</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs34983651(I;I)'>(I;I)</a></div>
        <div class='boxmag'>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.245194465865" style="display: inline;"><a href="javascript:toggle2('sec-0.245194465865')">...more...</a></div>
        <div class='boxrstext' id="sec-0.245194465865" style="display: none;"><a href="javascript:toggle2('sec-0.245194465865')">(hide)</a>
        <div class='rstext'>rs34983651 is one of four SNPs all describing an insertion/deletion polymorphism in the promoter region of the UGT1A1 gene; the primary entry in SNPedia for this set of SNPs is at rs34815109. The other two SNPs (besides rs34815109) that also describe the same polymorphism are: * rs35600288 * rs5839491</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs35600288'>rs35600288</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs35600288(D;I)'>(D;I)</a></div>
        <div class='boxmag'>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.5493010159" style="display: inline;"><a href="javascript:toggle2('sec-0.5493010159')">...more...</a></div>
        <div class='boxrstext' id="sec-0.5493010159" style="display: none;"><a href="javascript:toggle2('sec-0.5493010159')">(hide)</a>
        <div class='rstext'>rs35600288 is one of four SNPs all describing an insertion/deletion polymorphism in the promoter region of the UGT1A1 gene; the primary entry in SNPedia for this set of SNPs is at rs34815109. The other two SNPs (besides rs34815109) that also describe the same polymorphism are: * rs34983651 * rs5839491</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|30|0">Carbamazepine</a>

        <div class='boxshow' id="show-disease-490727368310668753" style="display: inline;"><a href="javascript:toggle2('disease-490727368310668753')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-490727368310668753" style="display: none;"><a href="javascript:toggle2('disease-490727368310668753')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Carbamazepine">Carbamazepine</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2844682'>rs2844682</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs2844682(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFBDBD;'>21.2%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.977142806521" style="display: inline;"><a href="javascript:toggle2('sec-0.977142806521')">...more...</a></div>
        <div class='boxrstext' id="sec-0.977142806521" style="display: none;"><a href="javascript:toggle2('sec-0.977142806521')">(hide)</a>
        <div class='rstext'>Helps to identify HLA-B*1502  [PharmGKB:Curated Risk or phenotype-associated allele: allele 4. Phenotype: Combined alleles of rs3909184 (2) and rs2844682 (4) are tagging SNPs for HLA-B*1502 (0.011 allele frequency). Study size: 45. Study population/ethnicity: Unrelated Han Chinese from Beijing, China. Significance metric(s): Type of association: GN]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1051740'>rs1051740</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1051740(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDBDB;'>46.0%</span><br/>References:37<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.504159076352" style="display: inline;"><a href="javascript:toggle2('sec-0.504159076352')">...more...</a></div>
        <div class='boxrstext' id="sec-0.504159076352" style="display: none;"><a href="javascript:toggle2('sec-0.504159076352')">(hide)</a>
        <div class='rstext'>rs1051740, also known as Tyr113His, is a SNP in the microsomal epoxide hydrolase EPHX1 gene. severe hypersensitivity syndrome, triggered by carbamazepine in the presence of a concomitant active human herpes virus (HHV) 6 and 7 infection with the allele HLA-A*3101 and rs1051740(C;C)  [PharmGKB:Curated Risk or phenotype-associated allele: T. Phenotype: In a logistic regression model adjusted for history of phenytoin use during the first trimester and maternal epilepsy, the maternal EPHX1 113 H (rs1051740 T/C) allele was associated with craniofacial abnormalities in the child. Study size: 157 pregnancies. Study population/ethnicity: phenytoin use during the first trimester and maternal epilepsy. metric(s): per rare allele OR: 2.43, 95% confidence interval (CI): 1.16-5.10, P=0.02. Type of asso...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1061235'>rs1061235</a><a href='http://www.snpedia.com/index.php/rs1061235(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0.1<br/>Repute:Good<br/>References:2<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Normal carbamazepine sensitivity; common in clinvar</div>
        <div class='boxshow' id="show-sec-0.532864286566" style="display: inline;"><a href="javascript:toggle2('sec-0.532864286566')">...more...</a></div>
        <div class='boxrstext' id="sec-0.532864286566" style="display: none;"><a href="javascript:toggle2('sec-0.532864286566')">(hide)</a>
        <div class='rstext'>rs1061235(T) serves as a proxy for the HLA-A*3101 allele. The HLA-A*3101 allele, found in about 2 - 5% of Northern Europeans, is significantly associated with carbamazepine hypersensitivity syndrome, with odds ratios above 10. The presence of this HLA allele increases the risk from 5% to 26%, whereas its absence reduces the risk from 5% to 4%.  [GWAS:None]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2273697'>rs2273697</a><a href='http://www.snpedia.com/index.php/rs2273697(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFE4E4;'>56.6%</span><br/>References:16<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal/common</div>
        <div class='boxshow' id="show-sec-0.309957254935" style="display: inline;"><a href="javascript:toggle2('sec-0.309957254935')">...more...</a></div>
        <div class='boxrstext' id="sec-0.309957254935" style="display: none;"><a href="javascript:toggle2('sec-0.309957254935')">(hide)</a>
        <div class='rstext'>rs2273697, also known as c1249G&gt;A or p.V471I, is a nonsynonymous polymorphism in the ABCC2 gene. From an initial case-control study of 146 patients with epilepsy, followed by replication (p=0.001) in another 279 patients, the rs2273697(A) allele was associated with neurological adverse drug reactions from taking carbamazepine. Functional studies showed that this SNP selectively reduced carbamazepine transport across the cell membrane.  [PharmGKB:Curated Risk or phenotype-associated allele: A. Phenotype: This SNP showed a strong association with the neurological adverse drug reaction caused (ADR) by carbamazepine (P=0.005). The study results indicate that the c.1249A variant is an independent risk factor of carbamazepine CNS ADR. Study size: 146 patients with epilepsy who had been prescr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3909184'>rs3909184</a><a href='http://www.snpedia.com/index.php/rs3909184(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:3<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common</div>
        <div class='boxshow' id="show-sec-0.969926962293" style="display: inline;"><a href="javascript:toggle2('sec-0.969926962293')">...more...</a></div>
        <div class='boxrstext' id="sec-0.969926962293" style="display: none;"><a href="javascript:toggle2('sec-0.969926962293')">(hide)</a>
        <div class='rstext'>Helps to identify HLA-B*1502  [PharmGKB:Curated Risk or phenotype-associated allele: allele 2. Phenotype: Combined alleles of rs3909184 (2) and rs2844682 (4) are tagging SNPs for HLA-B*1502 (0.011 allele frequency). Study size: 45. Study population/ethnicity: Unrelated Han Chinese from Beijing, China. Significance metric(s): Type of association: GN]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">5 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Carvedilol</a>

        <div class='boxshow' id="show-disease-1690395431465924169" style="display: inline;"><a href="javascript:toggle2('disease-1690395431465924169')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-1690395431465924169" style="display: none;"><a href="javascript:toggle2('disease-1690395431465924169')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Carvedilol">Carvedilol</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801253'>rs1801253</a><a href='http://www.snpedia.com/index.php/rs1801253(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 1.1<br/>Frequency: <span style='background-color: #F0D4F0;'>50.8%</span><br/>References:28<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>responds well to bucindolol; may also depend on rs1801252</div>
        <div class='boxshow' id="show-sec-0.00318538788372" style="display: inline;"><a href="javascript:toggle2('sec-0.00318538788372')">...more...</a></div>
        <div class='boxrstext' id="sec-0.00318538788372" style="display: none;"><a href="javascript:toggle2('sec-0.00318538788372')">(hide)</a>
        <div class='rstext'>Also known as Arg389, variation at this SNP, located in the ADRB1 gene, may encode either the amino acid glycine or arginine at amino acid position 389 of the corresponding protein, the beta-1 adrenergic receptor (hence why it is frequently called Arg389Gly). This protein is the target of beta blocker drugs, and so how well the drug works to help lower a patients high blood pressure depends in part on this SNP. The status of this SNP is often reported together with the status of SNP rs1801252, which encodes an amino acid variant at position 49 of the same (ADRB1) protein. The rs1801253(G) allele encodes the glycine. One of the best known studies of the effects of these 2 separate SNPs on the average efficacy of the beta blocker metoprolol in lowering blood pressure (BP) can be summarized f...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Celexa</a>

        <div class='boxshow' id="show-disease-8497009971890562326" style="display: inline;"><a href="javascript:toggle2('disease-8497009971890562326')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-8497009971890562326" style="display: none;"><a href="javascript:toggle2('disease-8497009971890562326')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Celexa">Celexa</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.276481079644" style="display: inline;"><a href="javascript:toggle2('sec-0.276481079644')">...more...</a></div>
        <div class='boxrstext' id="sec-0.276481079644" style="display: none;"><a href="javascript:toggle2('sec-0.276481079644')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|0|10">Cetuximab</a>

        <div class='boxshow' id="show-disease2297561507426016741" style="display: inline;"><a href="javascript:toggle2('disease2297561507426016741')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease2297561507426016741" style="display: none;"><a href="javascript:toggle2('disease2297561507426016741')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Cetuximab">Cetuximab</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801274'>rs1801274</a><a href='http://www.snpedia.com/index.php/rs1801274(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 1.5<br/>Frequency: <span style='background-color: #FFC5C5;'>26.5%</span><br/>Repute:Bad<br/>References:56<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>complex; generally greater risk for cancer progression</div>
        <div class='boxshow' id="show-sec-0.88262089771" style="display: inline;"><a href="javascript:toggle2('sec-0.88262089771')">...more...</a></div>
        <div class='boxrstext' id="sec-0.88262089771" style="display: none;"><a href="javascript:toggle2('sec-0.88262089771')">(hide)</a>
        <div class='rstext'>rs1801274 is a SNP in the Fc fragment of IgG, low affinity IIa, receptor (CD32) FCGR2A gene. rs1801274(C) encodes the arginine (R) allele, with the (T) allele encoding the variant histidine (H). The (H) isoform is considered high-binding to IgG2 and IgG3, while the (R) isoform is considered low-binding. This SNP is known in the literature by many names, including A519C and H131R. What's the importance of this? FcgR isoforms expressed on immune system cells have been linked to the pathogenic consequences triggered by autoantibodies or immune complexes in autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as well as to the efficacy of some immunotherapeutic treatments such as rituximab. Many studies have been published about this FCGR2A SNP, roughly...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Chlorthalidone</a>

        <div class='boxshow' id="show-disease-7327015636257733734" style="display: inline;"><a href="javascript:toggle2('disease-7327015636257733734')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-7327015636257733734" style="display: none;"><a href="javascript:toggle2('disease-7327015636257733734')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Chlorthalidone">Chlorthalidone</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5065'>rs5065</a><a href='http://www.snpedia.com/index.php/rs5065(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC5C5;'>26.5%</span><br/>References:21<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal risk</div>
        <div class='boxshow' id="show-sec-0.525081811777" style="display: inline;"><a href="javascript:toggle2('sec-0.525081811777')">...more...</a></div>
        <div class='boxrstext' id="sec-0.525081811777" style="display: none;"><a href="javascript:toggle2('sec-0.525081811777')">(hide)</a>
        <div class='rstext'>rs5065, also known as T2238C, is a SNP in the atrial natriuretic precursor A NPPA gene. A large study has been conducted in which 42,418 hypertensive participants 55 or older were followed for several years while on one of four medications: a diuretic, a calcium antagonist, an angiotensin-converting enzyme inhibitor, or an alpha-blocker. The primary endpoint was either fatal heart disease or a heart attack. The blood pressure after six months of rs5065(G;G) patients (note: genotype is in dbSNP orientation, not as published) was lower if the patients were treated with diuretics compared to other medications, with smaller variation seen for (A;A) genotypes. The authors noted that none of the findings retained statistical significance after correction for multiple comparisons, but since the t...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|10|0">Cisplatin</a>

        <div class='boxshow' id="show-disease8151298850606623460" style="display: inline;"><a href="javascript:toggle2('disease8151298850606623460')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease8151298850606623460" style="display: none;"><a href="javascript:toggle2('disease8151298850606623460')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Cisplatin">Cisplatin</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1042522'>rs1042522</a><a href='http://www.snpedia.com/index.php/rs1042522(C;G)'>(C;G)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFC9C9;'>29.2%</span><br/>Repute:Good<br/>References:123<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Slightly increased lifespan?</div>
        <div class='boxshow' id="show-sec-0.214721721804" style="display: inline;"><a href="javascript:toggle2('sec-0.214721721804')">...more...</a></div>
        <div class='boxrstext' id="sec-0.214721721804" style="display: none;"><a href="javascript:toggle2('sec-0.214721721804')">(hide)</a>
        <div class='rstext'>This SNP, a variant in the TP53 gene, is 1 of 25 SNPs reported to represent independently minor, but cumulatively significant, increased risk for breast cancer. For details of all 25 SNPs in this group, along with the two methods used to calculate overall risk estimates for breast cancer, refer to the SNPedia breast cancer entry. For this particular SNP, the G allele encodes an arginine at position 72 of the protein (where there's normally a proline), and the SNP is commonly called the Arg72 variant, although P72R and Arg72Pro are also common in the literature. Minor allele homozygotes, i.e. rs1042522(C;C) genotypes, live on average 3 years longer than major allele (G;G) homozygotes, based on a study of 9,200+ Danish individuals. The increased longevity is speculated to be related to the i...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs9332377'>rs9332377</a><a href='http://www.snpedia.com/index.php/rs9332377(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEDED;'>69.0%</span><br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.996623548165" style="display: inline;"><a href="javascript:toggle2('sec-0.996623548165')">...more...</a></div>
        <div class='boxrstext' id="sec-0.996623548165" style="display: none;"><a href="javascript:toggle2('sec-0.996623548165')">(hide)</a>
        <div class='rstext'>23andMe blog hearing loss linked to a chemotherapy drug named Cisplatin.  [PharmGKB:Curated Risk or phenotype-associated allele: A. Phenotype: This variant was associated with cisplatin-induced hearing loss from a large candidate gene screen in 2 pediatric cohorts.. Study size: 54 (discovery); 112 (replication). Study population/ethnicity: Children with neoplasms receiving cisplatin; Canada. Significance metric(s): OR = 5.52 (CI 1.91, 15.95); p = 0.000182 Type of association: CO; TOX; ADR] [OMIM:?]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1142345'>rs1142345</a><a href='http://www.snpedia.com/index.php/rs1142345(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFCFC;'>94.7%</span><br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in clinvar</div>
        <div class='boxshow' id="show-sec-0.0253254912407" style="display: inline;"><a href="javascript:toggle2('sec-0.0253254912407')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0253254912407" style="display: none;"><a href="javascript:toggle2('sec-0.0253254912407')">(hide)</a>
        <div class='rstext'>rs1142345 is a SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs. In general, individuals must have two nonfunctioning TPMT alleles for the toxicity to be pronounced. The risk allele for this SNP is rs1142345(G), and when it is the only variant in the TPMT gene, it encodes the TPMT*3C allele. While still rare, it is more common in African-Americans (2.4% of all alleles) than in Caucasians. Note that if the same allele also carries the rs1800460(A) SNP, the allele is actually a TPMT*3A allele (OMIM). The medicine 6-Mercaptopurine is metabolized by TPMT. Individual differences in TPMT activity associated with this SNP are now used to determine appropriate dosage range and interval for treatment. 23an...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:31|56|12">Citalopram</a>

        <div class='boxshow' id="show-disease7550753603683614376" style="display: inline;"><a href="javascript:toggle2('disease7550753603683614376')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease7550753603683614376" style="display: none;"><a href="javascript:toggle2('disease7550753603683614376')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Citalopram">Citalopram</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1360780'>rs1360780</a><a href='http://www.snpedia.com/index.php/rs1360780(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 2.1<br/>Frequency: <span style='background-color: #FF9696;'>6.2%</span><br/>Repute:Bad<br/>References:39<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>1.3x increased risk for depression</div>
        <div class='boxshow' id="show-sec-0.568580249649" style="display: inline;"><a href="javascript:toggle2('sec-0.568580249649')">...more...</a></div>
        <div class='boxrstext' id="sec-0.568580249649" style="display: none;"><a href="javascript:toggle2('sec-0.568580249649')">(hide)</a>
        <div class='rstext'>In Caucasian non-Hispanics, the rs1360780(T) allele is associated with increased risk for depression, with an odds ratio of 1.39 (CI: 1.14-1.70, p=0.046). This same SNP, which is in the FKBP5 gene, may influence how patients respond to antidepressants including citalopram. rs1360780(T;T) homozgyotes tend to report more depressive episodes, but they also respond better to treatment with antidepressants. rs9296158 rs3800373 rs1360780 rs9470080 linked with the severity of child abuse to predict level of adult PTSD symptoms after correcting for multiple testing.  [PharmGKB:Curated This variant is associated with higher chance of response to anti-depressant drugs.] [OMIM:FK506-BINDING PROTEIN 5; FKBP5]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.0157597296623" style="display: inline;"><a href="javascript:toggle2('sec-0.0157597296623')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0157597296623" style="display: none;"><a href="javascript:toggle2('sec-0.0157597296623')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1954787'>rs1954787</a><a href='http://www.snpedia.com/index.php/rs1954787(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC2C2;'>23.9%</span><br/>References:6<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>~10% more likely to respond to citalopram</div>
        <div class='boxshow' id="show-sec-0.0571484586991" style="display: inline;"><a href="javascript:toggle2('sec-0.0571484586991')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0571484586991" style="display: none;"><a href="javascript:toggle2('sec-0.0571484586991')">(hide)</a>
        <div class='rstext'>rs1954787, located in an intron of the GRIK4 gene, was found to be associated with a somewhat increased rate of successful response to treatment of depression with the drug citalopram. From the abstract of this article: 'The effect size of (this) GRIK4 marker alone was modest, but homozygote carriers of the treatment-response-associated marker alleles of both the GRIK4 and HTR2A (see rs7997012) genes were 23% less likely to experience nonresponse to (citalopram) treatment relative to participants who did not carry any of these marker alleles.' * See also Anxiety Blog posting  [PharmGKB:Curated A study in 1,816 eligible patients from the STAR*D cohort found that genetic variation in a kainic acid-type glutamate receptor is reproducibly associated with response to the antidepressant citalopr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs12720067'>rs12720067</a><a href='http://www.snpedia.com/index.php/rs12720067(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.62517764235" style="display: inline;"><a href="javascript:toggle2('sec-0.62517764235')">...more...</a></div>
        <div class='boxrstext' id="sec-0.62517764235" style="display: none;"><a href="javascript:toggle2('sec-0.62517764235')">(hide)</a>
        <div class='rstext'>rs12720067 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs12720067 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are kn...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2235040'>rs2235040</a><a href='http://www.snpedia.com/index.php/rs2235040(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Magnitude: 1<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.196263164528" style="display: inline;"><a href="javascript:toggle2('sec-0.196263164528')">...more...</a></div>
        <div class='boxrstext' id="sec-0.196263164528" style="display: none;"><a href="javascript:toggle2('sec-0.196263164528')">(hide)</a>
        <div class='rstext'>rs2235040 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2235040 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7787082'>rs7787082</a><a href='http://www.snpedia.com/index.php/rs7787082(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCDCD;'>32.3%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.498969308622" style="display: inline;"><a href="javascript:toggle2('sec-0.498969308622')">...more...</a></div>
        <div class='boxrstext' id="sec-0.498969308622" style="display: none;"><a href="javascript:toggle2('sec-0.498969308622')">(hide)</a>
        <div class='rstext'>rs7787082 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs7787082 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6966038'>rs6966038</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs6966038(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCDCD;'>32.7%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.202395797152" style="display: inline;"><a href="javascript:toggle2('sec-0.202395797152')">...more...</a></div>
        <div class='boxrstext' id="sec-0.202395797152" style="display: none;"><a href="javascript:toggle2('sec-0.202395797152')">(hide)</a>
        <div class='rstext'>[GWAS:Treatment response to citalopram]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7997012'>rs7997012</a><a href='http://www.snpedia.com/index.php/rs7997012(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD4D4;'>38.7%</span><br/>Repute:Bad<br/>References:22<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>~18% less likely to respond to citalopram</div>
        <div class='boxshow' id="show-sec-0.138678993089" style="display: inline;"><a href="javascript:toggle2('sec-0.138678993089')">...more...</a></div>
        <div class='boxrstext' id="sec-0.138678993089" style="display: none;"><a href="javascript:toggle2('sec-0.138678993089')">(hide)</a>
        <div class='rstext'>rs7997012, located in an intron of the HTR2A gene, was found to be associated with a somewhat increased rate of successful response to treatment of depression with the drug citalopram. From this article : 'HTR2A encodes the serotonin 2A receptor, which is downregulated by citalopram. Participants who were homozygous for the A allele had an 18% reduction in absolute risk of having no response to treatment, compared with those homozygous for the other allele.' * See also Anxiety Blog posting  [PharmGKB:Curated Risk or phenotype-associated allele: A. Phenotype: Patients with the 5-HTR2A intron 2 (rs7997012) AA genotype suffered from more pronounced side effects compared to carriers of the GA or GG genotype. Study size: 124. Study population/ethnicity: Caucasian; Patients with psychiatric diso...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7569963'>rs7569963</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs7569963(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD9D9;'>43.1%</span><br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.768747489234" style="display: inline;"><a href="javascript:toggle2('sec-0.768747489234')">...more...</a></div>
        <div class='boxrstext' id="sec-0.768747489234" style="display: none;"><a href="javascript:toggle2('sec-0.768747489234')">(hide)</a>
        <div class='rstext'>rs7569963 is directly adjacent to CREB1. Associated with significantly (p = 0.005) increased chance of suicide in a study of 1447 citalopram users (male only subgroup, 539 in total). Two haplotypes (see below) also showed significant association with suicidality in the male subgroup. *rs2709376(C),rs2253206(A),rs7569963(A),rs7594560(T),rs4675690(C) - common haplotype, reduced chance of suicide in males, p = 0.004 *rs2709376(C),rs2253206(A),rs7569963(G),rs7594560(T),rs4675690(T) - increased chance of suicide in males, p = 0.009  [PharmGKB:Curated In a nested case-control study derived from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study this SNP in the CREB1 gene was associated with treatment-emergent suicidality among men with depression.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7239368'>rs7239368</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs7239368(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDFDF;'>50.4%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.792025967705" style="display: inline;"><a href="javascript:toggle2('sec-0.792025967705')">...more...</a></div>
        <div class='boxrstext' id="sec-0.792025967705" style="display: none;"><a href="javascript:toggle2('sec-0.792025967705')">(hide)</a>
        <div class='rstext'>[GWAS:Treatment response to citalopram]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4675690'>rs4675690</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs4675690(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFE2E2;'>53.8%</span><br/>References:5<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.140987446977" style="display: inline;"><a href="javascript:toggle2('sec-0.140987446977')">...more...</a></div>
        <div class='boxrstext' id="sec-0.140987446977" style="display: none;"><a href="javascript:toggle2('sec-0.140987446977')">(hide)</a>
        <div class='rstext'>rs4675690 is in close proximity to CREB1, and adjacent to LOC151194. g2b2mh blog individuals with the TT genotype at rs4675690 (C/T) showed less disgust, but not happiness, desire or fear. T allele associated with increased chance of suicide (OR = 2.3, 95% CI 1.3-2.9, TT homozygotes vs CC homozygotes?) during the first 30 days (p &gt; 0.05 after the first month) of citalopram treatment, in a study of 1447 citalopram users (male only subgroup, 539 in total). Two haplotypes (see below) also showed significant association with suicidality in the male subgroup. *rs2709376(C),rs2253206(A),rs7569963(A),rs7594560(T),rs4675690(C) - common haplotype, reduced chance of suicide in males, p = 0.004 *rs2709376(C),rs2253206(A),rs7569963(G),rs7594560(T),rs4675690(T) - increased chance of suicide in males...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs809736'>rs809736</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs809736(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFE5E5;'>58.0%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.546966748112" style="display: inline;"><a href="javascript:toggle2('sec-0.546966748112')">...more...</a></div>
        <div class='boxrstext' id="sec-0.546966748112" style="display: none;"><a href="javascript:toggle2('sec-0.546966748112')">(hide)</a>
        <div class='rstext'>[GWAS:Treatment response to citalopram]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2830840'>rs2830840</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs2830840(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #F0D3F0;'>52.3%</span><br/>References:1<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.976967238333" style="display: inline;"><a href="javascript:toggle2('sec-0.976967238333')">...more...</a></div>
        <div class='boxrstext' id="sec-0.976967238333" style="display: none;"><a href="javascript:toggle2('sec-0.976967238333')">(hide)</a>
        <div class='rstext'>[GWAS:Treatment response to citalopram]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4825476'>rs4825476</a><a href='http://www.snpedia.com/index.php/rs4825476(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEBEB;'>65.5%</span><br/>References:5<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.163624341978" style="display: inline;"><a href="javascript:toggle2('sec-0.163624341978')">...more...</a></div>
        <div class='boxrstext' id="sec-0.163624341978" style="display: none;"><a href="javascript:toggle2('sec-0.163624341978')">(hide)</a>
        <div class='rstext'>This SNP, located in an intron of the GRIA3 gene (also known as AMPA3), has been linked in one study to increased thoughts of suicide in patients taking the anti-depressant drug citalopram. The increased risk is calculated to be 1.9x. If the individual is also carrying two rs2518224(C) alleles, i.e. is a rs2518224(C;C) homozygote, the odds ratio for having suicidal thoughts is increased to ~15x (CI: 3.7 - 60.6).  [PharmGKB:Curated This SNP in the GRIA3 gene was associated with treatment-emergent suicidal ideation during citalopram therapy in a clinically representative cohort of outpatients with major depressive disorder. DNA samples from 1,915 participants were genotyped.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2518224'>rs2518224</a><a href='http://www.snpedia.com/index.php/rs2518224(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEFEF;'>72.6%</span><br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.932851060477" style="display: inline;"><a href="javascript:toggle2('sec-0.932851060477')">...more...</a></div>
        <div class='boxrstext' id="sec-0.932851060477" style="display: none;"><a href="javascript:toggle2('sec-0.932851060477')">(hide)</a>
        <div class='rstext'>This SNP, located in an intron of the GRIK2 gene, has been linked in one study to increased thoughts of suicide in patients using the anti-depressant drug citalopram. The risk is only seen for individuals carrying two rs2518224(C) alleles, i.e. the rs2518224(C;C) homozygotes. The odds ratio for these individuals is 8.2. If the individual also has at least one rs4825476(G) allele, the odds ratio for having suicidal thoughts is increased to ~15x (CI: 3.7 - 60.6).  [PharmGKB:Curated This SNP in the GRIK2 gene was associated with treatment-emergent suicidal ideation during citalopram therapy in a clinically representative cohort of outpatients with major depressive disorder. DNA samples from 1,915 participants were genotyped.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6127921'>rs6127921</a><a href='http://www.snpedia.com/index.php/rs6127921(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF3F3;'>78.5%</span><br/>Repute:Good<br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.0566177380056" style="display: inline;"><a href="javascript:toggle2('sec-0.0566177380056')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0566177380056" style="display: none;"><a href="javascript:toggle2('sec-0.0566177380056')">(hide)</a>
        <div class='rstext'>Pharmacogenetics of antidepressant response.  [GWAS:Treatment response to citalopram]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">16 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Clomipramine</a>

        <div class='boxshow' id="show-disease-125616685318904432" style="display: inline;"><a href="javascript:toggle2('disease-125616685318904432')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-125616685318904432" style="display: none;"><a href="javascript:toggle2('disease-125616685318904432')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Clomipramine">Clomipramine</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.984600511716" style="display: inline;"><a href="javascript:toggle2('sec-0.984600511716')">...more...</a></div>
        <div class='boxrstext' id="sec-0.984600511716" style="display: none;"><a href="javascript:toggle2('sec-0.984600511716')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:80|0|20">Clopidogrel</a>

        <div class='boxshow' id="show-disease-8218819451684459739" style="display: inline;"><a href="javascript:toggle2('disease-8218819451684459739')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-8218819451684459739" style="display: none;"><a href="javascript:toggle2('disease-8218819451684459739')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Clopidogrel">Clopidogrel</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3842787'>rs3842787</a><a href='http://www.snpedia.com/index.php/rs3842787(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFB3B3;'>15.9%</span><br/>Repute:Bad<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Higher risk of bleeding during coronary angiography</div>
        <div class='boxshow' id="show-sec-0.459163788835" style="display: inline;"><a href="javascript:toggle2('sec-0.459163788835')">...more...</a></div>
        <div class='boxrstext' id="sec-0.459163788835" style="display: none;"><a href="javascript:toggle2('sec-0.459163788835')">(hide)</a>
        <div class='rstext'>rs3842787, also known as 50C&gt;T, is a SNP in the signal peptide region of the cyclooxygenase-1 PTGS1 gene. A study of 696 European patients undergoing elective diagnostic coronary angiographies (CAGs) because of suspected or proven stable coronary artery disease found that 23 experienced bleeding, perhaps the most common complication of this type of invasive coronary procedure. After controlling for various variables (especially gender), two co-inherited SNPs, rs10306114 and rs3842787, were found to be associated with higher risk for bleeding in otherwise low risk patients who (i) did undergo percutaneous coronary intervention and (ii) did not take clopidogrel. Having the less common haplotype (rs10306114(G) and/or rs3842787(T)) increases the bleeding risk upon CAG ~12 fold (p = 0.012). ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs10306114'>rs10306114</a><a href='http://www.snpedia.com/index.php/rs10306114(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Repute:Bad<br/>References:5<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Higher risk of bleeding during coronary angiography</div>
        <div class='boxshow' id="show-sec-0.807985138951" style="display: inline;"><a href="javascript:toggle2('sec-0.807985138951')">...more...</a></div>
        <div class='boxrstext' id="sec-0.807985138951" style="display: none;"><a href="javascript:toggle2('sec-0.807985138951')">(hide)</a>
        <div class='rstext'>rs10306114, also known as -842A&gt;G, is a SNP upstream of the cyclooxygenase-1 PTGS1 gene. A study of 696 European patients undergoing elective diagnostic coronary angiographies (CAGs) because of suspected or proven stable coronary artery disease found that 23 experienced bleeding, perhaps the most common complication of this type of invasive coronary procedure. After controlling for various variables (especially gender), two co-inherited SNPs, rs10306114 and rs3842787, were found to be associated with higher risk for bleeding in otherwise low risk patients who (i) did undergo percutaneous coronary intervention and (ii) did not take clopidogrel. Having the less common haplotype (rs10306114(G) and/or rs3842787(T)) increases the bleeding risk upon CAG ~12 fold (p = 0.012).</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs12248560'>rs12248560</a><a href='http://www.snpedia.com/index.php/rs12248560(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFE3E3;'>55.4%</span><br/>Repute:Good<br/>References:13<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.4247524536" style="display: inline;"><a href="javascript:toggle2('sec-0.4247524536')">...more...</a></div>
        <div class='boxrstext' id="sec-0.4247524536" style="display: none;"><a href="javascript:toggle2('sec-0.4247524536')">(hide)</a>
        <div class='rstext'>rs12248560(T) defines the CYP2C19*17 allele, an ultra fast metabolizer phenotype of the CYP2C19 gene. CYP2C19*17 is likely to lead to less effective drug treatment by, for example, proton pump inhibitors (such as omeprazole) and antidepressants. On the other hand, cancer patients who are CYP2C19*17 carriers are more likely to benefit from tamoxifen treatment, presumably because they break it down more rapidly into the antiestrogenic metabolites endoxifen and 4-hydroxytamoxifen. A study of 1,000+ breast cancer patients showed a 0.77x decreased risk of breast cancer for carriers of a CYP2C19*17 allele (CI: 0.65-0.93, p = 0.005). Analysis of a subgroup of such carriers who were using hormone therapy for ten years or longer showed an even stronger effect (odds ratio 0.57, CI: 0.39-0.83, p = 0....</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs12777823'>rs12777823</a><a href='http://www.snpedia.com/index.php/rs12777823(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF0F0;'>73.5%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.60864331638" style="display: inline;"><a href="javascript:toggle2('sec-0.60864331638')">...more...</a></div>
        <div class='boxrstext' id="sec-0.60864331638" style="display: none;"><a href="javascript:toggle2('sec-0.60864331638')">(hide)</a>
        <div class='rstext'>JAMA rs12777823 and rs4244285 implicated in platelet response to clopidogrel  [PharmGKB:Curated A GWAS found this variant (rs12777823) was the most significantly associated SNP with clopidogrel response. This SNP was in strong linkage disequilibrium with 12 further SNPs within the CYP2C18-CYP2C19-CYP2C9-CYP2C8 cluster (rs12777823; rs10109204; rs2025445; rs1326837; rs717238; rs2860838; rs2860903; rs9332105; rs9332113; rs12572351; rs10509679; rs1934951; rs1934680) and also with the loss-of-function variant CYP2C19*2 (rs4244285). Further findings in this study showed that the CYP2C19*2 genotype accounted for most of all the initially found association with diminished platelet response to clopidogrel.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4244285'>rs4244285</a><a href='http://www.snpedia.com/index.php/rs4244285(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF2F2;'>76.2%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.730593152598" style="display: inline;"><a href="javascript:toggle2('sec-0.730593152598')">...more...</a></div>
        <div class='boxrstext' id="sec-0.730593152598" style="display: none;"><a href="javascript:toggle2('sec-0.730593152598')">(hide)</a>
        <div class='rstext'>rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid). In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pyl...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs28399504'>rs28399504</a><a href='http://www.snpedia.com/index.php/rs28399504(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.47420532601" style="display: inline;"><a href="javascript:toggle2('sec-0.47420532601')">...more...</a></div>
        <div class='boxrstext' id="sec-0.47420532601" style="display: none;"><a href="javascript:toggle2('sec-0.47420532601')">(hide)</a>
        <div class='rstext'>rs28399504 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*4 variant. This variant has been linked to poor metabolism of compounds like mephenytoin. It is also known as M1V or Met1Val. The risk allele is rs28399504(G). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). According to a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504. Clopidogrel Efficacy  [Pharm...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs41291556'>rs41291556</a><a href='http://www.snpedia.com/index.php/rs41291556(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.873513644492" style="display: inline;"><a href="javascript:toggle2('sec-0.873513644492')">...more...</a></div>
        <div class='boxrstext' id="sec-0.873513644492" style="display: none;"><a href="javascript:toggle2('sec-0.873513644492')">(hide)</a>
        <div class='rstext'>Defines the CYP2C19 variant known as CYP2C19*8. Carriers of the rs41291556(C) allele may have decreased activity and poor metabolizer (PM) phenotype. This variant is associated with a dramatic (approximately 90% and 70%) reduction in the metabolism of S-mephenytoin and tolbutamide in vitro. Clopidogrel Efficacy  [PharmGKB:Curated This variant is the defining SNP for CYP2C19*8 and leads to decreased activity and poor metabolizer (PM) phenotype.This variant is associated with a dramatic (approximately 90% and 70%) reduction in the metabolism of S-mephenytoin and tolbutamide in vitro.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4986893'>rs4986893</a><a href='http://www.snpedia.com/index.php/rs4986893(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.360487629938" style="display: inline;"><a href="javascript:toggle2('sec-0.360487629938')">...more...</a></div>
        <div class='boxrstext' id="sec-0.360487629938" style="display: none;"><a href="javascript:toggle2('sec-0.360487629938')">(hide)</a>
        <div class='rstext'>rs4986893 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*3 variant. This variant has been linked to poor metabolism of compounds like mephenytoin as well as proguanil, and it therefore has implications for malaria prophylaxis. The risk allele is rs4986893(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). Clopidogrel Efficacy  [PharmGKB:Curated In contrast to other PPIs, esomeprazole-induced healing of GERD appears to be unrelated to the CYP2C19*3 variant.] [OMIM:MEPHENYTOIN, POOR METABOLISM OF]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs56337013'>rs56337013</a><a href='http://www.snpedia.com/index.php/rs56337013(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.960594257138" style="display: inline;"><a href="javascript:toggle2('sec-0.960594257138')">...more...</a></div>
        <div class='boxrstext' id="sec-0.960594257138" style="display: none;"><a href="javascript:toggle2('sec-0.960594257138')">(hide)</a>
        <div class='rstext'>The rs56337013(T) allele defines the CYP2C19 variant known as CYP2C19*5. This variant is quite rare (&lt; 1% of Caucasians or Chinese), and leads to a poor metabolizer phenotype.  [PharmGKB:Curated This variant is the defining SNP for CYP2C19*5 and contributes to the S-mephenytoin poor metabolizer phenotype in caucasians and chinese. The Arg433 to Trp mutation in the heme-binding region essentially abolishes CYP2C19 activity toward S-mephenytoin and tolbutamide.] [OMIM:?]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs72558186'>rs72558186</a><a href='http://www.snpedia.com/index.php/rs72558186(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:1<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.902425514445" style="display: inline;"><a href="javascript:toggle2('sec-0.902425514445')">...more...</a></div>
        <div class='boxrstext' id="sec-0.902425514445" style="display: none;"><a href="javascript:toggle2('sec-0.902425514445')">(hide)</a>
        <div class='rstext'>The rs72558186(A) SNP represents a CYP2C19 allele known as CYP2C19*7; it reflects a splice donor mutation that leads to a poor metabolizer phenotype. This SNP is also known as CYP2C19_19294T&gt;A, and in the Affymetrix DMET panel, as DMET3B10072. Note: absence of allele frequency data leaves this as a possible ambiguous flip.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">10 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|50|10">Clozapine</a>

        <div class='boxshow' id="show-disease1629500581198118736" style="display: inline;"><a href="javascript:toggle2('disease1629500581198118736')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease1629500581198118736" style="display: none;"><a href="javascript:toggle2('disease1629500581198118736')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Clozapine">Clozapine</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5443'>rs5443</a><a href='http://www.snpedia.com/index.php/rs5443(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2.1<br/>Frequency: <span style='background-color: #FFE3E3;'>55.6%</span><br/>Repute:Bad<br/>References:40<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>some risk  linked to a number of metabolic conditions including obesity, coronary artery disease, insulin resistance and therefore diabetes, left ventricular hypertrophy, and hypertension. It has also been linked to how well a patient responds to Viagra (sildenafil).</div>
        <div class='boxshow' id="show-sec-0.149351234455" style="display: inline;"><a href="javascript:toggle2('sec-0.149351234455')">...more...</a></div>
        <div class='boxrstext' id="sec-0.149351234455" style="display: none;"><a href="javascript:toggle2('sec-0.149351234455')">(hide)</a>
        <div class='rstext'>rs5443, a SNP in the G-protein beta3 subunit (GNB3) gene that is more commonly known as the C825T variant, has been linked to a number of metabolic conditions including obesity, coronary artery disease, insulin resistance and therefore diabetes, left ventricular hypertrophy, and hypertension. It has also been linked to how well a patient responds to Viagra (sildenafil). Several studies have been unable to replicate one or more of the associations in at least some populations between this SNP and these conditions. The more notable studies include: *rs5443(T) allele carriers are 2-3 fold more likely to be obese in Caucasian, Chinese, and African American populations. *rs5443(T) carriers are clearly at higher risk for hypertension, but this review indicates that whether they are also at incre...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs10499504'>rs10499504</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs10499504(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCECE;'>33.6%</span><br/>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.155077174195" style="display: inline;"><a href="javascript:toggle2('sec-0.155077174195')">...more...</a></div>
        <div class='boxrstext' id="sec-0.155077174195" style="display: none;"><a href="javascript:toggle2('sec-0.155077174195')">(hide)</a>
        <div class='rstext'>gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 4 x 10^-7 for total cholesterol as a result of clozapine use</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2994684'>rs2994684</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs2994684(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFECEC;'>68.1%</span><br/>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.838817780811" style="display: inline;"><a href="javascript:toggle2('sec-0.838817780811')">...more...</a></div>
        <div class='boxrstext' id="sec-0.838817780811" style="display: none;"><a href="javascript:toggle2('sec-0.838817780811')">(hide)</a>
        <div class='rstext'>gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 3 x 10^-7 for triglycerides as a result of clozapine use</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1057868'>rs1057868</a><a href='http://www.snpedia.com/index.php/rs1057868(C;C)'>(C;C)</a></div>
        <div class='boxmag'>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.586912217647" style="display: inline;"><a href="javascript:toggle2('sec-0.586912217647')">...more...</a></div>
        <div class='boxrstext' id="sec-0.586912217647" style="display: none;"><a href="javascript:toggle2('sec-0.586912217647')">(hide)</a>
        <div class='rstext'>rs1057868, also known as A503V, is a relatively common variant defining the POR*28 allele of the P450 (cytochrome) oxidoreductase POR gene. The POR gene encodes a protein involved in electron transport of cytochrome p450 enzymes such as CYP3A4, CYP3A5 and CYP3A7. A study of 251 individuals from two independent studies (182 patients treated with methadone and 69 patients with clozapine) for CYP3A activity found that CYP3A SNPs themselves did not predict particularly well inter-individual variability in overall CYP3A activity. However, rs1057868(T;T) individuals had a 1.6x increased CYP3A activity compared to rs1057868(C) carriers (n=182, p=0.004), and the finding was replicated in a second independent dataset. The authors conclude that this POR gene SNP is a better predictor of overall CYP3...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4606'>rs4606</a><a href='http://www.snpedia.com/index.php/rs4606(C;G)'>(C;G)</a></div>
        <div class='boxmag'>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>complex; possible association with anxiety related behaviours</div>
        <div class='boxshow' id="show-sec-0.64598661599" style="display: inline;"><a href="javascript:toggle2('sec-0.64598661599')">...more...</a></div>
        <div class='boxrstext' id="sec-0.64598661599" style="display: none;"><a href="javascript:toggle2('sec-0.64598661599')">(hide)</a>
        <div class='rstext'>In mice, the genetic locus best correlated to anxiety-related behaviour contains the 'regulator of G protein signaling 2' gene . In humans, SNPs in the equivalent RGS2 gene have now been studied to see if they are correlated to anxiety related disorders. In the first part of one study, 119 families including children underwent standard lab-based behavioural assessments of behavioural inhibition, defined as a heritable temperamental profile characterized by a tendency to be shy, avoident, and behaviourally restrained in situations that are novel or unfamiliar. Along with some other RGS2 SNPs, carriers of a rs4606(G) allele were 3 fold more likely to exhibit behavioural inhibition (CI: 1.31-6.84, p = 0.0026). In the second part of this study, 744 college undergraduates (228 men, 516 women) w...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1414334'>rs1414334</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1414334(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #F0B8F0;'>75.9%</span><br/>References:8<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.48093370769" style="display: inline;"><a href="javascript:toggle2('sec-0.48093370769')">...more...</a></div>
        <div class='boxrstext' id="sec-0.48093370769" style="display: none;"><a href="javascript:toggle2('sec-0.48093370769')">(hide)</a>
        <div class='rstext'>rs1414334(C) associated with the metabolic syndrome in patients using *clozapine (OR, 9.20; 95% CI, 1.95-43.45) *risperidone (OR, 5.35; 95% CI, 1.26-22.83)  [PharmGKB:Curated Risk or phenotype-associated allele: C. Phenotype: In a replication study, the C allele of HTR2C rs1414334 polymorphism is associated with development of the metabolic syndrome during treatment with antipsychotics. Study size: 186. Study population/ethnicity: 93% Caucasian; European; Dutch; The Netherlands. Significance metric(s): OR = 3.73; 95% CI= 1.29-10.79; P = 0.015. Type of association: CO.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs17385675'>rs17385675</a><a href='http://www.snpedia.com/index.php/rs17385675(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF6F6;'>84.1%</span><br/>Repute:Good<br/>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.262082607005" style="display: inline;"><a href="javascript:toggle2('sec-0.262082607005')">...more...</a></div>
        <div class='boxrstext' id="sec-0.262082607005" style="display: none;"><a href="javascript:toggle2('sec-0.262082607005')">(hide)</a>
        <div class='rstext'>gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 3 x 10^-6 for triglycerides as a result of clozapine use</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs13224682'>rs13224682</a><a href='http://www.snpedia.com/index.php/rs13224682(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF7F7;'>85.0%</span><br/>Repute:Good<br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common on affy axiom data</div>
        <div class='boxshow' id="show-sec-0.950617076412" style="display: inline;"><a href="javascript:toggle2('sec-0.950617076412')">...more...</a></div>
        <div class='boxrstext' id="sec-0.950617076412" style="display: none;"><a href="javascript:toggle2('sec-0.950617076412')">(hide)</a>
        <div class='rstext'>gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 6 x 10^-8 for triglycerides as a result of clozapine use</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">8 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:40|0|0">Codeine</a>

        <div class='boxshow' id="show-disease1428490708717616588" style="display: inline;"><a href="javascript:toggle2('disease1428490708717616588')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease1428490708717616588" style="display: none;"><a href="javascript:toggle2('disease1428490708717616588')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Codeine">Codeine</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5030655'>rs5030655</a><a href='http://www.snpedia.com/index.php/rs5030655(I;I)'>(I;I)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.678544739787" style="display: inline;"><a href="javascript:toggle2('sec-0.678544739787')">...more...</a></div>
        <div class='boxrstext' id="sec-0.678544739787" style="display: none;"><a href="javascript:toggle2('sec-0.678544739787')">(hide)</a>
        <div class='rstext'>The (-) form of this SNP, representing a deletion of one nucleotide, causes a frameshift such that the resulting CYP2D6 protein is nonfunctional. The associated allele is also known as CYP2D6*6, and there are several subtypes but they are all nonfunctional. If two copies of this (or similar) changes are inherited, CYP2D6 poor metabolism ('PM') is observed. CYP2D6 poor metabolism may affect the efficacy or degree of side effects of drugs metabolized by CYP2D6, such as dextromorphan, sparteine, nortriptyline, venlafaxine and codeine. Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms.  [PharmGKB:Curated This variant is part of the CYP2D6*6 PM haplotype. Plasma concentrations of metoprolol were shown to be were 4.9-fold higher in the PMs, with gr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1799971'>rs1799971</a><a href='http://www.snpedia.com/index.php/rs1799971(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEEEE;'>70.8%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.0983325585546" style="display: inline;"><a href="javascript:toggle2('sec-0.0983325585546')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0983325585546" style="display: none;"><a href="javascript:toggle2('sec-0.0983325585546')">(hide)</a>
        <div class='rstext'>The rs1799971(G) allele in exon 1 of the mu opioid receptor OPRM1 gene causes the normal amino acid at residue 40, asparagine (Asn), to be replaced by aspartic acid (Asp). In the literature this SNP is also known as A118G, N40D, or Asn40Asp. Carriers of at least one rs1799971(G) allele appear to have stronger cravings for alcohol than carriers of two rs1799971(A) alleles, and are thus hypothesized to be more at higher risk for alcoholism. However, subsequent research results are mixed, and there are other studies both agreeing or disagreeing with this finding Among 200+ alcoholics treated with naltrexone, rs1799971(G) carriers receiving the drug (even without behavioral intervention) had an increased percentage of days abstinent (p = .07) and a decreased percentage of heavy drinking days (...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1065852'>rs1065852</a><a href='http://www.snpedia.com/index.php/rs1065852(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.769642828196" style="display: inline;"><a href="javascript:toggle2('sec-0.769642828196')">...more...</a></div>
        <div class='boxrstext' id="sec-0.769642828196" style="display: none;"><a href="javascript:toggle2('sec-0.769642828196')">(hide)</a>
        <div class='rstext'>The wild type (normal) allele at this SNP is (C). The (T) variant indicates the presence of a non-wild type CYP2D6 variant, but it appears in many different variants so it can not be used to determine the presence of any particular variant. The most common variants it appears in are CYP2D6*10 and CYP2D6*4, but these are not the only ones. While this is the defining mutation for CYP2D6*10, it is not possible by itself for this mutation to determine a particular variant. In addition, the CYP2D6*4 variant includes this mutation, but the defining mutation 1846G&gt;A SNP is not available in the common direct to consumer testing services. While it is not possible for this mutation to identify one particular variant, all the variants in which it appears have reduced or no CYP2D6 activity. If two ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.237566001063" style="display: inline;"><a href="javascript:toggle2('sec-0.237566001063')">...more...</a></div>
        <div class='boxrstext' id="sec-0.237566001063" style="display: none;"><a href="javascript:toggle2('sec-0.237566001063')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Crestor</a>

        <div class='boxshow' id="show-disease7153282240723987161" style="display: inline;"><a href="javascript:toggle2('disease7153282240723987161')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease7153282240723987161" style="display: none;"><a href="javascript:toggle2('disease7153282240723987161')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Crestor">Crestor</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs20455'>rs20455</a><a href='http://www.snpedia.com/index.php/rs20455(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD3D3;'>37.2%</span><br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.0370549603614" style="display: inline;"><a href="javascript:toggle2('sec-0.0370549603614')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0370549603614" style="display: none;"><a href="javascript:toggle2('sec-0.0370549603614')">(hide)</a>
        <div class='rstext'>rs20455, often called Arg719 or 719Arg, is a reasonably well studied SNP in the KIF6 gene. The risk allele (encoding the arginine at position 719) is rs20455(C). An extensive 2010 meta-analysis, including over 17,000 patients, suggests this variant does not significantly influence coronary artery disease risk. This SNP is one of the 5 used by Celera's genetic risk score (GRS) for coronary heart disease (CHD). *rs20455, in the KIF6 gene *rs3900940, in the MYH15 gene *rs7439293, in the PALLD gene *rs2298566, in the SNX19 gene *rs1010, in the VAMP8 gene For each of the five variants, the GRS was increased by 1 if the subject was homozygous for the risk variant, unchanged if heterozygous, and decreased by 1 if the individual did not carry the variant. Therefore, individuals carrying all 10 pos...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Cyclophosphamide</a>

        <div class='boxshow' id="show-disease-1629915067541622676" style="display: inline;"><a href="javascript:toggle2('disease-1629915067541622676')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-1629915067541622676" style="display: none;"><a href="javascript:toggle2('disease-1629915067541622676')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Cyclophosphamide">Cyclophosphamide</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4880'>rs4880</a><a href='http://www.snpedia.com/index.php/rs4880(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 1.1<br/>Frequency: <span style='background-color: #FFCDCD;'>32.7%</span><br/>References:83<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>complex! see rs4880</div>
        <div class='boxshow' id="show-sec-0.458624605289" style="display: inline;"><a href="javascript:toggle2('sec-0.458624605289')">...more...</a></div>
        <div class='boxrstext' id="sec-0.458624605289" style="display: none;"><a href="javascript:toggle2('sec-0.458624605289')">(hide)</a>
        <div class='rstext'>The rs4880(T) allele, part of the codon for amino acid valine at codon 16 of the antioxidant protein from the mitochrondrial superoxide dismutase 2 SOD2 gene, is the most common in most populations studied. The rs4880(C) allele gives rise to an alanine at this position is it also known as Val16Ala manganese superoxide dismutase, or A16V. There appears to be some conflict in the literature over the effect of this SNP. Having a valine at codon 16 is said to reduce enzyme activity , and thus lead to increased oxidative stress, yet in at least one study of the actual enzyme levels measured in people, SOD2 activity was 33% higher in (C;T) or (T;T) individuals compared to (C;C) individuals . Regardless of how this resolves, several phenotypic associations have been reported for this SNP, includi...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1056836'>rs1056836</a><a href='http://www.snpedia.com/index.php/rs1056836(C;G)'>(C;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFD9D9;'>43.4%</span><br/>References:65<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.0144107367155" style="display: inline;"><a href="javascript:toggle2('sec-0.0144107367155')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0144107367155" style="display: none;"><a href="javascript:toggle2('sec-0.0144107367155')">(hide)</a>
        <div class='rstext'>rs1056836, also known as 4326C/G, Val432Leu or L432V, is a SNP in the cytochrome P450 1B1 (CYP1B1) gene. This gene is a member of the CYP1 gene family and one of the major enzymes involved in the hydroxylation of estrogens, a reaction likely to be relevant in hormonal carcinogenesis. [In dbSNP orientation, the (C) allele encodes the Leu; the (G) the Val.] In a study of 153 Hispanic Caucasians with prostate cancer the rs1056836(G;G) genotype showed decreased risk compared to the more common (C;C) genotype (odds ratio = 0.31, p = 0.04, CI: 0.10-0.96). This report cites another study as indicating that rs1056836(C;C) high-risk stage III and IV breast cancer patients receiving dose-intense paclitaxel in combination with doxorubicin and cyclophosphamide experience a longer progression-free surv...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Dapsone</a>

        <div class='boxshow' id="show-disease-677647054177425703" style="display: inline;"><a href="javascript:toggle2('disease-677647054177425703')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-677647054177425703" style="display: none;"><a href="javascript:toggle2('disease-677647054177425703')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Dapsone">Dapsone</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2844573'>rs2844573</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs2844573(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD7D7;'>41.6%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.147307487777" style="display: inline;"><a href="javascript:toggle2('sec-0.147307487777')">...more...</a></div>
        <div class='boxrstext' id="sec-0.147307487777" style="display: none;"><a href="javascript:toggle2('sec-0.147307487777')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|0|0">Desipramine</a>

        <div class='boxshow' id="show-disease8811125115654974258" style="display: inline;"><a href="javascript:toggle2('disease8811125115654974258')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease8811125115654974258" style="display: none;"><a href="javascript:toggle2('disease8811125115654974258')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Desipramine">Desipramine</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5558'>rs5558</a><a href='http://www.snpedia.com/index.php/rs5558(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFFFF;'>100.0%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.461388454369" style="display: inline;"><a href="javascript:toggle2('sec-0.461388454369')">...more...</a></div>
        <div class='boxrstext' id="sec-0.461388454369" style="display: none;"><a href="javascript:toggle2('sec-0.461388454369')">(hide)</a>
        <div class='rstext'>rs5558 (F528C) is a non-synonymous SNP in SLC6A2 (norepinephrine transporter), with a T encoding for Phenylalanine and C encoding the rare Cysteine variant. assoc. w/ major depression Cysteine variant exhibited increased norepinephrine transport, insensitivity to protein kinase C induced down-regulation, and a decrease in desipramine (tricyclic antidepressant) potency</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.31091542633" style="display: inline;"><a href="javascript:toggle2('sec-0.31091542633')">...more...</a></div>
        <div class='boxrstext' id="sec-0.31091542633" style="display: none;"><a href="javascript:toggle2('sec-0.31091542633')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|0|0">Dextromethorphan</a>

        <div class='boxshow' id="show-disease-3281168508832733492" style="display: inline;"><a href="javascript:toggle2('disease-3281168508832733492')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-3281168508832733492" style="display: none;"><a href="javascript:toggle2('disease-3281168508832733492')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Dextromethorphan">Dextromethorphan</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5030655'>rs5030655</a><a href='http://www.snpedia.com/index.php/rs5030655(I;I)'>(I;I)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.922784625061" style="display: inline;"><a href="javascript:toggle2('sec-0.922784625061')">...more...</a></div>
        <div class='boxrstext' id="sec-0.922784625061" style="display: none;"><a href="javascript:toggle2('sec-0.922784625061')">(hide)</a>
        <div class='rstext'>The (-) form of this SNP, representing a deletion of one nucleotide, causes a frameshift such that the resulting CYP2D6 protein is nonfunctional. The associated allele is also known as CYP2D6*6, and there are several subtypes but they are all nonfunctional. If two copies of this (or similar) changes are inherited, CYP2D6 poor metabolism ('PM') is observed. CYP2D6 poor metabolism may affect the efficacy or degree of side effects of drugs metabolized by CYP2D6, such as dextromorphan, sparteine, nortriptyline, venlafaxine and codeine. Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms.  [PharmGKB:Curated This variant is part of the CYP2D6*6 PM haplotype. Plasma concentrations of metoprolol were shown to be were 4.9-fold higher in the PMs, with gr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1065852'>rs1065852</a><a href='http://www.snpedia.com/index.php/rs1065852(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.345368380668" style="display: inline;"><a href="javascript:toggle2('sec-0.345368380668')">...more...</a></div>
        <div class='boxrstext' id="sec-0.345368380668" style="display: none;"><a href="javascript:toggle2('sec-0.345368380668')">(hide)</a>
        <div class='rstext'>The wild type (normal) allele at this SNP is (C). The (T) variant indicates the presence of a non-wild type CYP2D6 variant, but it appears in many different variants so it can not be used to determine the presence of any particular variant. The most common variants it appears in are CYP2D6*10 and CYP2D6*4, but these are not the only ones. While this is the defining mutation for CYP2D6*10, it is not possible by itself for this mutation to determine a particular variant. In addition, the CYP2D6*4 variant includes this mutation, but the defining mutation 1846G&gt;A SNP is not available in the common direct to consumer testing services. While it is not possible for this mutation to identify one particular variant, all the variants in which it appears have reduced or no CYP2D6 activity. If two ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.361017498347" style="display: inline;"><a href="javascript:toggle2('sec-0.361017498347')">...more...</a></div>
        <div class='boxrstext' id="sec-0.361017498347" style="display: none;"><a href="javascript:toggle2('sec-0.361017498347')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Disulfiram</a>

        <div class='boxshow' id="show-disease-29750014695253702" style="display: inline;"><a href="javascript:toggle2('disease-29750014695253702')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-29750014695253702" style="display: none;"><a href="javascript:toggle2('disease-29750014695253702')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Disulfiram">Disulfiram</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs671'>rs671</a><a href='http://www.snpedia.com/index.php/rs671(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFFFFF;'>100.0%</span><br/>Repute:Good<br/>References:52<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Alcohol Flush: Normal, doesn't flush. Normal hangovers. Normal risk of Alcoholism. Normal risk of Esophageal Cancer. Disulfiram is effective for alcoholism.  Two working copies of Aldehyde Dehydrogenase (ALDH2) mean you won't turn bright red when you drink alcohol, unlike most Asians. After your body turns alcohol into the dangerous acetaldehyde, this gene quickly turns the acetaldehyde into vinegar. It also stops the acetaldehyde in cigarettes from causing Esophageal Cancer. It reduces hangovers compared to Asians, but less hangovers and flushing obviously increases the risk of alcoholism. Alcoholism can be treated effectively with the drug Disulfiram (Antabuse) which would stop this gene from working and cause the Asian flush in non-Asians. PMC2659709 [http://www.ncbi.nlm.nih.gov/pmc/art...</div>
        <div class='boxshow' id="show-sec-0.214776866289" style="display: inline;"><a href="javascript:toggle2('sec-0.214776866289')">...more...</a></div>
        <div class='boxrstext' id="sec-0.214776866289" style="display: none;"><a href="javascript:toggle2('sec-0.214776866289')">(hide)</a>
        <div class='rstext'>rs671 is a classic SNP, well known in a sense through the phenomena known as the 'alcohol flush', also known as the 'Asian Flush' or 'Asian blush', in which certain individuals, often of Asian descent, have their face, neck and sometimes shoulders turn red after drinking alcohol. The rs671(A) allele of the ALDH2 gene is the culprit, in that it encodes a form of the aldehyde dehydrogenase 2 protein that is defective at metabolizing alcohol. This allele is known as the ALDH*2 form, and individuals possessing either one or two copies of it show alcohol-related sensitivity responses including facial flushing, and severe hangovers (and hence they are usually not regular drinkers). Perhaps not surprisingly they appear to suffer less from alcoholism and alcohol-related liver disease. Disulfiram (...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|0|0">Docetaxel</a>

        <div class='boxshow' id="show-disease2657395168590878780" style="display: inline;"><a href="javascript:toggle2('disease2657395168590878780')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease2657395168590878780" style="display: none;"><a href="javascript:toggle2('disease2657395168590878780')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Docetaxel">Docetaxel</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs11045585'>rs11045585</a><a href='http://www.snpedia.com/index.php/rs11045585(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFEFEF;'>72.3%</span><br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>24% chance (lower than average) of docetaxel-induced leukopenia/neutropenia</div>
        <div class='boxshow' id="show-sec-0.0754604148569" style="display: inline;"><a href="javascript:toggle2('sec-0.0754604148569')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0754604148569" style="display: none;"><a href="javascript:toggle2('sec-0.0754604148569')">(hide)</a>
        <div class='rstext'>rs12762549 and rs11045585 can be used to predict whether docetaxel will induce leukopenia/neutropenia, according to a study of ~100 Japanese patients. When patients were classified into three groups by the scoring system based on the genotypes of these two SNPs, patients with a score of 1 or 2 were shown to have a significantly higher risk of docetaxel-induced leukopenia/neutropenia as compared to those with a score of 0 (P = 0.0000057; odds ratio [OR], 7.00; 95% CI [confidence interval], 2.95-16.59). This prediction system correctly classified 69.2% of severe leukopenia/neutropenia and 75.7% of non-leukopenia/neutropenia into the respective categories. [Effect percentages provided in table are raw population fractions taken from the referenced study based on rs11045585 only. Total populat...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1695'>rs1695</a><a href='http://www.snpedia.com/index.php/rs1695(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFCCCC;'>31.9%</span><br/>Repute:Good<br/>References:98<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal asthma risk in certain populations</div>
        <div class='boxshow' id="show-sec-0.321494515131" style="display: inline;"><a href="javascript:toggle2('sec-0.321494515131')">...more...</a></div>
        <div class='boxrstext' id="sec-0.321494515131" style="display: none;"><a href="javascript:toggle2('sec-0.321494515131')">(hide)</a>
        <div class='rstext'>This SNP, in the GSTP1 gene influences asthma risk; the (A) allele encodes the Ile, while the (G) allele encodes the Val. This SNP is also known as GSTP1Val105, or GSTP1 Ile105Val. Despite evidence of antioxidant effects of vitamin E in vitro and in animal studies, large, randomized clinical trials have not substantiated a benefit of vitamin E in reducing inflammation in humans. In healthy control subjects, the effect of &#945;-tocopherol supplementation on the production of inflammatory cytokines appears to be dependent on an individual's genotype. These genotype-specific differences may help explain some of the discordant results in studies that used vitamin E. Persons having the alleles AA or AG had an increase in interleukin-6 (IL-6) upon supplementing alpha-tocopherol (the most common...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Dofetilide</a>

        <div class='boxshow' id="show-disease381562744664866043" style="display: inline;"><a href="javascript:toggle2('disease381562744664866043')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease381562744664866043" style="display: none;"><a href="javascript:toggle2('disease381562744664866043')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Dofetilide">Dofetilide</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs17221854'>rs17221854</a><a href='http://www.snpedia.com/index.php/rs17221854(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:6<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in clinvar</div>
        <div class='boxshow' id="show-sec-0.610082367169" style="display: inline;"><a href="javascript:toggle2('sec-0.610082367169')">...more...</a></div>
        <div class='boxrstext' id="sec-0.610082367169" style="display: none;"><a href="javascript:toggle2('sec-0.610082367169')">(hide)</a>
        <div class='rstext'>rs17221854, also known as Arg583Cys or R583C, is a SNP in the KCNQ1 gene on chromosome 11. The rs17221854(T) allele has been reported as associated with long QT syndrome. Additionally, a person who developed QT prolongation and torsade de pointes while taking the drug dofetilide carried this (T) allele, leading the authors to hypothesize that this mutation was responsible for the patient's drug response. This variant meets the criteria published in 2013 by the ACMG regarding incidental findings in exome or genome sequencing, as a variant that they do recommend informing a patient about.  [OMIM:LONG QT SYNDROME 1]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Effexor</a>

        <div class='boxshow' id="show-disease829048881587789466" style="display: inline;"><a href="javascript:toggle2('disease829048881587789466')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease829048881587789466" style="display: none;"><a href="javascript:toggle2('disease829048881587789466')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Effexor">Effexor</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.173483896917" style="display: inline;"><a href="javascript:toggle2('sec-0.173483896917')">...more...</a></div>
        <div class='boxrstext' id="sec-0.173483896917" style="display: none;"><a href="javascript:toggle2('sec-0.173483896917')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Elatrol</a>

        <div class='boxshow' id="show-disease-5774511657809461940" style="display: inline;"><a href="javascript:toggle2('disease-5774511657809461940')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-5774511657809461940" style="display: none;"><a href="javascript:toggle2('disease-5774511657809461940')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Elatrol">Elatrol</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.752587975725" style="display: inline;"><a href="javascript:toggle2('sec-0.752587975725')">...more...</a></div>
        <div class='boxrstext' id="sec-0.752587975725" style="display: none;"><a href="javascript:toggle2('sec-0.752587975725')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Elavil</a>

        <div class='boxshow' id="show-disease-7879193273374619709" style="display: inline;"><a href="javascript:toggle2('disease-7879193273374619709')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-7879193273374619709" style="display: none;"><a href="javascript:toggle2('disease-7879193273374619709')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Elavil">Elavil</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.726936005326" style="display: inline;"><a href="javascript:toggle2('sec-0.726936005326')">...more...</a></div>
        <div class='boxrstext' id="sec-0.726936005326" style="display: none;"><a href="javascript:toggle2('sec-0.726936005326')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Endep</a>

        <div class='boxshow' id="show-disease-3892909397030714907" style="display: inline;"><a href="javascript:toggle2('disease-3892909397030714907')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-3892909397030714907" style="display: none;"><a href="javascript:toggle2('disease-3892909397030714907')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Endep">Endep</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.795833298397" style="display: inline;"><a href="javascript:toggle2('sec-0.795833298397')">...more...</a></div>
        <div class='boxrstext' id="sec-0.795833298397" style="display: none;"><a href="javascript:toggle2('sec-0.795833298397')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|20|10">Escitalopram</a>

        <div class='boxshow' id="show-disease5253933260664469346" style="display: inline;"><a href="javascript:toggle2('disease5253933260664469346')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease5253933260664469346" style="display: none;"><a href="javascript:toggle2('disease5253933260664469346')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Escitalopram">Escitalopram</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1045642'>rs1045642</a><a href='http://www.snpedia.com/index.php/rs1045642(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFE4E4;'>55.8%</span><br/>Repute:Bad<br/>References:100<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Slower metaboliser for some drugs</div>
        <div class='boxshow' id="show-sec-0.0359132214493" style="display: inline;"><a href="javascript:toggle2('sec-0.0359132214493')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0359132214493" style="display: none;"><a href="javascript:toggle2('sec-0.0359132214493')">(hide)</a>
        <div class='rstext'>rs1045642, also known as C3435T, is a SNP located in the ABCB1 gene. It is often studied in conjunction with rs2032582. C3435T has been mentioned by: * A 'Silent' Polymorphism in the MDR1 Gene Changes Substrate Specificity (for example, to verapamil) * (R)-lansoprazole (Prevacid) concentrations are significantly increased in CYP2C19 extensive metabolizers with ABCB1 C3435T C allele. * In a Korean population, plasma concentrations of fexofenadine (Allegra) were 17% lower in 2677AA/3435CC subjects and 47% higher in the 2677TT/3435TT subjects compared to 2677GG/3435CC subjects. * In contrast, in this study no association was observed between the C3435T polymorphism and fexofenadine plasma or urine concentrations in a German Caucasian population. * A meta-analysis including 9 case-control stud...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.0795911734669" style="display: inline;"><a href="javascript:toggle2('sec-0.0795911734669')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0795911734669" style="display: none;"><a href="javascript:toggle2('sec-0.0795911734669')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1126757'>rs1126757</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1126757(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDEDE;'>49.6%</span><br/>References:5<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.636137744837" style="display: inline;"><a href="javascript:toggle2('sec-0.636137744837')">...more...</a></div>
        <div class='boxrstext' id="sec-0.636137744837" style="display: none;"><a href="javascript:toggle2('sec-0.636137744837')">(hide)</a>
        <div class='rstext'>escitalopram response  [GWAS:Response to antidepressants]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs25532'>rs25532</a><a href='http://www.snpedia.com/index.php/rs25532(C;C)'>(C;C)</a></div>
        <div class='boxmag'>References:6<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>may be part of a haplotype associated with OCD</div>
        <div class='boxshow' id="show-sec-0.744596595098" style="display: inline;"><a href="javascript:toggle2('sec-0.744596595098')">...more...</a></div>
        <div class='boxrstext' id="sec-0.744596595098" style="display: none;"><a href="javascript:toggle2('sec-0.744596595098')">(hide)</a>
        <div class='rstext'>rs25532 is a SNP in a regulatory region upstream of the serotonin transporter SLC6A4 gene. The more common allele, rs25532(C), is the higher-expressing allele. A study of patients with obsessive compulsive disorder (OCD) concluded that the major allele of rs25532 was a major contributor to the association of a corresponding haplotype with this disorder.  [PharmGKB:Curated This study found that the minor allele of the functional C &gt; T single nucleotide polymorphism, rs25532, located less than 150 nucleotides centromeric of the serotonin transporter-linked polymorphic region indel (known as 5-HTTLPR) significantly decreased luciferase reporter gene expression levels by 15-80%, depending on 5-HTTLPR allele background and cell type.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2020933'>rs2020933</a><a href='http://www.snpedia.com/index.php/rs2020933(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #F09DF0;'>89.1%</span><br/>Repute:Good<br/>References:7<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.978277307144" style="display: inline;"><a href="javascript:toggle2('sec-0.978277307144')">...more...</a></div>
        <div class='boxrstext' id="sec-0.978277307144" style="display: none;"><a href="javascript:toggle2('sec-0.978277307144')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">5 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|0|0">Esomeprazole</a>

        <div class='boxshow' id="show-disease-7572554279421370732" style="display: inline;"><a href="javascript:toggle2('disease-7572554279421370732')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-7572554279421370732" style="display: none;"><a href="javascript:toggle2('disease-7572554279421370732')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Esomeprazole">Esomeprazole</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4244285'>rs4244285</a><a href='http://www.snpedia.com/index.php/rs4244285(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF2F2;'>76.2%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.357856892226" style="display: inline;"><a href="javascript:toggle2('sec-0.357856892226')">...more...</a></div>
        <div class='boxrstext' id="sec-0.357856892226" style="display: none;"><a href="javascript:toggle2('sec-0.357856892226')">(hide)</a>
        <div class='rstext'>rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid). In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pyl...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs28399504'>rs28399504</a><a href='http://www.snpedia.com/index.php/rs28399504(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.858705339831" style="display: inline;"><a href="javascript:toggle2('sec-0.858705339831')">...more...</a></div>
        <div class='boxrstext' id="sec-0.858705339831" style="display: none;"><a href="javascript:toggle2('sec-0.858705339831')">(hide)</a>
        <div class='rstext'>rs28399504 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*4 variant. This variant has been linked to poor metabolism of compounds like mephenytoin. It is also known as M1V or Met1Val. The risk allele is rs28399504(G). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). According to a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504. Clopidogrel Efficacy  [Pharm...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4986893'>rs4986893</a><a href='http://www.snpedia.com/index.php/rs4986893(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.181910112892" style="display: inline;"><a href="javascript:toggle2('sec-0.181910112892')">...more...</a></div>
        <div class='boxrstext' id="sec-0.181910112892" style="display: none;"><a href="javascript:toggle2('sec-0.181910112892')">(hide)</a>
        <div class='rstext'>rs4986893 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*3 variant. This variant has been linked to poor metabolism of compounds like mephenytoin as well as proguanil, and it therefore has implications for malaria prophylaxis. The risk allele is rs4986893(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). Clopidogrel Efficacy  [PharmGKB:Curated In contrast to other PPIs, esomeprazole-induced healing of GERD appears to be unrelated to the CYP2C19*3 variant.] [OMIM:MEPHENYTOIN, POOR METABOLISM OF]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|0|10">Finasteride</a>

        <div class='boxshow' id="show-disease-3306481756399644909" style="display: inline;"><a href="javascript:toggle2('disease-3306481756399644909')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-3306481756399644909" style="display: none;"><a href="javascript:toggle2('disease-3306481756399644909')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Finasteride">Finasteride</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs279858'>rs279858</a><a href='http://www.snpedia.com/index.php/rs279858(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 2.1<br/>Frequency: <span style='background-color: #FFC3C3;'>24.8%</span><br/>Repute:Bad<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>apparently more prone to alcoholism  interacts with the medicine Finasteride</div>
        <div class='boxshow' id="show-sec-0.885640237659" style="display: inline;"><a href="javascript:toggle2('sec-0.885640237659')">...more...</a></div>
        <div class='boxrstext' id="sec-0.885640237659" style="display: none;"><a href="javascript:toggle2('sec-0.885640237659')">(hide)</a>
        <div class='rstext'>This SNP in the GABRA2 gene has been linked to Alcoholism. The effect of this SNP, a synonymous change at amino acid residue 132, is unknown, but it does not change the GABRA2 protein sequence. Carriers of at least one rs279858(G) allele respond slower to the effects of alcohol and are thereby apparently more prone to alcoholism than carriers of two rs279858(A) alleles. Finasteride, an FDA approved drug for the treatment of benign prostatic hypertrophy and a modulator of GABRA2, was shown to have more of a blocking effect on rs279858(A) homozygotes. Note that nearby SNPs have been grouped into a haplotype that shows statistically stronger association with alcohol dependence, namely the haplotype consisting of the rs279871(A) + rs279845(T) + rs279836(A) alleles . 1050 nicotine-dependent cas...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|0|0">Flucloxacillin</a>

        <div class='boxshow' id="show-disease3487855602903220463" style="display: inline;"><a href="javascript:toggle2('disease3487855602903220463')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease3487855602903220463" style="display: none;"><a href="javascript:toggle2('disease3487855602903220463')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Flucloxacillin">Flucloxacillin</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs10937275'>rs10937275</a><a href='http://www.snpedia.com/index.php/rs10937275(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF7F7;'>85.0%</span><br/>Repute:Good<br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.304134309407" style="display: inline;"><a href="javascript:toggle2('sec-0.304134309407')">...more...</a></div>
        <div class='boxrstext' id="sec-0.304134309407" style="display: none;"><a href="javascript:toggle2('sec-0.304134309407')">(hide)</a>
        <div class='rstext'>In HLA-B*5701 carrier cases, i.e. rs2395029(G) carriers, rs10937275 showed an increased in risk for drug-induced liver injury for patients taking flucloxacillin. The odds ratio was 4.1 (p = 1.4 x 10(-8)).  [PharmGKB:Curated This intronic variant of ST6GAL1 was significantly associated with flucloxacillin-induced liver injury in a GWAS screen (OR = 4.1, P = 1.4x10-8).] [OMIM:HLA COMPLEX P5 GENE; HCP5]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2395029'>rs2395029</a><a href='http://www.snpedia.com/index.php/rs2395029(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF9F9;'>88.5%</span><br/>Repute:Good<br/>References:32<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common  The rs2395029(T;T) genotype is the common genotype for this SNP, against which the rs2395029(T;G) and rs2395029(G;G) genotypes that are associated with reduced HIV viral load in HIV carriers are compared. See also rs9264942 and HIV.</div>
        <div class='boxshow' id="show-sec-0.204452821085" style="display: inline;"><a href="javascript:toggle2('sec-0.204452821085')">...more...</a></div>
        <div class='boxrstext' id="sec-0.204452821085" style="display: none;"><a href="javascript:toggle2('sec-0.204452821085')">(hide)</a>
        <div class='rstext'>rs2395029 is a SNP in the major histocompatibility complex (MHC) region, and several studies have shown that the rs2395029(G) allele is 99.9% predictive of the presence of an HLA-B*5701 allele. This HLA allele, in turn, has been associated with several conditions. A study of 51 cases of flucloxacillin drug-induced liver injury (DILI), an important cause of serious liver disease, along with a replication study of another 23 cases, found that the rs2395029(G) carriers were at highly increased risk (odds ratio 80, p=8.7x10(-33)). * see also: 23andMe blog rs2395029(G;G) increases the odds of drug-induced liver injury in response to flucloxacillin by 45x This SNP is thought to be involved in determining the HIV viral load set point during the asymptomatic period of infection. This SNP is estima...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|50|0">Fluoropyrimidines</a>

        <div class='boxshow' id="show-disease-8849519710253126827" style="display: inline;"><a href="javascript:toggle2('disease-8849519710253126827')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-8849519710253126827" style="display: none;"><a href="javascript:toggle2('disease-8849519710253126827')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Fluoropyrimidines">Fluoropyrimidines</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801268'>rs1801268</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1801268(G;G)'>(G;G)</a></div>
        <div class='boxmag'>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.0727928311072" style="display: inline;"><a href="javascript:toggle2('sec-0.0727928311072')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0727928311072" style="display: none;"><a href="javascript:toggle2('sec-0.0727928311072')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs59086055'>rs59086055</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs59086055(G;G)'>(G;G)</a></div>
        <div class='boxmag'>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.380310190199" style="display: inline;"><a href="javascript:toggle2('sec-0.380310190199')">...more...</a></div>
        <div class='boxrstext' id="sec-0.380310190199" style="display: none;"><a href="javascript:toggle2('sec-0.380310190199')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs72549304'>rs72549304</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs72549304(G;G)'>(G;G)</a></div>
        <div class='boxmag'>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.665336010385" style="display: inline;"><a href="javascript:toggle2('sec-0.665336010385')">...more...</a></div>
        <div class='boxrstext' id="sec-0.665336010385" style="display: none;"><a href="javascript:toggle2('sec-0.665336010385')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs72549307'>rs72549307</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs72549307(T;T)'>(T;T)</a></div>
        <div class='boxmag'>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.514193986848" style="display: inline;"><a href="javascript:toggle2('sec-0.514193986848')">...more...</a></div>
        <div class='boxrstext' id="sec-0.514193986848" style="display: none;"><a href="javascript:toggle2('sec-0.514193986848')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs72549308'>rs72549308</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs72549308(T;T)'>(T;T)</a></div>
        <div class='boxmag'>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.193802771402" style="display: inline;"><a href="javascript:toggle2('sec-0.193802771402')">...more...</a></div>
        <div class='boxrstext' id="sec-0.193802771402" style="display: none;"><a href="javascript:toggle2('sec-0.193802771402')">(hide)</a>
        <div class='rstext'></div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3918290'>rs3918290</a><a href='http://www.snpedia.com/index.php/rs3918290(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFEFE;'>99.1%</span><br/>Repute:Good<br/>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.620866828944" style="display: inline;"><a href="javascript:toggle2('sec-0.620866828944')">...more...</a></div>
        <div class='boxrstext' id="sec-0.620866828944" style="display: none;"><a href="javascript:toggle2('sec-0.620866828944')">(hide)</a>
        <div class='rstext'>23andMe reports that the A allele of rs3918290 is associated with the rare recessive disorder dihydropyrimidine dehydrogenase deficiency (DPD), also known as hereditary thymine-uraciluria or familial pyrimidinemia. Note that the terms used in the literature for this gene can be confusing, since the gene is in reverse orientation to the chromosome strand on the reference genome. pharmgkb - defines *2A allele, which has a significantly higher chance of 5-fluorouracil toxicity Fluorouracil Toxicity  [PharmGKB:In-Depth Heterozygosity for the A allele of this SNP is associated with mucositis and leukopenia drug toxicity in cancer patients treated with fluorouracil. Heterozygous males were more likely than heterozygous females to develop severe toxicity. In this study, no A/A homozygotes were ob...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs55886062'>rs55886062</a><a href='http://www.snpedia.com/index.php/rs55886062(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common/normal</div>
        <div class='boxshow' id="show-sec-0.0682561089358" style="display: inline;"><a href="javascript:toggle2('sec-0.0682561089358')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0682561089358" style="display: none;"><a href="javascript:toggle2('sec-0.0682561089358')">(hide)</a>
        <div class='rstext'>rs55886062, also known as c.1679 T&gt;G, encodes the DPYD*13 allele of the DPYD gene on chromosome 1. Note that the terms used in the literature for this gene can be confusing, since the gene is in reverse orientation to the chromosome strand on the reference genome.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs67376798'>rs67376798</a><a href='http://www.snpedia.com/index.php/rs67376798(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:0<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common/normal</div>
        <div class='boxshow' id="show-sec-0.11317773448" style="display: inline;"><a href="javascript:toggle2('sec-0.11317773448')">...more...</a></div>
        <div class='boxrstext' id="sec-0.11317773448" style="display: none;"><a href="javascript:toggle2('sec-0.11317773448')">(hide)</a>
        <div class='rstext'>rs67376798, also known as c.2846 A&gt;T, is a SNP in the DPYD gene on chromosome 1. Note that the 'A&gt;T' term in the name used in the literature for this SNP can be confusing, since the gene is in reverse orientation to the chromosome strand on the reference genome.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">8 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Fluticasone propionate</a>

        <div class='boxshow' id="show-disease5346342102654022110" style="display: inline;"><a href="javascript:toggle2('disease5346342102654022110')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease5346342102654022110" style="display: none;"><a href="javascript:toggle2('disease5346342102654022110')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Fluticasone%20propionate">Fluticasone propionate</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs242941'>rs242941</a><a href='http://www.snpedia.com/index.php/rs242941(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>better response to inhaled corticosteroid in patients with COPD</div>
        <div class='boxshow' id="show-sec-0.0714610466225" style="display: inline;"><a href="javascript:toggle2('sec-0.0714610466225')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0714610466225" style="display: none;"><a href="javascript:toggle2('sec-0.0714610466225')">(hide)</a>
        <div class='rstext'>rs242941 is a SNP in the corticotrophin-releasing hormone receptor 1 CRHR1 gene. (G;G) better response to inhaled corticosteroids fluticasone propionate and salmeterol in patients with COPD in a Korean study with 84 subjects.  [PharmGKB:Curated Haplotype tagging SNP.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|0|0">Gefitinib</a>

        <div class='boxshow' id="show-disease-6576563485747127124" style="display: inline;"><a href="javascript:toggle2('disease-6576563485747127124')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-6576563485747127124" style="display: none;"><a href="javascript:toggle2('disease-6576563485747127124')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Gefitinib">Gefitinib</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2293347'>rs2293347</a><a href='http://www.snpedia.com/index.php/rs2293347(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 1.1<br/>Frequency: <span style='background-color: #FFF5F5;'>81.4%</span><br/>Repute:Good<br/>References:9<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>among NSCLC patients, better Gefitinib response; common</div>
        <div class='boxshow' id="show-sec-0.446540391605" style="display: inline;"><a href="javascript:toggle2('sec-0.446540391605')">...more...</a></div>
        <div class='boxrstext' id="sec-0.446540391605" style="display: none;"><a href="javascript:toggle2('sec-0.446540391605')">(hide)</a>
        <div class='rstext'>rs2293347, also known as D994D, is a SNP in the epidermal growth factor receptor EGFR gene. In a study of therapeutic outcome and survival in 84 advanced non-small-cell lung cancer (NSCLC) patients treated with Gefitinib, the response rate for rs2293347(G;G) patients was almost double that of other genotypes for this SNP (71.2% versus 37.5%, p=0.0043). The rs2293347(G;G) genotype was also associated with longer progression-free survival compared with the rs2293347(A;G) or (A;A) genotypes (11 months versus 3 months, p=0.0018).</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2231142'>rs2231142</a><a href='http://www.snpedia.com/index.php/rs2231142(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF3F3;'>78.8%</span><br/>Repute:Good<br/>References:48<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.651176265821" style="display: inline;"><a href="javascript:toggle2('sec-0.651176265821')">...more...</a></div>
        <div class='boxrstext' id="sec-0.651176265821" style="display: none;"><a href="javascript:toggle2('sec-0.651176265821')">(hide)</a>
        <div class='rstext'>rs2231142, also known as Q141K and C421A, is a SNP in the ABCG2 gene, indicating a missense variant. 'Our data indicate that at least 10% of all gout cases in whites are attributable to this causal variant.' A is the risk allele. A large study totaling 7,699 participants in the Framingham cohort and 4,148 participants in the Rotterdam cohort was conducted, with genome-wide significant SNPs then replicated in 11,000+ Caucasian and ~4,000 African-American individuals who took part in the study of Atherosclerosis Risk in Communities (ARIC). This study calculated an odds ratio of 1.74 for rs2231142 (CI: 1.51-1.99, p = 3.3x10e-15). A genetic score comprised of this SNP plus 2 others may stratify risk for gout. Among non-small cell lung cancer patients treated with gefitinib, there's a 4-5x high...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Herceptin</a>

        <div class='boxshow' id="show-disease2829104805215997901" style="display: inline;"><a href="javascript:toggle2('disease2829104805215997901')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease2829104805215997901" style="display: none;"><a href="javascript:toggle2('disease2829104805215997901')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Herceptin">Herceptin</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs351855'>rs351855</a><a href='http://www.snpedia.com/index.php/rs351855(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFD9D9;'>43.1%</span><br/>Repute:Good<br/>References:15<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.502680474022" style="display: inline;"><a href="javascript:toggle2('sec-0.502680474022')">...more...</a></div>
        <div class='boxrstext' id="sec-0.502680474022" style="display: none;"><a href="javascript:toggle2('sec-0.502680474022')">(hide)</a>
        <div class='rstext'>rs351855, a SNP in the fibroblast growth factor receptor 4 (FGFR4) gene, is also known as the Gly388Arg variant. The rs351855(T) allele encodes the risk (Arg) allele. The Arg form of this SNP is likely to cause a harder to treat version of node-positive breast cancer, including reducing the efficacy of Herceptin, based on a study of 372 patients. A study of ~500 Japanese prostate cancer patients found that individuals with a rs351855(T;T) genotype had a 2.2- and 1.9-fold increased risk of prostate cancer and benign prostate hyperplasia (BPH), and a 1.8-fold increased risk of metastatic prostate cancer compared to the (C;C) genotype. A meta-analysis published in 2011, surveying a total of 2,618 cases of prostate cancer, concluded that the odds ratio per rs351855(T) allele was 1.17 (CI: 1.07...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|40|10">Ibuprofen</a>

        <div class='boxshow' id="show-disease-7681817905086278281" style="display: inline;"><a href="javascript:toggle2('disease-7681817905086278281')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-7681817905086278281" style="display: none;"><a href="javascript:toggle2('disease-7681817905086278281')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Ibuprofen">Ibuprofen</a>
  <div id="gs191"  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs191'>gs191</a></div></div>
        <div class='boxmag'>Magnitude: 3.1</div>
        <div class='boxrep'>Repute: Bad</div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>problem metabolizing NSAIDs</div>
        <div class='gsboxeffect'>impaired NSAID drug metabolism, which is a risk factor for gastrointestinal bleeding when taking any of these medications: aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib. You have one of these *CYP2C8*3 (rs11572080 and rs10509681) *CYP2C9*2 (rs1799853) *CYP2C9*3 (rs1057910)</div>
      </div>
      <div class="boxfooter"></div>
  </div>


  <div id="gs161"  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs161'>gs161</a></div></div>
        <div class='boxmag'>Magnitude: 2.5</div>
        <div class='boxrep'></div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>CYP2C9 Intermediate Metabolizers</div>
        <div class='gsboxeffect'>CYP2C9 intermediate metabolizers are 30% of the population. May require slightly different dosages for drugs such as tamoxifen, warfarin, fluvastin, and many nonsteroidal anti-inflammatory agents such as aspirin, ibuprofen and naproxen.</div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1799853'>rs1799853</a><a href='http://www.snpedia.com/index.php/rs1799853(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFB9B9;'>19.0%</span><br/>References:22<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>CYP2C9*2 carrier; average 20% reduction in warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.368943246788" style="display: inline;"><a href="javascript:toggle2('sec-0.368943246788')">...more...</a></div>
        <div class='boxrstext' id="sec-0.368943246788" style="display: none;"><a href="javascript:toggle2('sec-0.368943246788')">(hide)</a>
        <div class='rstext'>rs1799853 is a SNP in the CYP2C9 gene and is linked to poor warfarin metabolism. Advanced knowledge of this may influence initial warfarin dosing by physicians. Warfarin is monitored through INR (international normalized ratio) and proper dosing is influenced by a variety of factors including warfarin metabolism and diet. rs1799853 is a SNP in the CYP2C9 gene. The rs1799853(T) allele encodes a variant amino acid, cysteine, which has been linked to poor metabolism of warfarin and thus sensitivity . The common nomenclature for this polymorphism is CYP2C9*2 (Cys amino acid, T allele; the SNP is also known as C430T or Cys144Arg). The CYP2C9*2 allele is also associated with higher sensitivity to the anti-epileptic drug phenytoin. The effect of CYP2C9 variants on drug metabolism should not be pr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs11572080'>rs11572080</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs11572080(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFBBBB;'>20.2%</span><br/>References:17<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.790297427825" style="display: inline;"><a href="javascript:toggle2('sec-0.790297427825')">...more...</a></div>
        <div class='boxrstext' id="sec-0.790297427825" style="display: none;"><a href="javascript:toggle2('sec-0.790297427825')">(hide)</a>
        <div class='rstext'>CYP2C8 SNP, defining the CYP2C8*3 allele (along with rs10509681). Individuals carrying this SNP may show increased risk of developing acute gastrointestinal bleeding during the use of NSAIDs that are CYP2C8 or CYP2C9 substrates, such as aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib.  [PharmGKB:Curated Risk or phenotype-associated allele: A. Phenotype: This variant was associated with increased risk for neurotoxicity with paclitaxel treatment. Study size: 132. Study population/ethnicity: Patients with Neoplasms receiving paclitaxel; Spain. Significance metric(s): HR = 1.54 (0.96-2.47); p = 0.072. Type of association: PK; TOX.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs10509681'>rs10509681</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs10509681(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFBFBF;'>22.1%</span><br/>References:16<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.889471346767" style="display: inline;"><a href="javascript:toggle2('sec-0.889471346767')">...more...</a></div>
        <div class='boxrstext' id="sec-0.889471346767" style="display: none;"><a href="javascript:toggle2('sec-0.889471346767')">(hide)</a>
        <div class='rstext'>CYP2C8 SNP, defining the CYP2C8*3 allele (along with rs11572080). Individuals carrying this SNP may show increased risk of developing acute gastrointestinal bleeding during the use of NSAIDs that are CYP2C8 or CYP2C9 substrates, such as aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib.  [PharmGKB:Curated Risk or phenotype-associated allele: G. Phenotype: In woman, the risk of acute myocardial infarction (AMI) tended to be higher for subjects carrying the CYP2C8*3*3 genotype versus *1*1 (OR = 1.9). The CYP2C8*3 variants are 416G&gt;A (rs10509681) and 1196A&gt;G (rs11572080). Tested in all subjects, the risk of AMI was also higher in individuals carrying the CYP2C8*3 allele (*3*3; *1*3 versus*1*1) [1.2 (1.0-1.5...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1057910'>rs1057910</a><a href='http://www.snpedia.com/index.php/rs1057910(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0.1<br/>Frequency: <span style='background-color: #FFF9F9;'>88.5%</span><br/>Repute:Good<br/>References:65<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal; no effect on warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.930827340067" style="display: inline;"><a href="javascript:toggle2('sec-0.930827340067')">...more...</a></div>
        <div class='boxrstext' id="sec-0.930827340067" style="display: none;"><a href="javascript:toggle2('sec-0.930827340067')">(hide)</a>
        <div class='rstext'>SNP rs1057910(A), located in the cytochrome p450 CYP2C9 gene, most commonly encodes the amino acid isoleucine at position 359, and the resulting allele is also known as CYP2C9*1. rs1057910(C) encodes a leucine at this same position, and the resulting allele is called CYP2C9*3. This SNP is also known as Ile359Leu or A1075C. The effect of CYP2C9 variants on drug metabolism should not be predicted without also considering CYP2C9*2, defined as the common loss of function variant rs1799853(T) (NM_000771:c.430C&gt;T, NP_000762:p.144R&gt;C) Studies of the effects of these alleles include: * rs1057910(C;C)] genotypes may clear drugs like celecoxib (trade name Celebrex) twice as slowly as rs1057910(A;A) genotypes; the rs1057910(A;C) genotypes are in-between clearance rates. Lower clearance rates wi...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 genosets 4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Imipramine</a>

        <div class='boxshow' id="show-disease1172866450301319181" style="display: inline;"><a href="javascript:toggle2('disease1172866450301319181')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease1172866450301319181" style="display: none;"><a href="javascript:toggle2('disease1172866450301319181')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Imipramine">Imipramine</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.176359990886" style="display: inline;"><a href="javascript:toggle2('sec-0.176359990886')">...more...</a></div>
        <div class='boxrstext' id="sec-0.176359990886" style="display: none;"><a href="javascript:toggle2('sec-0.176359990886')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|0|10">Infliximab</a>

        <div class='boxshow' id="show-disease4249890024167226389" style="display: inline;"><a href="javascript:toggle2('disease4249890024167226389')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease4249890024167226389" style="display: none;"><a href="javascript:toggle2('disease4249890024167226389')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Infliximab">Infliximab</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801274'>rs1801274</a><a href='http://www.snpedia.com/index.php/rs1801274(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 1.5<br/>Frequency: <span style='background-color: #FFC5C5;'>26.5%</span><br/>Repute:Bad<br/>References:56<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>complex; generally greater risk for cancer progression</div>
        <div class='boxshow' id="show-sec-0.961315266681" style="display: inline;"><a href="javascript:toggle2('sec-0.961315266681')">...more...</a></div>
        <div class='boxrstext' id="sec-0.961315266681" style="display: none;"><a href="javascript:toggle2('sec-0.961315266681')">(hide)</a>
        <div class='rstext'>rs1801274 is a SNP in the Fc fragment of IgG, low affinity IIa, receptor (CD32) FCGR2A gene. rs1801274(C) encodes the arginine (R) allele, with the (T) allele encoding the variant histidine (H). The (H) isoform is considered high-binding to IgG2 and IgG3, while the (R) isoform is considered low-binding. This SNP is known in the literature by many names, including A519C and H131R. What's the importance of this? FcgR isoforms expressed on immune system cells have been linked to the pathogenic consequences triggered by autoantibodies or immune complexes in autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as well as to the efficacy of some immunotherapeutic treatments such as rituximab. Many studies have been published about this FCGR2A SNP, roughly...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Interferon</a>

        <div class='boxshow' id="show-disease-5579572618787027104" style="display: inline;"><a href="javascript:toggle2('disease-5579572618787027104')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-5579572618787027104" style="display: none;"><a href="javascript:toggle2('disease-5579572618787027104')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Interferon">Interferon</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6139030'>rs6139030</a><a href='http://www.snpedia.com/index.php/rs6139030(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF7F7;'>85.7%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common on affy axiom data</div>
        <div class='boxshow' id="show-sec-0.998033223363" style="display: inline;"><a href="javascript:toggle2('sec-0.998033223363')">...more...</a></div>
        <div class='boxrstext' id="sec-0.998033223363" style="display: none;"><a href="javascript:toggle2('sec-0.998033223363')">(hide)</a>
        <div class='rstext'>Carriers of the C allele at rs6139030 have a higher risk of developing thrombocytopenia when treated with interferon. Hepatitis C Treatment Side Effects  [GWAS:None]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Iressa</a>

        <div class='boxshow' id="show-disease-8166479864027554753" style="display: inline;"><a href="javascript:toggle2('disease-8166479864027554753')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-8166479864027554753" style="display: none;"><a href="javascript:toggle2('disease-8166479864027554753')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Iressa">Iressa</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2231142'>rs2231142</a><a href='http://www.snpedia.com/index.php/rs2231142(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF3F3;'>78.8%</span><br/>Repute:Good<br/>References:48<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.000226766562112" style="display: inline;"><a href="javascript:toggle2('sec-0.000226766562112')">...more...</a></div>
        <div class='boxrstext' id="sec-0.000226766562112" style="display: none;"><a href="javascript:toggle2('sec-0.000226766562112')">(hide)</a>
        <div class='rstext'>rs2231142, also known as Q141K and C421A, is a SNP in the ABCG2 gene, indicating a missense variant. 'Our data indicate that at least 10% of all gout cases in whites are attributable to this causal variant.' A is the risk allele. A large study totaling 7,699 participants in the Framingham cohort and 4,148 participants in the Rotterdam cohort was conducted, with genome-wide significant SNPs then replicated in 11,000+ Caucasian and ~4,000 African-American individuals who took part in the study of Atherosclerosis Risk in Communities (ARIC). This study calculated an odds ratio of 1.74 for rs2231142 (CI: 1.51-1.99, p = 3.3x10e-15). A genetic score comprised of this SNP plus 2 others may stratify risk for gout. Among non-small cell lung cancer patients treated with gefitinib, there's a 4-5x high...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|20|0">Irinotecan</a>

        <div class='boxshow' id="show-disease648985134339074258" style="display: inline;"><a href="javascript:toggle2('disease648985134339074258')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease648985134339074258" style="display: none;"><a href="javascript:toggle2('disease648985134339074258')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Irinotecan">Irinotecan</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1042522'>rs1042522</a><a href='http://www.snpedia.com/index.php/rs1042522(C;G)'>(C;G)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFC9C9;'>29.2%</span><br/>Repute:Good<br/>References:123<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Slightly increased lifespan?</div>
        <div class='boxshow' id="show-sec-0.389598598075" style="display: inline;"><a href="javascript:toggle2('sec-0.389598598075')">...more...</a></div>
        <div class='boxrstext' id="sec-0.389598598075" style="display: none;"><a href="javascript:toggle2('sec-0.389598598075')">(hide)</a>
        <div class='rstext'>This SNP, a variant in the TP53 gene, is 1 of 25 SNPs reported to represent independently minor, but cumulatively significant, increased risk for breast cancer. For details of all 25 SNPs in this group, along with the two methods used to calculate overall risk estimates for breast cancer, refer to the SNPedia breast cancer entry. For this particular SNP, the G allele encodes an arginine at position 72 of the protein (where there's normally a proline), and the SNP is commonly called the Arg72 variant, although P72R and Arg72Pro are also common in the literature. Minor allele homozygotes, i.e. rs1042522(C;C) genotypes, live on average 3 years longer than major allele (G;G) homozygotes, based on a study of 9,200+ Danish individuals. The increased longevity is speculated to be related to the i...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs34983651'>rs34983651</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs34983651(I;I)'>(I;I)</a></div>
        <div class='boxmag'>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.357862565511" style="display: inline;"><a href="javascript:toggle2('sec-0.357862565511')">...more...</a></div>
        <div class='boxrstext' id="sec-0.357862565511" style="display: none;"><a href="javascript:toggle2('sec-0.357862565511')">(hide)</a>
        <div class='rstext'>rs34983651 is one of four SNPs all describing an insertion/deletion polymorphism in the promoter region of the UGT1A1 gene; the primary entry in SNPedia for this set of SNPs is at rs34815109. The other two SNPs (besides rs34815109) that also describe the same polymorphism are: * rs35600288 * rs5839491</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs35600288'>rs35600288</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs35600288(D;I)'>(D;I)</a></div>
        <div class='boxmag'>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.468243121644" style="display: inline;"><a href="javascript:toggle2('sec-0.468243121644')">...more...</a></div>
        <div class='boxrstext' id="sec-0.468243121644" style="display: none;"><a href="javascript:toggle2('sec-0.468243121644')">(hide)</a>
        <div class='rstext'>rs35600288 is one of four SNPs all describing an insertion/deletion polymorphism in the promoter region of the UGT1A1 gene; the primary entry in SNPedia for this set of SNPs is at rs34815109. The other two SNPs (besides rs34815109) that also describe the same polymorphism are: * rs34983651 * rs5839491</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4149056'>rs4149056</a><a href='http://www.snpedia.com/index.php/rs4149056(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEEEE;'>70.8%</span><br/>Repute:Good<br/>References:60<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.431029770421" style="display: inline;"><a href="javascript:toggle2('sec-0.431029770421')">...more...</a></div>
        <div class='boxrstext' id="sec-0.431029770421" style="display: none;"><a href="javascript:toggle2('sec-0.431029770421')">(hide)</a>
        <div class='rstext'>influences statin response *rs72559745 (SLCO1B1*1)	AA	AA *rs56061388 (SLCO1B1*3)	TT	TT *rs4149056 (SLCO1B1*5)	TT	TT *rs55901008 (SLCO1B1*6)	TT	TT rs4149056, also known as 37041T&gt;C or V174A, is a SNP in the SLCO1B1 gene, which encodes the 'organic anion transporting polypeptide 1B1' (OATP1B1) protein. This protein, found primarily in the liver, regulates the uptake of numerous drugs and natural compounds. The rs4149056(C) SNP defines the SLCO1B1*5 allele. The rs4149056(C) allele gives rise to an amino acid change (from valine to alanine at residue 174) which has reduced uptake/transport activity. Therefore, drugs metabolized by OATP1B1 tend to build up to higher circulating concentrations than they would otherwise.. The drugs known (or in some cases, thought) to be transported less well ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Ivacaftor</a>

        <div class='boxshow' id="show-disease735577282848676946" style="display: inline;"><a href="javascript:toggle2('disease735577282848676946')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease735577282848676946" style="display: none;"><a href="javascript:toggle2('disease735577282848676946')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Ivacaftor">Ivacaftor</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs75527207'>rs75527207</a><a href='http://www.snpedia.com/index.php/rs75527207(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in clinvar</div>
        <div class='boxshow' id="show-sec-0.786994090732" style="display: inline;"><a href="javascript:toggle2('sec-0.786994090732')">...more...</a></div>
        <div class='boxrstext' id="sec-0.786994090732" style="display: none;"><a href="javascript:toggle2('sec-0.786994090732')">(hide)</a>
        <div class='rstext'>. Known primarily as G551D (although sometimes also called G511D) and also known as i4000305 by 23andMe, rs75527207 is a rare variant in the cystic fibrosis CFTR gene is thought to be present in ~1,200 patients in the US. The risk allele is rs75527207(A). G551D is termed a 'gating mutant', and is considered to be a somewhat different class of cystic fibrosis mutation compared to variants that lead to misfolded proteins. Like almost all cystic fibrosis variants, individuals must inherit two defective CFTR alleles to manifest the disease; since G551D is ~20 times rarer than the most common CFTR variant, deltaF508, patients carrying one G551D variant are likely to be compound heterozygotes harboring an additional CFTR variant. In early 2012, the biotech company Vertex Pharmaceutics received F...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Janimine</a>

        <div class='boxshow' id="show-disease-2115809581909188591" style="display: inline;"><a href="javascript:toggle2('disease-2115809581909188591')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-2115809581909188591" style="display: none;"><a href="javascript:toggle2('disease-2115809581909188591')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Janimine">Janimine</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.07119652529" style="display: inline;"><a href="javascript:toggle2('sec-0.07119652529')">...more...</a></div>
        <div class='boxrstext' id="sec-0.07119652529" style="display: none;"><a href="javascript:toggle2('sec-0.07119652529')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Kalydeco</a>

        <div class='boxshow' id="show-disease8473716631699081282" style="display: inline;"><a href="javascript:toggle2('disease8473716631699081282')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease8473716631699081282" style="display: none;"><a href="javascript:toggle2('disease8473716631699081282')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Kalydeco">Kalydeco</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs75527207'>rs75527207</a><a href='http://www.snpedia.com/index.php/rs75527207(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in clinvar</div>
        <div class='boxshow' id="show-sec-0.854076229907" style="display: inline;"><a href="javascript:toggle2('sec-0.854076229907')">...more...</a></div>
        <div class='boxrstext' id="sec-0.854076229907" style="display: none;"><a href="javascript:toggle2('sec-0.854076229907')">(hide)</a>
        <div class='rstext'>. Known primarily as G551D (although sometimes also called G511D) and also known as i4000305 by 23andMe, rs75527207 is a rare variant in the cystic fibrosis CFTR gene is thought to be present in ~1,200 patients in the US. The risk allele is rs75527207(A). G551D is termed a 'gating mutant', and is considered to be a somewhat different class of cystic fibrosis mutation compared to variants that lead to misfolded proteins. Like almost all cystic fibrosis variants, individuals must inherit two defective CFTR alleles to manifest the disease; since G551D is ~20 times rarer than the most common CFTR variant, deltaF508, patients carrying one G551D variant are likely to be compound heterozygotes harboring an additional CFTR variant. In early 2012, the biotech company Vertex Pharmaceutics received F...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|0|10">Lansoprazole</a>

        <div class='boxshow' id="show-disease4129765641909324298" style="display: inline;"><a href="javascript:toggle2('disease4129765641909324298')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease4129765641909324298" style="display: none;"><a href="javascript:toggle2('disease4129765641909324298')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Lansoprazole">Lansoprazole</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1045642'>rs1045642</a><a href='http://www.snpedia.com/index.php/rs1045642(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFE4E4;'>55.8%</span><br/>Repute:Bad<br/>References:100<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Slower metaboliser for some drugs</div>
        <div class='boxshow' id="show-sec-0.517431385554" style="display: inline;"><a href="javascript:toggle2('sec-0.517431385554')">...more...</a></div>
        <div class='boxrstext' id="sec-0.517431385554" style="display: none;"><a href="javascript:toggle2('sec-0.517431385554')">(hide)</a>
        <div class='rstext'>rs1045642, also known as C3435T, is a SNP located in the ABCB1 gene. It is often studied in conjunction with rs2032582. C3435T has been mentioned by: * A 'Silent' Polymorphism in the MDR1 Gene Changes Substrate Specificity (for example, to verapamil) * (R)-lansoprazole (Prevacid) concentrations are significantly increased in CYP2C19 extensive metabolizers with ABCB1 C3435T C allele. * In a Korean population, plasma concentrations of fexofenadine (Allegra) were 17% lower in 2677AA/3435CC subjects and 47% higher in the 2677TT/3435TT subjects compared to 2677GG/3435CC subjects. * In contrast, in this study no association was observed between the C3435T polymorphism and fexofenadine plasma or urine concentrations in a German Caucasian population. * A meta-analysis including 9 case-control stud...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4244285'>rs4244285</a><a href='http://www.snpedia.com/index.php/rs4244285(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF2F2;'>76.2%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.400706374495" style="display: inline;"><a href="javascript:toggle2('sec-0.400706374495')">...more...</a></div>
        <div class='boxrstext' id="sec-0.400706374495" style="display: none;"><a href="javascript:toggle2('sec-0.400706374495')">(hide)</a>
        <div class='rstext'>rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid). In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pyl...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs28399504'>rs28399504</a><a href='http://www.snpedia.com/index.php/rs28399504(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.13513305257" style="display: inline;"><a href="javascript:toggle2('sec-0.13513305257')">...more...</a></div>
        <div class='boxrstext' id="sec-0.13513305257" style="display: none;"><a href="javascript:toggle2('sec-0.13513305257')">(hide)</a>
        <div class='rstext'>rs28399504 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*4 variant. This variant has been linked to poor metabolism of compounds like mephenytoin. It is also known as M1V or Met1Val. The risk allele is rs28399504(G). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). According to a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504. Clopidogrel Efficacy  [Pharm...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4986893'>rs4986893</a><a href='http://www.snpedia.com/index.php/rs4986893(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.187294241824" style="display: inline;"><a href="javascript:toggle2('sec-0.187294241824')">...more...</a></div>
        <div class='boxrstext' id="sec-0.187294241824" style="display: none;"><a href="javascript:toggle2('sec-0.187294241824')">(hide)</a>
        <div class='rstext'>rs4986893 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*3 variant. This variant has been linked to poor metabolism of compounds like mephenytoin as well as proguanil, and it therefore has implications for malaria prophylaxis. The risk allele is rs4986893(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). Clopidogrel Efficacy  [PharmGKB:Curated In contrast to other PPIs, esomeprazole-induced healing of GERD appears to be unrelated to the CYP2C19*3 variant.] [OMIM:MEPHENYTOIN, POOR METABOLISM OF]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Laroxyl</a>

        <div class='boxshow' id="show-disease-6812040244589502320" style="display: inline;"><a href="javascript:toggle2('disease-6812040244589502320')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-6812040244589502320" style="display: none;"><a href="javascript:toggle2('disease-6812040244589502320')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Laroxyl">Laroxyl</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.00702753479668" style="display: inline;"><a href="javascript:toggle2('sec-0.00702753479668')">...more...</a></div>
        <div class='boxrstext' id="sec-0.00702753479668" style="display: none;"><a href="javascript:toggle2('sec-0.00702753479668')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Lipitor</a>

        <div class='boxshow' id="show-disease-8018957504983314872" style="display: inline;"><a href="javascript:toggle2('disease-8018957504983314872')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-8018957504983314872" style="display: none;"><a href="javascript:toggle2('disease-8018957504983314872')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Lipitor">Lipitor</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs20455'>rs20455</a><a href='http://www.snpedia.com/index.php/rs20455(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD3D3;'>37.2%</span><br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.572814193862" style="display: inline;"><a href="javascript:toggle2('sec-0.572814193862')">...more...</a></div>
        <div class='boxrstext' id="sec-0.572814193862" style="display: none;"><a href="javascript:toggle2('sec-0.572814193862')">(hide)</a>
        <div class='rstext'>rs20455, often called Arg719 or 719Arg, is a reasonably well studied SNP in the KIF6 gene. The risk allele (encoding the arginine at position 719) is rs20455(C). An extensive 2010 meta-analysis, including over 17,000 patients, suggests this variant does not significantly influence coronary artery disease risk. This SNP is one of the 5 used by Celera's genetic risk score (GRS) for coronary heart disease (CHD). *rs20455, in the KIF6 gene *rs3900940, in the MYH15 gene *rs7439293, in the PALLD gene *rs2298566, in the SNX19 gene *rs1010, in the VAMP8 gene For each of the five variants, the GRS was increased by 1 if the subject was homozygous for the risk variant, unchanged if heterozygous, and decreased by 1 if the individual did not carry the variant. Therefore, individuals carrying all 10 pos...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|20|0">Lithium</a>

        <div class='boxshow' id="show-disease5664998773267365787" style="display: inline;"><a href="javascript:toggle2('disease5664998773267365787')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease5664998773267365787" style="display: none;"><a href="javascript:toggle2('disease5664998773267365787')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Lithium">Lithium</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs9784453'>rs9784453</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs9784453(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCECE;'>33.0%</span><br/>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.323531298336" style="display: inline;"><a href="javascript:toggle2('sec-0.323531298336')">...more...</a></div>
        <div class='boxrstext' id="sec-0.323531298336" style="display: none;"><a href="javascript:toggle2('sec-0.323531298336')">(hide)</a>
        <div class='rstext'>journal When using lithium as a treatment for Bipolar disorder rs9784453 appears to be associated with time to recurrence of a mood episode while on. By my reading of Figure 3, the median time to recurrence is about 230 days for homozygote carriers with the 'poor response' allele and about 520 days for homozygote carriers with the 'good response' allele, with heterozygote carriers falling in between.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs334558'>rs334558</a><a href='http://www.snpedia.com/index.php/rs334558(A;G)'>(A;G)</a></div>
        <div class='boxmag'>References:22<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>later onset of BP</div>
        <div class='boxshow' id="show-sec-0.606803638679" style="display: inline;"><a href="javascript:toggle2('sec-0.606803638679')">...more...</a></div>
        <div class='boxrstext' id="sec-0.606803638679" style="display: none;"><a href="javascript:toggle2('sec-0.606803638679')">(hide)</a>
        <div class='rstext'>Although not associated with increased risk for developing bipolar disorder, amongst those with it, the (G) allele of this SNP has been reported to have a somewhat protective effect in that individuals who have a (G) allele develop bipolar disorder at a later age than those with the more common (A;A) genotypes. Also known as the -50T/C SNP from this GSK3-beta (GSK3B) gene. may effect lithium treatment response - C allele carriers showed considerably greater response with lithium treatment, with remissions of 56.25% after 4 weeks compared to 31% for T/T carriers  [PharmGKB:Curated This variant is in the promoter region of GSK3B. T allele is associated with greater transcription activity compared with the A allele. This variant is associated with antidepressant treatment response in Chinese ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|0|0">Losec</a>

        <div class='boxshow' id="show-disease-2616307139028698529" style="display: inline;"><a href="javascript:toggle2('disease-2616307139028698529')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-2616307139028698529" style="display: none;"><a href="javascript:toggle2('disease-2616307139028698529')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Losec">Losec</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4244285'>rs4244285</a><a href='http://www.snpedia.com/index.php/rs4244285(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF2F2;'>76.2%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.281928337772" style="display: inline;"><a href="javascript:toggle2('sec-0.281928337772')">...more...</a></div>
        <div class='boxrstext' id="sec-0.281928337772" style="display: none;"><a href="javascript:toggle2('sec-0.281928337772')">(hide)</a>
        <div class='rstext'>rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid). In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pyl...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs28399504'>rs28399504</a><a href='http://www.snpedia.com/index.php/rs28399504(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.613237395937" style="display: inline;"><a href="javascript:toggle2('sec-0.613237395937')">...more...</a></div>
        <div class='boxrstext' id="sec-0.613237395937" style="display: none;"><a href="javascript:toggle2('sec-0.613237395937')">(hide)</a>
        <div class='rstext'>rs28399504 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*4 variant. This variant has been linked to poor metabolism of compounds like mephenytoin. It is also known as M1V or Met1Val. The risk allele is rs28399504(G). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). According to a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504. Clopidogrel Efficacy  [Pharm...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4986893'>rs4986893</a><a href='http://www.snpedia.com/index.php/rs4986893(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.533369895898" style="display: inline;"><a href="javascript:toggle2('sec-0.533369895898')">...more...</a></div>
        <div class='boxrstext' id="sec-0.533369895898" style="display: none;"><a href="javascript:toggle2('sec-0.533369895898')">(hide)</a>
        <div class='rstext'>rs4986893 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*3 variant. This variant has been linked to poor metabolism of compounds like mephenytoin as well as proguanil, and it therefore has implications for malaria prophylaxis. The risk allele is rs4986893(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). Clopidogrel Efficacy  [PharmGKB:Curated In contrast to other PPIs, esomeprazole-induced healing of GERD appears to be unrelated to the CYP2C19*3 variant.] [OMIM:MEPHENYTOIN, POOR METABOLISM OF]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Metformin</a>

        <div class='boxshow' id="show-disease-603166522641092836" style="display: inline;"><a href="javascript:toggle2('disease-603166522641092836')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-603166522641092836" style="display: none;"><a href="javascript:toggle2('disease-603166522641092836')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Metformin">Metformin</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4585'>rs4585</a><a href='http://www.snpedia.com/index.php/rs4585(G;T)'>(G;T)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFE2E2;'>54.0%</span><br/>Repute:Neutral<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>average response to metformin in type 2 diabetics</div>
        <div class='boxshow' id="show-sec-0.882318726018" style="display: inline;"><a href="javascript:toggle2('sec-0.882318726018')">...more...</a></div>
        <div class='boxrstext' id="sec-0.882318726018" style="display: none;"><a href="javascript:toggle2('sec-0.882318726018')">(hide)</a>
        <div class='rstext'>rs4585 has been found to modify the metformin response in patients with type 2 diabetes. Metformin Response</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs734312'>rs734312</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs734312(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD4D4;'>38.9%</span><br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.539452606907" style="display: inline;"><a href="javascript:toggle2('sec-0.539452606907')">...more...</a></div>
        <div class='boxrstext' id="sec-0.539452606907" style="display: none;"><a href="javascript:toggle2('sec-0.539452606907')">(hide)</a>
        <div class='rstext'>rs734312, or '''His611Arg''', is a SNP located in exon 8 of the WFS1 gene. An A at this SNP encodes for histamine and a G encodes for arginine. A single study found this SNP to be associated with medication overuse headache (sample consisting of 82 MOH patients). Compared to the His/His genotypes, those carrying two Arg alleles had a significantly higher monthly drug consumption (p = 0.00075) and higher severe depressive scores on the Beck Depression Index (p = 0.003). His611Arg is also potentially implicated in type-2 diabetes. In a sample of 3,234 high diabetes risk individuals, Arg/Arg carriers had a generally higher insulinogenic index and lower insulin sensitivity levels, while His allele carriers followed the opposite pattern. Arg/Arg carriers also responded strongly to metformin and...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|20|10">Methadone</a>

        <div class='boxshow' id="show-disease1975604888527032534" style="display: inline;"><a href="javascript:toggle2('disease1975604888527032534')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease1975604888527032534" style="display: none;"><a href="javascript:toggle2('disease1975604888527032534')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Methadone">Methadone</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1045642'>rs1045642</a><a href='http://www.snpedia.com/index.php/rs1045642(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFE4E4;'>55.8%</span><br/>Repute:Bad<br/>References:100<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Slower metaboliser for some drugs</div>
        <div class='boxshow' id="show-sec-0.370858467455" style="display: inline;"><a href="javascript:toggle2('sec-0.370858467455')">...more...</a></div>
        <div class='boxrstext' id="sec-0.370858467455" style="display: none;"><a href="javascript:toggle2('sec-0.370858467455')">(hide)</a>
        <div class='rstext'>rs1045642, also known as C3435T, is a SNP located in the ABCB1 gene. It is often studied in conjunction with rs2032582. C3435T has been mentioned by: * A 'Silent' Polymorphism in the MDR1 Gene Changes Substrate Specificity (for example, to verapamil) * (R)-lansoprazole (Prevacid) concentrations are significantly increased in CYP2C19 extensive metabolizers with ABCB1 C3435T C allele. * In a Korean population, plasma concentrations of fexofenadine (Allegra) were 17% lower in 2677AA/3435CC subjects and 47% higher in the 2677TT/3435TT subjects compared to 2677GG/3435CC subjects. * In contrast, in this study no association was observed between the C3435T polymorphism and fexofenadine plasma or urine concentrations in a German Caucasian population. * A meta-analysis including 9 case-control stud...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1057868'>rs1057868</a><a href='http://www.snpedia.com/index.php/rs1057868(C;C)'>(C;C)</a></div>
        <div class='boxmag'>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.914368524309" style="display: inline;"><a href="javascript:toggle2('sec-0.914368524309')">...more...</a></div>
        <div class='boxrstext' id="sec-0.914368524309" style="display: none;"><a href="javascript:toggle2('sec-0.914368524309')">(hide)</a>
        <div class='rstext'>rs1057868, also known as A503V, is a relatively common variant defining the POR*28 allele of the P450 (cytochrome) oxidoreductase POR gene. The POR gene encodes a protein involved in electron transport of cytochrome p450 enzymes such as CYP3A4, CYP3A5 and CYP3A7. A study of 251 individuals from two independent studies (182 patients treated with methadone and 69 patients with clozapine) for CYP3A activity found that CYP3A SNPs themselves did not predict particularly well inter-individual variability in overall CYP3A activity. However, rs1057868(T;T) individuals had a 1.6x increased CYP3A activity compared to rs1057868(C) carriers (n=182, p=0.004), and the finding was replicated in a second independent dataset. The authors conclude that this POR gene SNP is a better predictor of overall CYP3...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1128503'>rs1128503</a><a href='http://www.snpedia.com/index.php/rs1128503(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFC5C5;'>26.5%</span><br/>References:32<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.192437605725" style="display: inline;"><a href="javascript:toggle2('sec-0.192437605725')">...more...</a></div>
        <div class='boxrstext' id="sec-0.192437605725" style="display: none;"><a href="javascript:toggle2('sec-0.192437605725')">(hide)</a>
        <div class='rstext'>rs1128503 is a SNP in the transporter P-glycoprotein (P-gp) 170, encoded by the ABCB1 (also known as MDR1) gene. Methadone is a substrate of this protein, so variants may affect the efficacy and optimal dosage of this drug as used for treating opiate dependence. A study of 98 methadone-maintaining patients concluded that the higher (&gt;150 mg/day) and lower (&lt; or =150 mg/day) methadone dose groups differed significantly in their rs1128503 status (experiment-wise p = 0.0325). Furthermore, individuals with the 3-locus genotype pattern (T;T)-(T;T)-(T;T) for SNPs rs1045642, rs2032582 and rs1128503, respectively, had an approximately 5-fold chance of requiring the 'higher' methadone dose, while individuals heterozygous for these three SNPs have an approximately 3-fold chance of stabilizing ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Methamphetamine</a>

        <div class='boxshow' id="show-disease-5405615295922057822" style="display: inline;"><a href="javascript:toggle2('disease-5405615295922057822')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-5405615295922057822" style="display: none;"><a href="javascript:toggle2('disease-5405615295922057822')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Methamphetamine">Methamphetamine</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs135745'>rs135745</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs135745(C;G)'>(C;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFE2E2;'>54.0%</span><br/>References:6<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.432335842396" style="display: inline;"><a href="javascript:toggle2('sec-0.432335842396')">...more...</a></div>
        <div class='boxrstext' id="sec-0.432335842396" style="display: none;"><a href="javascript:toggle2('sec-0.432335842396')">(hide)</a>
        <div class='rstext'>This SNP, located in the 3' UTR of the CSNK1E gene, has been associated with sensitivity to the acute effects of d-amphetamine. Sensitivity to psychoactive drugs has been associated with potential to develop drug abuse. The more sensitive allele is rs135745(C). However, in a separate study, this SNP did not affect susceptibility to methamphetamine dependence or psychosis, at least in a Japanese population. Note: orientation relative to dbSNP needs to be confirmed/checked.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|10|0">Metoprolol</a>

        <div class='boxshow' id="show-disease-9160544518564130343" style="display: inline;"><a href="javascript:toggle2('disease-9160544518564130343')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-9160544518564130343" style="display: none;"><a href="javascript:toggle2('disease-9160544518564130343')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Metoprolol">Metoprolol</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801253'>rs1801253</a><a href='http://www.snpedia.com/index.php/rs1801253(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 1.1<br/>Frequency: <span style='background-color: #F0D4F0;'>50.8%</span><br/>References:28<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>responds well to bucindolol; may also depend on rs1801252</div>
        <div class='boxshow' id="show-sec-0.683323080913" style="display: inline;"><a href="javascript:toggle2('sec-0.683323080913')">...more...</a></div>
        <div class='boxrstext' id="sec-0.683323080913" style="display: none;"><a href="javascript:toggle2('sec-0.683323080913')">(hide)</a>
        <div class='rstext'>Also known as Arg389, variation at this SNP, located in the ADRB1 gene, may encode either the amino acid glycine or arginine at amino acid position 389 of the corresponding protein, the beta-1 adrenergic receptor (hence why it is frequently called Arg389Gly). This protein is the target of beta blocker drugs, and so how well the drug works to help lower a patients high blood pressure depends in part on this SNP. The status of this SNP is often reported together with the status of SNP rs1801252, which encodes an amino acid variant at position 49 of the same (ADRB1) protein. The rs1801253(G) allele encodes the glycine. One of the best known studies of the effects of these 2 separate SNPs on the average efficacy of the beta blocker metoprolol in lowering blood pressure (BP) can be summarized f...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1065852'>rs1065852</a><a href='http://www.snpedia.com/index.php/rs1065852(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.902944796151" style="display: inline;"><a href="javascript:toggle2('sec-0.902944796151')">...more...</a></div>
        <div class='boxrstext' id="sec-0.902944796151" style="display: none;"><a href="javascript:toggle2('sec-0.902944796151')">(hide)</a>
        <div class='rstext'>The wild type (normal) allele at this SNP is (C). The (T) variant indicates the presence of a non-wild type CYP2D6 variant, but it appears in many different variants so it can not be used to determine the presence of any particular variant. The most common variants it appears in are CYP2D6*10 and CYP2D6*4, but these are not the only ones. While this is the defining mutation for CYP2D6*10, it is not possible by itself for this mutation to determine a particular variant. In addition, the CYP2D6*4 variant includes this mutation, but the defining mutation 1846G&gt;A SNP is not available in the common direct to consumer testing services. While it is not possible for this mutation to identify one particular variant, all the variants in which it appears have reduced or no CYP2D6 activity. If two ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.987313901523" style="display: inline;"><a href="javascript:toggle2('sec-0.987313901523')">...more...</a></div>
        <div class='boxrstext' id="sec-0.987313901523" style="display: none;"><a href="javascript:toggle2('sec-0.987313901523')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Modafinil</a>

        <div class='boxshow' id="show-disease2908806343100535798" style="display: inline;"><a href="javascript:toggle2('disease2908806343100535798')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease2908806343100535798" style="display: none;"><a href="javascript:toggle2('disease2908806343100535798')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Modafinil">Modafinil</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4680'>rs4680</a><a href='http://www.snpedia.com/index.php/rs4680(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDBDB;'>46.0%</span><br/>References:276<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>multiple associations, see details</div>
        <div class='boxshow' id="show-sec-0.354593064639" style="display: inline;"><a href="javascript:toggle2('sec-0.354593064639')">...more...</a></div>
        <div class='boxrstext' id="sec-0.354593064639" style="display: none;"><a href="javascript:toggle2('sec-0.354593064639')">(hide)</a>
        <div class='rstext'>rs4680 (Val158Met) is a well studied SNP in the COMT gene. 23andMe blog summarizes them as *rs4680(A) = Worrier. Met, more exploratory, lower COMT enzymatic activity, therefore higher dopamine levels; lower pain threshold, enhanced vulnerability to stress, yet also more efficient at processing information under most conditions *rs4680(G) = Warrior. Val, less exploratory, higher COMT enzymatic activity, therefore lower dopamine levels; higher pain threshold, better stress resiliency, albeit with a modest reduction in executive cognition performance under most conditions Roughly speaking, the predominant wisdom (known colloquially as the warrior/worrier hypothesis; summary at ) posits that people with Val alleles have increased COMT activity and lower prefrontal extracellular dopamine compar...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Morphine</a>

        <div class='boxshow' id="show-disease-2989980478222796988" style="display: inline;"><a href="javascript:toggle2('disease-2989980478222796988')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-2989980478222796988" style="display: none;"><a href="javascript:toggle2('disease-2989980478222796988')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Morphine">Morphine</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1799971'>rs1799971</a><a href='http://www.snpedia.com/index.php/rs1799971(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEEEE;'>70.8%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.396747458414" style="display: inline;"><a href="javascript:toggle2('sec-0.396747458414')">...more...</a></div>
        <div class='boxrstext' id="sec-0.396747458414" style="display: none;"><a href="javascript:toggle2('sec-0.396747458414')">(hide)</a>
        <div class='rstext'>The rs1799971(G) allele in exon 1 of the mu opioid receptor OPRM1 gene causes the normal amino acid at residue 40, asparagine (Asn), to be replaced by aspartic acid (Asp). In the literature this SNP is also known as A118G, N40D, or Asn40Asp. Carriers of at least one rs1799971(G) allele appear to have stronger cravings for alcohol than carriers of two rs1799971(A) alleles, and are thus hypothesized to be more at higher risk for alcoholism. However, subsequent research results are mixed, and there are other studies both agreeing or disagreeing with this finding Among 200+ alcoholics treated with naltrexone, rs1799971(G) carriers receiving the drug (even without behavioral intervention) had an increased percentage of days abstinent (p = .07) and a decreased percentage of heavy drinking days (...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Naltrexone</a>

        <div class='boxshow' id="show-disease-4968416242237937782" style="display: inline;"><a href="javascript:toggle2('disease-4968416242237937782')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-4968416242237937782" style="display: none;"><a href="javascript:toggle2('disease-4968416242237937782')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Naltrexone">Naltrexone</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1799971'>rs1799971</a><a href='http://www.snpedia.com/index.php/rs1799971(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEEEE;'>70.8%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.907649659673" style="display: inline;"><a href="javascript:toggle2('sec-0.907649659673')">...more...</a></div>
        <div class='boxrstext' id="sec-0.907649659673" style="display: none;"><a href="javascript:toggle2('sec-0.907649659673')">(hide)</a>
        <div class='rstext'>The rs1799971(G) allele in exon 1 of the mu opioid receptor OPRM1 gene causes the normal amino acid at residue 40, asparagine (Asn), to be replaced by aspartic acid (Asp). In the literature this SNP is also known as A118G, N40D, or Asn40Asp. Carriers of at least one rs1799971(G) allele appear to have stronger cravings for alcohol than carriers of two rs1799971(A) alleles, and are thus hypothesized to be more at higher risk for alcoholism. However, subsequent research results are mixed, and there are other studies both agreeing or disagreeing with this finding Among 200+ alcoholics treated with naltrexone, rs1799971(G) carriers receiving the drug (even without behavioral intervention) had an increased percentage of days abstinent (p = .07) and a decreased percentage of heavy drinking days (...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|40|10">Naproxen</a>

        <div class='boxshow' id="show-disease3084938226691113493" style="display: inline;"><a href="javascript:toggle2('disease3084938226691113493')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease3084938226691113493" style="display: none;"><a href="javascript:toggle2('disease3084938226691113493')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Naproxen">Naproxen</a>
  <div id="gs191"  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs191'>gs191</a></div></div>
        <div class='boxmag'>Magnitude: 3.1</div>
        <div class='boxrep'>Repute: Bad</div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>problem metabolizing NSAIDs</div>
        <div class='gsboxeffect'>impaired NSAID drug metabolism, which is a risk factor for gastrointestinal bleeding when taking any of these medications: aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib. You have one of these *CYP2C8*3 (rs11572080 and rs10509681) *CYP2C9*2 (rs1799853) *CYP2C9*3 (rs1057910)</div>
      </div>
      <div class="boxfooter"></div>
  </div>


  <div id="gs161"  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs161'>gs161</a></div></div>
        <div class='boxmag'>Magnitude: 2.5</div>
        <div class='boxrep'></div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>CYP2C9 Intermediate Metabolizers</div>
        <div class='gsboxeffect'>CYP2C9 intermediate metabolizers are 30% of the population. May require slightly different dosages for drugs such as tamoxifen, warfarin, fluvastin, and many nonsteroidal anti-inflammatory agents such as aspirin, ibuprofen and naproxen.</div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1799853'>rs1799853</a><a href='http://www.snpedia.com/index.php/rs1799853(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFB9B9;'>19.0%</span><br/>References:22<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>CYP2C9*2 carrier; average 20% reduction in warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.0350300879598" style="display: inline;"><a href="javascript:toggle2('sec-0.0350300879598')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0350300879598" style="display: none;"><a href="javascript:toggle2('sec-0.0350300879598')">(hide)</a>
        <div class='rstext'>rs1799853 is a SNP in the CYP2C9 gene and is linked to poor warfarin metabolism. Advanced knowledge of this may influence initial warfarin dosing by physicians. Warfarin is monitored through INR (international normalized ratio) and proper dosing is influenced by a variety of factors including warfarin metabolism and diet. rs1799853 is a SNP in the CYP2C9 gene. The rs1799853(T) allele encodes a variant amino acid, cysteine, which has been linked to poor metabolism of warfarin and thus sensitivity . The common nomenclature for this polymorphism is CYP2C9*2 (Cys amino acid, T allele; the SNP is also known as C430T or Cys144Arg). The CYP2C9*2 allele is also associated with higher sensitivity to the anti-epileptic drug phenytoin. The effect of CYP2C9 variants on drug metabolism should not be pr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs11572080'>rs11572080</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs11572080(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFBBBB;'>20.2%</span><br/>References:17<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.430378270815" style="display: inline;"><a href="javascript:toggle2('sec-0.430378270815')">...more...</a></div>
        <div class='boxrstext' id="sec-0.430378270815" style="display: none;"><a href="javascript:toggle2('sec-0.430378270815')">(hide)</a>
        <div class='rstext'>CYP2C8 SNP, defining the CYP2C8*3 allele (along with rs10509681). Individuals carrying this SNP may show increased risk of developing acute gastrointestinal bleeding during the use of NSAIDs that are CYP2C8 or CYP2C9 substrates, such as aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib.  [PharmGKB:Curated Risk or phenotype-associated allele: A. Phenotype: This variant was associated with increased risk for neurotoxicity with paclitaxel treatment. Study size: 132. Study population/ethnicity: Patients with Neoplasms receiving paclitaxel; Spain. Significance metric(s): HR = 1.54 (0.96-2.47); p = 0.072. Type of association: PK; TOX.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs10509681'>rs10509681</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs10509681(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFBFBF;'>22.1%</span><br/>References:16<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.20217148622" style="display: inline;"><a href="javascript:toggle2('sec-0.20217148622')">...more...</a></div>
        <div class='boxrstext' id="sec-0.20217148622" style="display: none;"><a href="javascript:toggle2('sec-0.20217148622')">(hide)</a>
        <div class='rstext'>CYP2C8 SNP, defining the CYP2C8*3 allele (along with rs11572080). Individuals carrying this SNP may show increased risk of developing acute gastrointestinal bleeding during the use of NSAIDs that are CYP2C8 or CYP2C9 substrates, such as aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib.  [PharmGKB:Curated Risk or phenotype-associated allele: G. Phenotype: In woman, the risk of acute myocardial infarction (AMI) tended to be higher for subjects carrying the CYP2C8*3*3 genotype versus *1*1 (OR = 1.9). The CYP2C8*3 variants are 416G&gt;A (rs10509681) and 1196A&gt;G (rs11572080). Tested in all subjects, the risk of AMI was also higher in individuals carrying the CYP2C8*3 allele (*3*3; *1*3 versus*1*1) [1.2 (1.0-1.5...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1057910'>rs1057910</a><a href='http://www.snpedia.com/index.php/rs1057910(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0.1<br/>Frequency: <span style='background-color: #FFF9F9;'>88.5%</span><br/>Repute:Good<br/>References:65<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal; no effect on warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.652649849043" style="display: inline;"><a href="javascript:toggle2('sec-0.652649849043')">...more...</a></div>
        <div class='boxrstext' id="sec-0.652649849043" style="display: none;"><a href="javascript:toggle2('sec-0.652649849043')">(hide)</a>
        <div class='rstext'>SNP rs1057910(A), located in the cytochrome p450 CYP2C9 gene, most commonly encodes the amino acid isoleucine at position 359, and the resulting allele is also known as CYP2C9*1. rs1057910(C) encodes a leucine at this same position, and the resulting allele is called CYP2C9*3. This SNP is also known as Ile359Leu or A1075C. The effect of CYP2C9 variants on drug metabolism should not be predicted without also considering CYP2C9*2, defined as the common loss of function variant rs1799853(T) (NM_000771:c.430C&gt;T, NP_000762:p.144R&gt;C) Studies of the effects of these alleles include: * rs1057910(C;C)] genotypes may clear drugs like celecoxib (trade name Celebrex) twice as slowly as rs1057910(A;A) genotypes; the rs1057910(A;C) genotypes are in-between clearance rates. Lower clearance rates wi...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 genosets 4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Neobloc</a>

        <div class='boxshow' id="show-disease-77630767142658647" style="display: inline;"><a href="javascript:toggle2('disease-77630767142658647')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-77630767142658647" style="display: none;"><a href="javascript:toggle2('disease-77630767142658647')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Neobloc">Neobloc</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801253'>rs1801253</a><a href='http://www.snpedia.com/index.php/rs1801253(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 1.1<br/>Frequency: <span style='background-color: #F0D4F0;'>50.8%</span><br/>References:28<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>responds well to bucindolol; may also depend on rs1801252</div>
        <div class='boxshow' id="show-sec-0.142146882961" style="display: inline;"><a href="javascript:toggle2('sec-0.142146882961')">...more...</a></div>
        <div class='boxrstext' id="sec-0.142146882961" style="display: none;"><a href="javascript:toggle2('sec-0.142146882961')">(hide)</a>
        <div class='rstext'>Also known as Arg389, variation at this SNP, located in the ADRB1 gene, may encode either the amino acid glycine or arginine at amino acid position 389 of the corresponding protein, the beta-1 adrenergic receptor (hence why it is frequently called Arg389Gly). This protein is the target of beta blocker drugs, and so how well the drug works to help lower a patients high blood pressure depends in part on this SNP. The status of this SNP is often reported together with the status of SNP rs1801252, which encodes an amino acid variant at position 49 of the same (ADRB1) protein. The rs1801253(G) allele encodes the glycine. One of the best known studies of the effects of these 2 separate SNPs on the average efficacy of the beta blocker metoprolol in lowering blood pressure (BP) can be summarized f...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|0|0">Nexium</a>

        <div class='boxshow' id="show-disease8030777593017581326" style="display: inline;"><a href="javascript:toggle2('disease8030777593017581326')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease8030777593017581326" style="display: none;"><a href="javascript:toggle2('disease8030777593017581326')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Nexium">Nexium</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4244285'>rs4244285</a><a href='http://www.snpedia.com/index.php/rs4244285(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF2F2;'>76.2%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.814242511653" style="display: inline;"><a href="javascript:toggle2('sec-0.814242511653')">...more...</a></div>
        <div class='boxrstext' id="sec-0.814242511653" style="display: none;"><a href="javascript:toggle2('sec-0.814242511653')">(hide)</a>
        <div class='rstext'>rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid). In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pyl...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs28399504'>rs28399504</a><a href='http://www.snpedia.com/index.php/rs28399504(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.951589338633" style="display: inline;"><a href="javascript:toggle2('sec-0.951589338633')">...more...</a></div>
        <div class='boxrstext' id="sec-0.951589338633" style="display: none;"><a href="javascript:toggle2('sec-0.951589338633')">(hide)</a>
        <div class='rstext'>rs28399504 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*4 variant. This variant has been linked to poor metabolism of compounds like mephenytoin. It is also known as M1V or Met1Val. The risk allele is rs28399504(G). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). According to a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504. Clopidogrel Efficacy  [Pharm...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4986893'>rs4986893</a><a href='http://www.snpedia.com/index.php/rs4986893(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.216522526386" style="display: inline;"><a href="javascript:toggle2('sec-0.216522526386')">...more...</a></div>
        <div class='boxrstext' id="sec-0.216522526386" style="display: none;"><a href="javascript:toggle2('sec-0.216522526386')">(hide)</a>
        <div class='rstext'>rs4986893 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*3 variant. This variant has been linked to poor metabolism of compounds like mephenytoin as well as proguanil, and it therefore has implications for malaria prophylaxis. The risk allele is rs4986893(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). Clopidogrel Efficacy  [PharmGKB:Curated In contrast to other PPIs, esomeprazole-induced healing of GERD appears to be unrelated to the CYP2C19*3 variant.] [OMIM:MEPHENYTOIN, POOR METABOLISM OF]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|30|0">Nonsteroidal anti-inflammatory drug</a>

        <div class='boxshow' id="show-disease-6164344293544267053" style="display: inline;"><a href="javascript:toggle2('disease-6164344293544267053')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-6164344293544267053" style="display: none;"><a href="javascript:toggle2('disease-6164344293544267053')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Nonsteroidal%20anti-inflammatory%20drug">Nonsteroidal anti-inflammatory drug</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1799853'>rs1799853</a><a href='http://www.snpedia.com/index.php/rs1799853(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFB9B9;'>19.0%</span><br/>References:22<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>CYP2C9*2 carrier; average 20% reduction in warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.226608925941" style="display: inline;"><a href="javascript:toggle2('sec-0.226608925941')">...more...</a></div>
        <div class='boxrstext' id="sec-0.226608925941" style="display: none;"><a href="javascript:toggle2('sec-0.226608925941')">(hide)</a>
        <div class='rstext'>rs1799853 is a SNP in the CYP2C9 gene and is linked to poor warfarin metabolism. Advanced knowledge of this may influence initial warfarin dosing by physicians. Warfarin is monitored through INR (international normalized ratio) and proper dosing is influenced by a variety of factors including warfarin metabolism and diet. rs1799853 is a SNP in the CYP2C9 gene. The rs1799853(T) allele encodes a variant amino acid, cysteine, which has been linked to poor metabolism of warfarin and thus sensitivity . The common nomenclature for this polymorphism is CYP2C9*2 (Cys amino acid, T allele; the SNP is also known as C430T or Cys144Arg). The CYP2C9*2 allele is also associated with higher sensitivity to the anti-epileptic drug phenytoin. The effect of CYP2C9 variants on drug metabolism should not be pr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3129900'>rs3129900</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs3129900(G;T)'>(G;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC8C8;'>28.3%</span><br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.200079312682" style="display: inline;"><a href="javascript:toggle2('sec-0.200079312682')">...more...</a></div>
        <div class='boxrstext' id="sec-0.200079312682" style="display: none;"><a href="javascript:toggle2('sec-0.200079312682')">(hide)</a>
        <div class='rstext'>People with one or two copies of the G allele at this SNP are 3.5 times more likely to suffer liver injury than TT carriers when taking the prescription nonsteroidal anti-inflammatory drug (NSAID) lumiracoxib. This new pain medication was approved in Europe in late 2006, but because of a higher incidence of liver injury and patient deaths than among patients using other NSAIDs, it was withdrawn from the market in most countries. It is still sold in some countries under the brand names Prexige and Joicela.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs9270986'>rs9270986</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs9270986(A;C)'>(A;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCCCC;'>31.9%</span><br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.594765975414" style="display: inline;"><a href="javascript:toggle2('sec-0.594765975414')">...more...</a></div>
        <div class='boxrstext' id="sec-0.594765975414" style="display: none;"><a href="javascript:toggle2('sec-0.594765975414')">(hide)</a>
        <div class='rstext'>This SNP is associated with a higher risk of liver injury in patients taking the nonsteroidal anti-inflammatory drug lumiracoxib, which has been withdrawn from most markets.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|20|0">Nortriptyline</a>

        <div class='boxshow' id="show-disease-1166413939415383830" style="display: inline;"><a href="javascript:toggle2('disease-1166413939415383830')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-1166413939415383830" style="display: none;"><a href="javascript:toggle2('disease-1166413939415383830')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Nortriptyline">Nortriptyline</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2500535'>rs2500535</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs2500535(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FF9696;'>6.2%</span><br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.0643953039979" style="display: inline;"><a href="javascript:toggle2('sec-0.0643953039979')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0643953039979" style="display: none;"><a href="javascript:toggle2('sec-0.0643953039979')">(hide)</a>
        <div class='rstext'>nortriptyline response  [PharmGKB:Curated Risk or phenotype-associated allele: A Phenotype: The SNP within an intron of the uronyl 2-sulphotransferase gene was associated with outcome at a genome-wide level of significance and with a very small posterior probability of being a false positive. Carriers of the minor A allele experienced less improvement of depression symptoms than carriers of the GG homozygote from week 4 onward. Study size: 312 Study population/ethnicity: Individuals with unipolar depression of at least moderate severity treated with nortriptyline. Type of association: GN] [GWAS:Response to antidepressants]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4651156'>rs4651156</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs4651156(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD9D9;'>43.4%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.231812160984" style="display: inline;"><a href="javascript:toggle2('sec-0.231812160984')">...more...</a></div>
        <div class='boxrstext' id="sec-0.231812160984" style="display: none;"><a href="javascript:toggle2('sec-0.231812160984')">(hide)</a>
        <div class='rstext'>nortriptyline response  [GWAS:Response to antidepressants]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5030655'>rs5030655</a><a href='http://www.snpedia.com/index.php/rs5030655(I;I)'>(I;I)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.339610357856" style="display: inline;"><a href="javascript:toggle2('sec-0.339610357856')">...more...</a></div>
        <div class='boxrstext' id="sec-0.339610357856" style="display: none;"><a href="javascript:toggle2('sec-0.339610357856')">(hide)</a>
        <div class='rstext'>The (-) form of this SNP, representing a deletion of one nucleotide, causes a frameshift such that the resulting CYP2D6 protein is nonfunctional. The associated allele is also known as CYP2D6*6, and there are several subtypes but they are all nonfunctional. If two copies of this (or similar) changes are inherited, CYP2D6 poor metabolism ('PM') is observed. CYP2D6 poor metabolism may affect the efficacy or degree of side effects of drugs metabolized by CYP2D6, such as dextromorphan, sparteine, nortriptyline, venlafaxine and codeine. Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms.  [PharmGKB:Curated This variant is part of the CYP2D6*6 PM haplotype. Plasma concentrations of metoprolol were shown to be were 4.9-fold higher in the PMs, with gr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1065852'>rs1065852</a><a href='http://www.snpedia.com/index.php/rs1065852(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:8<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.169844054535" style="display: inline;"><a href="javascript:toggle2('sec-0.169844054535')">...more...</a></div>
        <div class='boxrstext' id="sec-0.169844054535" style="display: none;"><a href="javascript:toggle2('sec-0.169844054535')">(hide)</a>
        <div class='rstext'>The wild type (normal) allele at this SNP is (C). The (T) variant indicates the presence of a non-wild type CYP2D6 variant, but it appears in many different variants so it can not be used to determine the presence of any particular variant. The most common variants it appears in are CYP2D6*10 and CYP2D6*4, but these are not the only ones. While this is the defining mutation for CYP2D6*10, it is not possible by itself for this mutation to determine a particular variant. In addition, the CYP2D6*4 variant includes this mutation, but the defining mutation 1846G&gt;A SNP is not available in the common direct to consumer testing services. While it is not possible for this mutation to identify one particular variant, all the variants in which it appears have reduced or no CYP2D6 activity. If two ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.652110320223" style="display: inline;"><a href="javascript:toggle2('sec-0.652110320223')">...more...</a></div>
        <div class='boxrstext' id="sec-0.652110320223" style="display: none;"><a href="javascript:toggle2('sec-0.652110320223')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">5 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|50|40">Olanzapine</a>

        <div class='boxshow' id="show-disease-4756675874851090341" style="display: inline;"><a href="javascript:toggle2('disease-4756675874851090341')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-4756675874851090341" style="display: none;"><a href="javascript:toggle2('disease-4756675874851090341')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Olanzapine">Olanzapine</a>
  <div id="gs155"  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs155'>gs155</a></div></div>
        <div class='boxmag'>Magnitude: 2.5</div>
        <div class='boxrep'>Repute: Bad</div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>CYP3A5 non-expressor</div>
        <div class='gsboxeffect'>This is common for Caucasians, but rare for African populations. As a CYP3A5 non-expressor you are unable to metabolize some common medications. This influences the synthesis of cholesterol, steroids and other lipids. The enzyme metabolizes drugs such as olanzapine, tacrolimus, nifedipine and cyclosporine as well as the steroid hormones testosterone, progesterone and androstenedione.</div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4765623'>rs4765623</a><a href='http://www.snpedia.com/index.php/rs4765623(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD8D8;'>42.5%</span><br/>Repute:Bad<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>more likely to gain weight if taking olanzapine</div>
        <div class='boxshow' id="show-sec-0.946316481798" style="display: inline;"><a href="javascript:toggle2('sec-0.946316481798')">...more...</a></div>
        <div class='boxrstext' id="sec-0.946316481798" style="display: none;"><a href="javascript:toggle2('sec-0.946316481798')">(hide)</a>
        <div class='rstext'>rs4765623 is a SNP in the scavenger receptor class B, member 1 SCARB1 gene. In a study of 67 mostly Caucasian patients prescribed the atypical antipsychotic olanzapine, carriers of a rs4765623(C) allele were more likely to gain significant weight compared to rs4765623(T;T) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, rs5092 and rs7412, were also significantly associated with weight profiles in these patients. Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA.  [GWAS:None]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4783227'>rs4783227</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs4783227(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDEDE;'>49.6%</span><br/>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.450913959262" style="display: inline;"><a href="javascript:toggle2('sec-0.450913959262')">...more...</a></div>
        <div class='boxrstext' id="sec-0.450913959262" style="display: none;"><a href="javascript:toggle2('sec-0.450913959262')">(hide)</a>
        <div class='rstext'>gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 4 x 10^-7 for total cholesterol as a result of olanzapine use</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3813929'>rs3813929</a><a href='http://www.snpedia.com/index.php/rs3813929(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Repute:Bad<br/>References:13<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>possible weight gain if taking olanzapine</div>
        <div class='boxshow' id="show-sec-0.790224880386" style="display: inline;"><a href="javascript:toggle2('sec-0.790224880386')">...more...</a></div>
        <div class='boxrstext' id="sec-0.790224880386" style="display: none;"><a href="javascript:toggle2('sec-0.790224880386')">(hide)</a>
        <div class='rstext'>rs3813929, also known as -759C/T, is a SNP in the 5-hydroxytryptamine (serotonin) receptor 2C HTR2C gene. A study of 107 patients with schizophrenia being treated with olanzapine reported a protective effect against weight-gain from the (T) allele of this SNP; zero patients (of 28) with a rs3813929(T) allele had a body mass index increase of &gt;=10% (p=0.002), whereas (C;C) homozygotes did. This effect may also involve nearby SNP rs518147. T allele showed borderline significant association with higher BMI and incidence of lifetime major depressive disorder among 4978 persons from the European Prospective Investigation into Cancer (EPIC)-Norfolk study, however, only the association with BMI remained borderline significant within the full EPIC-Norfolk cohort (20,981 persons) The association...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4606'>rs4606</a><a href='http://www.snpedia.com/index.php/rs4606(C;G)'>(C;G)</a></div>
        <div class='boxmag'>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>complex; possible association with anxiety related behaviours</div>
        <div class='boxshow' id="show-sec-0.949162894104" style="display: inline;"><a href="javascript:toggle2('sec-0.949162894104')">...more...</a></div>
        <div class='boxrstext' id="sec-0.949162894104" style="display: none;"><a href="javascript:toggle2('sec-0.949162894104')">(hide)</a>
        <div class='rstext'>In mice, the genetic locus best correlated to anxiety-related behaviour contains the 'regulator of G protein signaling 2' gene . In humans, SNPs in the equivalent RGS2 gene have now been studied to see if they are correlated to anxiety related disorders. In the first part of one study, 119 families including children underwent standard lab-based behavioural assessments of behavioural inhibition, defined as a heritable temperamental profile characterized by a tendency to be shy, avoident, and behaviourally restrained in situations that are novel or unfamiliar. Along with some other RGS2 SNPs, carriers of a rs4606(G) allele were 3 fold more likely to exhibit behavioural inhibition (CI: 1.31-6.84, p = 0.0026). In the second part of this study, 744 college undergraduates (228 men, 516 women) w...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5092'>rs5092</a><a href='http://www.snpedia.com/index.php/rs5092(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Repute:Bad<br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>more likely to gain weight if taking olanzapine</div>
        <div class='boxshow' id="show-sec-0.111186206447" style="display: inline;"><a href="javascript:toggle2('sec-0.111186206447')">...more...</a></div>
        <div class='boxrstext' id="sec-0.111186206447" style="display: none;"><a href="javascript:toggle2('sec-0.111186206447')">(hide)</a>
        <div class='rstext'>rs5092 is a SNP in the apolipoprotein A4 APOA4 gene. In a study of 67 mostly Caucasian patients prescribed the atypical antipsychotic olanzapine, carriers of a rs5092(G) allele were less likely to gain significant weight compared to rs5092(A;A) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, rs4765623 and rs7412, were also significantly associated with weight profiles in these patients.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7412'>rs7412</a><a href='http://www.snpedia.com/index.php/rs7412(T;T)'>(T;T)</a></div>
        <div class='boxmag'>References:32<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.180692662849" style="display: inline;"><a href="javascript:toggle2('sec-0.180692662849')">...more...</a></div>
        <div class='boxrstext' id="sec-0.180692662849" style="display: none;"><a href="javascript:toggle2('sec-0.180692662849')">(hide)</a>
        <div class='rstext'>The ancestral allele is C. The rs7412(T) allele, also known as Arg176Cys, generally indicates the presence of an Apo&#949;2 allele; see the ApoE page for a full discussion of the ApoE alleles and their association with Alzheimer's disease. Another SNP related to ApoE is rs429358. In a study of 67 mostly Caucasian patients prescribed the atypical antipsychotic olanzapine, carriers of a rs7412(C) allele were more likely to gain significant weight compared to rs7412(T;T) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, rs5092 and rs4765623, were also significantly associated with weight profiles in these patients. Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs518147'>rs518147</a><a href='http://www.snpedia.com/index.php/rs518147(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #F0D1F0;'>46.2%</span><br/>References:4<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>less weight gain if taking olanzapine</div>
        <div class='boxshow' id="show-sec-0.817310190183" style="display: inline;"><a href="javascript:toggle2('sec-0.817310190183')">...more...</a></div>
        <div class='boxrstext' id="sec-0.817310190183" style="display: none;"><a href="javascript:toggle2('sec-0.817310190183')">(hide)</a>
        <div class='rstext'>rs518147, also known as -697G/C, is a SNP in the 5-hydroxytryptamine (serotonin) receptor 2C HTR2C gene. A study of 107 patients with schizophrenia being treated with olanzapine reported a protective effect against weight-gain from the (C) allele of this SNP; fewer patients (of 28) with a rs518147(C) allele had a body mass index increase of &gt;=10% (p=0.0006), whereas (G;G) homozygotes did. This effect may also involve nearby SNP rs3813929. The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. HTR2C gene ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6280'>rs6280</a><a href='http://www.snpedia.com/index.php/rs6280(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFDADA;'>44.2%</span><br/>References:37<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.524777205573" style="display: inline;"><a href="javascript:toggle2('sec-0.524777205573')">...more...</a></div>
        <div class='boxrstext' id="sec-0.524777205573" style="display: none;"><a href="javascript:toggle2('sec-0.524777205573')">(hide)</a>
        <div class='rstext'>rs6280, also known as '''Ser9Gly''', is a SNP in the dopamine receptor D3 DRD3 gene. The rs6280(C) allele encodes a glycine, and the (T) allele encodes a serine (in dbSNP orientation). In a study of 88 patients being treated for schizophrenia with olanzapine, those who were rs6280(C;C) homozygotes had greater positive symptom remission (endpoint rating of minimal or none on all PANSS clinical response positive items, 39.1%), as compared with (C;T) or (T;T) genotypes (13.8%; p = 0.033). Ser9Gly has been implicated in executive function in some studies, but the results are conflicting. * Gly/Gly carriers showed significantly (p = 0.002) poorer performance than Ser/Ser carriers on executive functioning tasks in a somewhat small Caucasian sample (84 patients with first-episode psychosis and 85...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs977396'>rs977396</a><a href='http://www.snpedia.com/index.php/rs977396(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF3F3;'>77.9%</span><br/>Repute:Good<br/>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common on affy axiom data</div>
        <div class='boxshow' id="show-sec-0.216099347555" style="display: inline;"><a href="javascript:toggle2('sec-0.216099347555')">...more...</a></div>
        <div class='boxrstext' id="sec-0.216099347555" style="display: none;"><a href="javascript:toggle2('sec-0.216099347555')">(hide)</a>
        <div class='rstext'>gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 3 x 10^-7 for total cholesterol as a result of olanzapine use</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 genoset 9 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:40|0|0">Omeprazole</a>

        <div class='boxshow' id="show-disease473986084207562518" style="display: inline;"><a href="javascript:toggle2('disease473986084207562518')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease473986084207562518" style="display: none;"><a href="javascript:toggle2('disease473986084207562518')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Omeprazole">Omeprazole</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs12248560'>rs12248560</a><a href='http://www.snpedia.com/index.php/rs12248560(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFE3E3;'>55.4%</span><br/>Repute:Good<br/>References:13<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.110674048754" style="display: inline;"><a href="javascript:toggle2('sec-0.110674048754')">...more...</a></div>
        <div class='boxrstext' id="sec-0.110674048754" style="display: none;"><a href="javascript:toggle2('sec-0.110674048754')">(hide)</a>
        <div class='rstext'>rs12248560(T) defines the CYP2C19*17 allele, an ultra fast metabolizer phenotype of the CYP2C19 gene. CYP2C19*17 is likely to lead to less effective drug treatment by, for example, proton pump inhibitors (such as omeprazole) and antidepressants. On the other hand, cancer patients who are CYP2C19*17 carriers are more likely to benefit from tamoxifen treatment, presumably because they break it down more rapidly into the antiestrogenic metabolites endoxifen and 4-hydroxytamoxifen. A study of 1,000+ breast cancer patients showed a 0.77x decreased risk of breast cancer for carriers of a CYP2C19*17 allele (CI: 0.65-0.93, p = 0.005). Analysis of a subgroup of such carriers who were using hormone therapy for ten years or longer showed an even stronger effect (odds ratio 0.57, CI: 0.39-0.83, p = 0....</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4244285'>rs4244285</a><a href='http://www.snpedia.com/index.php/rs4244285(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF2F2;'>76.2%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.687112775363" style="display: inline;"><a href="javascript:toggle2('sec-0.687112775363')">...more...</a></div>
        <div class='boxrstext' id="sec-0.687112775363" style="display: none;"><a href="javascript:toggle2('sec-0.687112775363')">(hide)</a>
        <div class='rstext'>rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid). In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pyl...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs28399504'>rs28399504</a><a href='http://www.snpedia.com/index.php/rs28399504(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.514035920362" style="display: inline;"><a href="javascript:toggle2('sec-0.514035920362')">...more...</a></div>
        <div class='boxrstext' id="sec-0.514035920362" style="display: none;"><a href="javascript:toggle2('sec-0.514035920362')">(hide)</a>
        <div class='rstext'>rs28399504 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*4 variant. This variant has been linked to poor metabolism of compounds like mephenytoin. It is also known as M1V or Met1Val. The risk allele is rs28399504(G). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). According to a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504. Clopidogrel Efficacy  [Pharm...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4986893'>rs4986893</a><a href='http://www.snpedia.com/index.php/rs4986893(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.428861302738" style="display: inline;"><a href="javascript:toggle2('sec-0.428861302738')">...more...</a></div>
        <div class='boxrstext' id="sec-0.428861302738" style="display: none;"><a href="javascript:toggle2('sec-0.428861302738')">(hide)</a>
        <div class='rstext'>rs4986893 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*3 variant. This variant has been linked to poor metabolism of compounds like mephenytoin as well as proguanil, and it therefore has implications for malaria prophylaxis. The risk allele is rs4986893(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). Clopidogrel Efficacy  [PharmGKB:Curated In contrast to other PPIs, esomeprazole-induced healing of GERD appears to be unrelated to the CYP2C19*3 variant.] [OMIM:MEPHENYTOIN, POOR METABOLISM OF]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|10|0">Paclitaxel</a>

        <div class='boxshow' id="show-disease-5619371254823163959" style="display: inline;"><a href="javascript:toggle2('disease-5619371254823163959')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-5619371254823163959" style="display: none;"><a href="javascript:toggle2('disease-5619371254823163959')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Paclitaxel">Paclitaxel</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1042522'>rs1042522</a><a href='http://www.snpedia.com/index.php/rs1042522(C;G)'>(C;G)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFC9C9;'>29.2%</span><br/>Repute:Good<br/>References:123<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Slightly increased lifespan?</div>
        <div class='boxshow' id="show-sec-0.727263571842" style="display: inline;"><a href="javascript:toggle2('sec-0.727263571842')">...more...</a></div>
        <div class='boxrstext' id="sec-0.727263571842" style="display: none;"><a href="javascript:toggle2('sec-0.727263571842')">(hide)</a>
        <div class='rstext'>This SNP, a variant in the TP53 gene, is 1 of 25 SNPs reported to represent independently minor, but cumulatively significant, increased risk for breast cancer. For details of all 25 SNPs in this group, along with the two methods used to calculate overall risk estimates for breast cancer, refer to the SNPedia breast cancer entry. For this particular SNP, the G allele encodes an arginine at position 72 of the protein (where there's normally a proline), and the SNP is commonly called the Arg72 variant, although P72R and Arg72Pro are also common in the literature. Minor allele homozygotes, i.e. rs1042522(C;C) genotypes, live on average 3 years longer than major allele (G;G) homozygotes, based on a study of 9,200+ Danish individuals. The increased longevity is speculated to be related to the i...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1056836'>rs1056836</a><a href='http://www.snpedia.com/index.php/rs1056836(C;G)'>(C;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFD9D9;'>43.4%</span><br/>References:65<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.540117978147" style="display: inline;"><a href="javascript:toggle2('sec-0.540117978147')">...more...</a></div>
        <div class='boxrstext' id="sec-0.540117978147" style="display: none;"><a href="javascript:toggle2('sec-0.540117978147')">(hide)</a>
        <div class='rstext'>rs1056836, also known as 4326C/G, Val432Leu or L432V, is a SNP in the cytochrome P450 1B1 (CYP1B1) gene. This gene is a member of the CYP1 gene family and one of the major enzymes involved in the hydroxylation of estrogens, a reaction likely to be relevant in hormonal carcinogenesis. [In dbSNP orientation, the (C) allele encodes the Leu; the (G) the Val.] In a study of 153 Hispanic Caucasians with prostate cancer the rs1056836(G;G) genotype showed decreased risk compared to the more common (C;C) genotype (odds ratio = 0.31, p = 0.04, CI: 0.10-0.96). This report cites another study as indicating that rs1056836(C;C) high-risk stage III and IV breast cancer patients receiving dose-intense paclitaxel in combination with doxorubicin and cyclophosphamide experience a longer progression-free surv...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:40|10|10">Paroxetine</a>

        <div class='boxshow' id="show-disease-127923243649189151" style="display: inline;"><a href="javascript:toggle2('disease-127923243649189151')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-127923243649189151" style="display: none;"><a href="javascript:toggle2('disease-127923243649189151')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Paroxetine">Paroxetine</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.338877394358" style="display: inline;"><a href="javascript:toggle2('sec-0.338877394358')">...more...</a></div>
        <div class='boxrstext' id="sec-0.338877394358" style="display: none;"><a href="javascript:toggle2('sec-0.338877394358')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs12720067'>rs12720067</a><a href='http://www.snpedia.com/index.php/rs12720067(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.976025687104" style="display: inline;"><a href="javascript:toggle2('sec-0.976025687104')">...more...</a></div>
        <div class='boxrstext' id="sec-0.976025687104" style="display: none;"><a href="javascript:toggle2('sec-0.976025687104')">(hide)</a>
        <div class='rstext'>rs12720067 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs12720067 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are kn...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2235040'>rs2235040</a><a href='http://www.snpedia.com/index.php/rs2235040(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Magnitude: 1<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.529199035471" style="display: inline;"><a href="javascript:toggle2('sec-0.529199035471')">...more...</a></div>
        <div class='boxrstext' id="sec-0.529199035471" style="display: none;"><a href="javascript:toggle2('sec-0.529199035471')">(hide)</a>
        <div class='rstext'>rs2235040 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2235040 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7787082'>rs7787082</a><a href='http://www.snpedia.com/index.php/rs7787082(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCDCD;'>32.3%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.708158372499" style="display: inline;"><a href="javascript:toggle2('sec-0.708158372499')">...more...</a></div>
        <div class='boxrstext' id="sec-0.708158372499" style="display: none;"><a href="javascript:toggle2('sec-0.708158372499')">(hide)</a>
        <div class='rstext'>rs7787082 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs7787082 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4680'>rs4680</a><a href='http://www.snpedia.com/index.php/rs4680(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDBDB;'>46.0%</span><br/>References:276<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>multiple associations, see details</div>
        <div class='boxshow' id="show-sec-0.108461872234" style="display: inline;"><a href="javascript:toggle2('sec-0.108461872234')">...more...</a></div>
        <div class='boxrstext' id="sec-0.108461872234" style="display: none;"><a href="javascript:toggle2('sec-0.108461872234')">(hide)</a>
        <div class='rstext'>rs4680 (Val158Met) is a well studied SNP in the COMT gene. 23andMe blog summarizes them as *rs4680(A) = Worrier. Met, more exploratory, lower COMT enzymatic activity, therefore higher dopamine levels; lower pain threshold, enhanced vulnerability to stress, yet also more efficient at processing information under most conditions *rs4680(G) = Warrior. Val, less exploratory, higher COMT enzymatic activity, therefore lower dopamine levels; higher pain threshold, better stress resiliency, albeit with a modest reduction in executive cognition performance under most conditions Roughly speaking, the predominant wisdom (known colloquially as the warrior/worrier hypothesis; summary at ) posits that people with Val alleles have increased COMT activity and lower prefrontal extracellular dopamine compar...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6314'>rs6314</a><a href='http://www.snpedia.com/index.php/rs6314(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF8F8;'>87.6%</span><br/>Repute:Bad<br/>References:20<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>higher risk for RA</div>
        <div class='boxshow' id="show-sec-0.257943852253" style="display: inline;"><a href="javascript:toggle2('sec-0.257943852253')">...more...</a></div>
        <div class='boxrstext' id="sec-0.257943852253" style="display: none;"><a href="javascript:toggle2('sec-0.257943852253')">(hide)</a>
        <div class='rstext'>rs6314, also known as C1354T or His452Tyr/H452Y, is a SNP in the serotonin 2A receptor HTR2A gene. Based on a study of 166 Caucasian patients being treated for depression with paroxetine, rs6314 heterozygotes were associated with better response. There was a significantly higher frequency of heterozygotes in the remitter and response groups in comparison to the non-remitter (odds ratio 7.50, p=0.002) and non-response groups (odds ratio 5.25, p=0.01). * rs6314 is part of a 4-SNP haplotype in the serotonin 2A receptor gene HTR2A that has been associated with rheumatoid arthritis in a study of 1800 European patients. The risk allele is rs6314(C). The overall risk for the haplotype CTCC of SNPs rs6311-rs1328674-rs6313-rs6314 is 1.68 (CI: 1.20 - 2.34, p = 0.02). Note: the orientation of rs13286...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">6 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Paxil</a>

        <div class='boxshow' id="show-disease-5040710939979238543" style="display: inline;"><a href="javascript:toggle2('disease-5040710939979238543')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-5040710939979238543" style="display: none;"><a href="javascript:toggle2('disease-5040710939979238543')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Paxil">Paxil</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.680421455513" style="display: inline;"><a href="javascript:toggle2('sec-0.680421455513')">...more...</a></div>
        <div class='boxrstext' id="sec-0.680421455513" style="display: none;"><a href="javascript:toggle2('sec-0.680421455513')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|20|0">Penicillin</a>

        <div class='boxshow' id="show-disease3161947972234060029" style="display: inline;"><a href="javascript:toggle2('disease3161947972234060029')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease3161947972234060029" style="display: none;"><a href="javascript:toggle2('disease3161947972234060029')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Penicillin">Penicillin</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs10062446'>rs10062446</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs10062446(A;T)'>(A;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD3D3;'>38.1%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.077610000845" style="display: inline;"><a href="javascript:toggle2('sec-0.077610000845')">...more...</a></div>
        <div class='boxrstext' id="sec-0.077610000845" style="display: none;"><a href="javascript:toggle2('sec-0.077610000845')">(hide)</a>
        <div class='rstext'>rs10062446 is one of two SNPs in the IL4 gene that is (somewhat) associated with penicillin allergy, based on a relatively small study of 23 cases and 39 controls, t the other SNP being rs11740584.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs11740584'>rs11740584</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs11740584(C;G)'>(C;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD7D7;'>41.5%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.961169511939" style="display: inline;"><a href="javascript:toggle2('sec-0.961169511939')">...more...</a></div>
        <div class='boxrstext' id="sec-0.961169511939" style="display: none;"><a href="javascript:toggle2('sec-0.961169511939')">(hide)</a>
        <div class='rstext'>rs11740584 is one of two SNPs in the IL4 gene that is (somewhat) associated with penicillin allergy, based on a relatively small study of 23 cases and 39 controls, t the other SNP being rs10062446.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|10|0">Phenytoin</a>

        <div class='boxshow' id="show-disease4260502860547585569" style="display: inline;"><a href="javascript:toggle2('disease4260502860547585569')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease4260502860547585569" style="display: none;"><a href="javascript:toggle2('disease4260502860547585569')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Phenytoin">Phenytoin</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1799853'>rs1799853</a><a href='http://www.snpedia.com/index.php/rs1799853(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFB9B9;'>19.0%</span><br/>References:22<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>CYP2C9*2 carrier; average 20% reduction in warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.781067823327" style="display: inline;"><a href="javascript:toggle2('sec-0.781067823327')">...more...</a></div>
        <div class='boxrstext' id="sec-0.781067823327" style="display: none;"><a href="javascript:toggle2('sec-0.781067823327')">(hide)</a>
        <div class='rstext'>rs1799853 is a SNP in the CYP2C9 gene and is linked to poor warfarin metabolism. Advanced knowledge of this may influence initial warfarin dosing by physicians. Warfarin is monitored through INR (international normalized ratio) and proper dosing is influenced by a variety of factors including warfarin metabolism and diet. rs1799853 is a SNP in the CYP2C9 gene. The rs1799853(T) allele encodes a variant amino acid, cysteine, which has been linked to poor metabolism of warfarin and thus sensitivity . The common nomenclature for this polymorphism is CYP2C9*2 (Cys amino acid, T allele; the SNP is also known as C430T or Cys144Arg). The CYP2C9*2 allele is also associated with higher sensitivity to the anti-epileptic drug phenytoin. The effect of CYP2C9 variants on drug metabolism should not be pr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1057910'>rs1057910</a><a href='http://www.snpedia.com/index.php/rs1057910(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0.1<br/>Frequency: <span style='background-color: #FFF9F9;'>88.5%</span><br/>Repute:Good<br/>References:65<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal; no effect on warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.733141937205" style="display: inline;"><a href="javascript:toggle2('sec-0.733141937205')">...more...</a></div>
        <div class='boxrstext' id="sec-0.733141937205" style="display: none;"><a href="javascript:toggle2('sec-0.733141937205')">(hide)</a>
        <div class='rstext'>SNP rs1057910(A), located in the cytochrome p450 CYP2C9 gene, most commonly encodes the amino acid isoleucine at position 359, and the resulting allele is also known as CYP2C9*1. rs1057910(C) encodes a leucine at this same position, and the resulting allele is called CYP2C9*3. This SNP is also known as Ile359Leu or A1075C. The effect of CYP2C9 variants on drug metabolism should not be predicted without also considering CYP2C9*2, defined as the common loss of function variant rs1799853(T) (NM_000771:c.430C&gt;T, NP_000762:p.144R&gt;C) Studies of the effects of these alleles include: * rs1057910(C;C)] genotypes may clear drugs like celecoxib (trade name Celebrex) twice as slowly as rs1057910(A;A) genotypes; the rs1057910(A;C) genotypes are in-between clearance rates. Lower clearance rates wi...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Phytoestrogens</a>

        <div class='boxshow' id="show-disease-4711148470015075772" style="display: inline;"><a href="javascript:toggle2('disease-4711148470015075772')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-4711148470015075772" style="display: none;"><a href="javascript:toggle2('disease-4711148470015075772')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Phytoestrogens">Phytoestrogens</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2987983'>rs2987983</a><a href='http://www.snpedia.com/index.php/rs2987983(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFDEDE;'>49.6%</span><br/>References:17<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal risk This is the typical form, exhibiting normal risk for prostate cancer to learn more visit rs2987983</div>
        <div class='boxshow' id="show-sec-0.722843376069" style="display: inline;"><a href="javascript:toggle2('sec-0.722843376069')">...more...</a></div>
        <div class='boxrstext' id="sec-0.722843376069" style="display: none;"><a href="javascript:toggle2('sec-0.722843376069')">(hide)</a>
        <div class='rstext'>In one large Swedish study, men with one or two rs2987983(C) alleles were reported to be at somewhat increased (odds ratio 1.22) risk for Prostate cancer compared to men homozygous for the wild type rs2987983(T) allele, however the risk can be reduced by adding phytoestrogens to the diet.  [PharmGKB:Curated Haplotype tagging SNP.] [OMIM:ESTROGEN RECEPTOR 2; ESR2]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|40|0">Placebo</a>

        <div class='boxshow' id="show-disease-4945067883471882533" style="display: inline;"><a href="javascript:toggle2('disease-4945067883471882533')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-4945067883471882533" style="display: none;"><a href="javascript:toggle2('disease-4945067883471882533')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Placebo">Placebo</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4570625'>rs4570625</a><a href='http://www.snpedia.com/index.php/rs4570625(G;T)'>(G;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC9C9;'>29.2%</span><br/>References:17<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.733262122148" style="display: inline;"><a href="javascript:toggle2('sec-0.733262122148')">...more...</a></div>
        <div class='boxrstext' id="sec-0.733262122148" style="display: none;"><a href="javascript:toggle2('sec-0.733262122148')">(hide)</a>
        <div class='rstext'>rs4570625, also known as G-703T, is a SNP in the tryptophan hydroxylase 2 TPH2 gene. This SNP has been linked to several psychiatric and/or behavioural phenomena, including: * rs4570625 and rs4565946 linked to the pathogenesis of early-onset obsessive compulsive disorder * rs4570625 and rs11178997 in TPH2's regulatory region display preferential transmission * rs4570625(G;G) homozygosity was a significant predictor of clinical placebo response, being associated with greater improvement in anxiety symptoms. g2b2mh is rs4570625(G;G) is a significant predictor of clinical placebo response? maybe not panic disorder with a possible gender-dependent effect Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Associa...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4565946'>rs4565946</a><a href='http://www.snpedia.com/index.php/rs4565946(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDADA;'>45.1%</span><br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.43403562859" style="display: inline;"><a href="javascript:toggle2('sec-0.43403562859')">...more...</a></div>
        <div class='boxrstext' id="sec-0.43403562859" style="display: none;"><a href="javascript:toggle2('sec-0.43403562859')">(hide)</a>
        <div class='rstext'>rs4570625 and rs4565946 linked to the pathogenesis of early-onset obsessive compulsive disorder Tourette's Syndrome</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4680'>rs4680</a><a href='http://www.snpedia.com/index.php/rs4680(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDBDB;'>46.0%</span><br/>References:276<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>multiple associations, see details</div>
        <div class='boxshow' id="show-sec-0.454523938322" style="display: inline;"><a href="javascript:toggle2('sec-0.454523938322')">...more...</a></div>
        <div class='boxrstext' id="sec-0.454523938322" style="display: none;"><a href="javascript:toggle2('sec-0.454523938322')">(hide)</a>
        <div class='rstext'>rs4680 (Val158Met) is a well studied SNP in the COMT gene. 23andMe blog summarizes them as *rs4680(A) = Worrier. Met, more exploratory, lower COMT enzymatic activity, therefore higher dopamine levels; lower pain threshold, enhanced vulnerability to stress, yet also more efficient at processing information under most conditions *rs4680(G) = Warrior. Val, less exploratory, higher COMT enzymatic activity, therefore lower dopamine levels; higher pain threshold, better stress resiliency, albeit with a modest reduction in executive cognition performance under most conditions Roughly speaking, the predominant wisdom (known colloquially as the warrior/worrier hypothesis; summary at ) posits that people with Val alleles have increased COMT activity and lower prefrontal extracellular dopamine compar...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs11178997'>rs11178997</a><a href='http://www.snpedia.com/index.php/rs11178997(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>References:9<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common for Caucasians on the 23andme platform</div>
        <div class='boxshow' id="show-sec-0.521975759072" style="display: inline;"><a href="javascript:toggle2('sec-0.521975759072')">...more...</a></div>
        <div class='boxrstext' id="sec-0.521975759072" style="display: none;"><a href="javascript:toggle2('sec-0.521975759072')">(hide)</a>
        <div class='rstext'>rs4570625 and rs11178997 in TPH2's regulatory region display preferential transmission paper Association with and bipolar disorder in a Northern Swedish, Isolated Population. 182 patients and 364 unrelated control individuals. P = .001 rs11178997 significantly reduced TPH2 transcriptional activity by 22% and 7% in cell lines might have implications for the development and function of the serotonergic system in the brain. paper Carriers of the A-Allele of rs11178997 showed a decreased cortisol and ACTH stimulation. might be crucial factors for major depression pdf paper associated with bipolar disorder Minor allele yielded odds ratio of 1.5 (CI:1.2-1.9) for increased risk for bipolar disorder in a study of 883 Russian patients. Transmission disequilibrium of polymorphic variants in the tryp...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Plavix</a>

        <div class='boxshow' id="show-disease11745042239015816" style="display: inline;"><a href="javascript:toggle2('disease11745042239015816')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease11745042239015816" style="display: none;"><a href="javascript:toggle2('disease11745042239015816')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Plavix">Plavix</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4244285'>rs4244285</a><a href='http://www.snpedia.com/index.php/rs4244285(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF2F2;'>76.2%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.313731443249" style="display: inline;"><a href="javascript:toggle2('sec-0.313731443249')">...more...</a></div>
        <div class='boxrstext' id="sec-0.313731443249" style="display: none;"><a href="javascript:toggle2('sec-0.313731443249')">(hide)</a>
        <div class='rstext'>rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid). In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pyl...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Pravachol</a>

        <div class='boxshow' id="show-disease1974716652005694249" style="display: inline;"><a href="javascript:toggle2('disease1974716652005694249')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease1974716652005694249" style="display: none;"><a href="javascript:toggle2('disease1974716652005694249')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Pravachol">Pravachol</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs20455'>rs20455</a><a href='http://www.snpedia.com/index.php/rs20455(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD3D3;'>37.2%</span><br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.844145842295" style="display: inline;"><a href="javascript:toggle2('sec-0.844145842295')">...more...</a></div>
        <div class='boxrstext' id="sec-0.844145842295" style="display: none;"><a href="javascript:toggle2('sec-0.844145842295')">(hide)</a>
        <div class='rstext'>rs20455, often called Arg719 or 719Arg, is a reasonably well studied SNP in the KIF6 gene. The risk allele (encoding the arginine at position 719) is rs20455(C). An extensive 2010 meta-analysis, including over 17,000 patients, suggests this variant does not significantly influence coronary artery disease risk. This SNP is one of the 5 used by Celera's genetic risk score (GRS) for coronary heart disease (CHD). *rs20455, in the KIF6 gene *rs3900940, in the MYH15 gene *rs7439293, in the PALLD gene *rs2298566, in the SNX19 gene *rs1010, in the VAMP8 gene For each of the five variants, the GRS was increased by 1 if the subject was homozygous for the risk variant, unchanged if heterozygous, and decreased by 1 if the individual did not carry the variant. Therefore, individuals carrying all 10 pos...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|10|0">Pravastatin</a>

        <div class='boxshow' id="show-disease3428883727861773452" style="display: inline;"><a href="javascript:toggle2('disease3428883727861773452')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease3428883727861773452" style="display: none;"><a href="javascript:toggle2('disease3428883727861773452')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Pravastatin">Pravastatin</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs20455'>rs20455</a><a href='http://www.snpedia.com/index.php/rs20455(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD3D3;'>37.2%</span><br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.117362145635" style="display: inline;"><a href="javascript:toggle2('sec-0.117362145635')">...more...</a></div>
        <div class='boxrstext' id="sec-0.117362145635" style="display: none;"><a href="javascript:toggle2('sec-0.117362145635')">(hide)</a>
        <div class='rstext'>rs20455, often called Arg719 or 719Arg, is a reasonably well studied SNP in the KIF6 gene. The risk allele (encoding the arginine at position 719) is rs20455(C). An extensive 2010 meta-analysis, including over 17,000 patients, suggests this variant does not significantly influence coronary artery disease risk. This SNP is one of the 5 used by Celera's genetic risk score (GRS) for coronary heart disease (CHD). *rs20455, in the KIF6 gene *rs3900940, in the MYH15 gene *rs7439293, in the PALLD gene *rs2298566, in the SNX19 gene *rs1010, in the VAMP8 gene For each of the five variants, the GRS was increased by 1 if the subject was homozygous for the risk variant, unchanged if heterozygous, and decreased by 1 if the individual did not carry the variant. Therefore, individuals carrying all 10 pos...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4149056'>rs4149056</a><a href='http://www.snpedia.com/index.php/rs4149056(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEEEE;'>70.8%</span><br/>Repute:Good<br/>References:60<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.437839432384" style="display: inline;"><a href="javascript:toggle2('sec-0.437839432384')">...more...</a></div>
        <div class='boxrstext' id="sec-0.437839432384" style="display: none;"><a href="javascript:toggle2('sec-0.437839432384')">(hide)</a>
        <div class='rstext'>influences statin response *rs72559745 (SLCO1B1*1)	AA	AA *rs56061388 (SLCO1B1*3)	TT	TT *rs4149056 (SLCO1B1*5)	TT	TT *rs55901008 (SLCO1B1*6)	TT	TT rs4149056, also known as 37041T&gt;C or V174A, is a SNP in the SLCO1B1 gene, which encodes the 'organic anion transporting polypeptide 1B1' (OATP1B1) protein. This protein, found primarily in the liver, regulates the uptake of numerous drugs and natural compounds. The rs4149056(C) SNP defines the SLCO1B1*5 allele. The rs4149056(C) allele gives rise to an amino acid change (from valine to alanine at residue 174) which has reduced uptake/transport activity. Therefore, drugs metabolized by OATP1B1 tend to build up to higher circulating concentrations than they would otherwise.. The drugs known (or in some cases, thought) to be transported less well ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs17238540'>rs17238540</a><a href='http://www.snpedia.com/index.php/rs17238540(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:5<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common</div>
        <div class='boxshow' id="show-sec-0.321973776255" style="display: inline;"><a href="javascript:toggle2('sec-0.321973776255')">...more...</a></div>
        <div class='boxrstext' id="sec-0.321973776255" style="display: none;"><a href="javascript:toggle2('sec-0.321973776255')">(hide)</a>
        <div class='rstext'>rs17238540, also known as SNP 29, is located in the HMG-CoA reductase HMGCR gene. The protein encoded by this gene is the target for drugs designed to inhibit its action, in order to lower cholesterol levels. SNPs in the HMGCR gene may affect how well such drugs (typically statins) work. In a study of ~1,500 patients treated with 40mg/d of pravastatin, rs17238540(G;T) heterozgyotes had a mean decrease in total cholesterol of 32.5 mg/dL (0.85 mmol/L), while the mean change for rs17238540(T;T) homozygotes was 41.8 mg/dL (1.09 mmol/L), a reduction in overall efficacy of 22.3% (absolute difference, 9.3 mg/dL, CI: 3.8-14.7 mg/dL, p&lt;.001). The drop in total cholesterol was almost completely due to the decrease in LDL cholesterol, as there was no significant difference in the change in HDL cho...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs17244841'>rs17244841</a><a href='http://www.snpedia.com/index.php/rs17244841(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:4<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>more responsive to statin treatment</div>
        <div class='boxshow' id="show-sec-0.787044667677" style="display: inline;"><a href="javascript:toggle2('sec-0.787044667677')">...more...</a></div>
        <div class='boxrstext' id="sec-0.787044667677" style="display: none;"><a href="javascript:toggle2('sec-0.787044667677')">(hide)</a>
        <div class='rstext'>rs17244841, also known as SNP 12, is located in the HMG-CoA reductase HMGCR gene. The protein encoded by this gene is the target for drugs designed to inhibit its action, in order to lower cholesterol levels. SNPs in the HMGCR gene may affect how well such drugs (typically statins) work. In a study of ~1,500 patients treated with 40mg/d of pravastatin, rs17244841(A;T) heterozgyotes had a mean decrease in total cholesterol of &#226;&#8364;&#8220;32.8 mg/dL (&#226;&#8364;&#8220;0.85 mmol/L), while the mean change for rs17244841(A;A) homozygotes was &#226;&#8364;&#8220;42.0 mg/dL (&#226;&#8364;&#8220;1.09 mmol/L), a reduction in overall efficacy of 21.8% (absolute difference, 9.2 mg/dL, CI: 3.8-14.6 mg/dL, p=.001). The drop in total cholesterol was almost completely due to the decrease in LDL...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|0|10">Prevacid</a>

        <div class='boxshow' id="show-disease4773048424588611496" style="display: inline;"><a href="javascript:toggle2('disease4773048424588611496')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease4773048424588611496" style="display: none;"><a href="javascript:toggle2('disease4773048424588611496')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Prevacid">Prevacid</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1045642'>rs1045642</a><a href='http://www.snpedia.com/index.php/rs1045642(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFE4E4;'>55.8%</span><br/>Repute:Bad<br/>References:100<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Slower metaboliser for some drugs</div>
        <div class='boxshow' id="show-sec-0.249569692258" style="display: inline;"><a href="javascript:toggle2('sec-0.249569692258')">...more...</a></div>
        <div class='boxrstext' id="sec-0.249569692258" style="display: none;"><a href="javascript:toggle2('sec-0.249569692258')">(hide)</a>
        <div class='rstext'>rs1045642, also known as C3435T, is a SNP located in the ABCB1 gene. It is often studied in conjunction with rs2032582. C3435T has been mentioned by: * A 'Silent' Polymorphism in the MDR1 Gene Changes Substrate Specificity (for example, to verapamil) * (R)-lansoprazole (Prevacid) concentrations are significantly increased in CYP2C19 extensive metabolizers with ABCB1 C3435T C allele. * In a Korean population, plasma concentrations of fexofenadine (Allegra) were 17% lower in 2677AA/3435CC subjects and 47% higher in the 2677TT/3435TT subjects compared to 2677GG/3435CC subjects. * In contrast, in this study no association was observed between the C3435T polymorphism and fexofenadine plasma or urine concentrations in a German Caucasian population. * A meta-analysis including 9 case-control stud...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4244285'>rs4244285</a><a href='http://www.snpedia.com/index.php/rs4244285(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF2F2;'>76.2%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.432646933755" style="display: inline;"><a href="javascript:toggle2('sec-0.432646933755')">...more...</a></div>
        <div class='boxrstext' id="sec-0.432646933755" style="display: none;"><a href="javascript:toggle2('sec-0.432646933755')">(hide)</a>
        <div class='rstext'>rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid). In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pyl...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs28399504'>rs28399504</a><a href='http://www.snpedia.com/index.php/rs28399504(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.3152218635" style="display: inline;"><a href="javascript:toggle2('sec-0.3152218635')">...more...</a></div>
        <div class='boxrstext' id="sec-0.3152218635" style="display: none;"><a href="javascript:toggle2('sec-0.3152218635')">(hide)</a>
        <div class='rstext'>rs28399504 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*4 variant. This variant has been linked to poor metabolism of compounds like mephenytoin. It is also known as M1V or Met1Val. The risk allele is rs28399504(G). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). According to a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504. Clopidogrel Efficacy  [Pharm...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4986893'>rs4986893</a><a href='http://www.snpedia.com/index.php/rs4986893(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.385929594439" style="display: inline;"><a href="javascript:toggle2('sec-0.385929594439')">...more...</a></div>
        <div class='boxrstext' id="sec-0.385929594439" style="display: none;"><a href="javascript:toggle2('sec-0.385929594439')">(hide)</a>
        <div class='rstext'>rs4986893 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*3 variant. This variant has been linked to poor metabolism of compounds like mephenytoin as well as proguanil, and it therefore has implications for malaria prophylaxis. The risk allele is rs4986893(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). Clopidogrel Efficacy  [PharmGKB:Curated In contrast to other PPIs, esomeprazole-induced healing of GERD appears to be unrelated to the CYP2C19*3 variant.] [OMIM:MEPHENYTOIN, POOR METABOLISM OF]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|0|0">Prilosec</a>

        <div class='boxshow' id="show-disease-4795903106317059445" style="display: inline;"><a href="javascript:toggle2('disease-4795903106317059445')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-4795903106317059445" style="display: none;"><a href="javascript:toggle2('disease-4795903106317059445')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Prilosec">Prilosec</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4244285'>rs4244285</a><a href='http://www.snpedia.com/index.php/rs4244285(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF2F2;'>76.2%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.144886965236" style="display: inline;"><a href="javascript:toggle2('sec-0.144886965236')">...more...</a></div>
        <div class='boxrstext' id="sec-0.144886965236" style="display: none;"><a href="javascript:toggle2('sec-0.144886965236')">(hide)</a>
        <div class='rstext'>rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid). In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pyl...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs28399504'>rs28399504</a><a href='http://www.snpedia.com/index.php/rs28399504(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.931511936149" style="display: inline;"><a href="javascript:toggle2('sec-0.931511936149')">...more...</a></div>
        <div class='boxrstext' id="sec-0.931511936149" style="display: none;"><a href="javascript:toggle2('sec-0.931511936149')">(hide)</a>
        <div class='rstext'>rs28399504 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*4 variant. This variant has been linked to poor metabolism of compounds like mephenytoin. It is also known as M1V or Met1Val. The risk allele is rs28399504(G). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). According to a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504. Clopidogrel Efficacy  [Pharm...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4986893'>rs4986893</a><a href='http://www.snpedia.com/index.php/rs4986893(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.0335158458856" style="display: inline;"><a href="javascript:toggle2('sec-0.0335158458856')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0335158458856" style="display: none;"><a href="javascript:toggle2('sec-0.0335158458856')">(hide)</a>
        <div class='rstext'>rs4986893 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*3 variant. This variant has been linked to poor metabolism of compounds like mephenytoin as well as proguanil, and it therefore has implications for malaria prophylaxis. The risk allele is rs4986893(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). Clopidogrel Efficacy  [PharmGKB:Curated In contrast to other PPIs, esomeprazole-induced healing of GERD appears to be unrelated to the CYP2C19*3 variant.] [OMIM:MEPHENYTOIN, POOR METABOLISM OF]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|0|0">Proguanil</a>

        <div class='boxshow' id="show-disease4344349130392173718" style="display: inline;"><a href="javascript:toggle2('disease4344349130392173718')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease4344349130392173718" style="display: none;"><a href="javascript:toggle2('disease4344349130392173718')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Proguanil">Proguanil</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4244285'>rs4244285</a><a href='http://www.snpedia.com/index.php/rs4244285(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF2F2;'>76.2%</span><br/>Repute:Good<br/>References:30<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.416135673885" style="display: inline;"><a href="javascript:toggle2('sec-0.416135673885')">...more...</a></div>
        <div class='boxrstext' id="sec-0.416135673885" style="display: none;"><a href="javascript:toggle2('sec-0.416135673885')">(hide)</a>
        <div class='rstext'>rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid). In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pyl...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4986893'>rs4986893</a><a href='http://www.snpedia.com/index.php/rs4986893(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:19<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.877219314412" style="display: inline;"><a href="javascript:toggle2('sec-0.877219314412')">...more...</a></div>
        <div class='boxrstext' id="sec-0.877219314412" style="display: none;"><a href="javascript:toggle2('sec-0.877219314412')">(hide)</a>
        <div class='rstext'>rs4986893 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*3 variant. This variant has been linked to poor metabolism of compounds like mephenytoin as well as proguanil, and it therefore has implications for malaria prophylaxis. The risk allele is rs4986893(A). As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid). Clopidogrel Efficacy  [PharmGKB:Curated In contrast to other PPIs, esomeprazole-induced healing of GERD appears to be unrelated to the CYP2C19*3 variant.] [OMIM:MEPHENYTOIN, POOR METABOLISM OF]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|0|10">Remicade</a>

        <div class='boxshow' id="show-disease245773432153419356" style="display: inline;"><a href="javascript:toggle2('disease245773432153419356')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease245773432153419356" style="display: none;"><a href="javascript:toggle2('disease245773432153419356')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Remicade">Remicade</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801274'>rs1801274</a><a href='http://www.snpedia.com/index.php/rs1801274(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 1.5<br/>Frequency: <span style='background-color: #FFC5C5;'>26.5%</span><br/>Repute:Bad<br/>References:56<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>complex; generally greater risk for cancer progression</div>
        <div class='boxshow' id="show-sec-0.836713075727" style="display: inline;"><a href="javascript:toggle2('sec-0.836713075727')">...more...</a></div>
        <div class='boxrstext' id="sec-0.836713075727" style="display: none;"><a href="javascript:toggle2('sec-0.836713075727')">(hide)</a>
        <div class='rstext'>rs1801274 is a SNP in the Fc fragment of IgG, low affinity IIa, receptor (CD32) FCGR2A gene. rs1801274(C) encodes the arginine (R) allele, with the (T) allele encoding the variant histidine (H). The (H) isoform is considered high-binding to IgG2 and IgG3, while the (R) isoform is considered low-binding. This SNP is known in the literature by many names, including A519C and H131R. What's the importance of this? FcgR isoforms expressed on immune system cells have been linked to the pathogenic consequences triggered by autoantibodies or immune complexes in autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as well as to the efficacy of some immunotherapeutic treatments such as rituximab. Many studies have been published about this FCGR2A SNP, roughly...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Rhinocort</a>

        <div class='boxshow' id="show-disease7976277731111616787" style="display: inline;"><a href="javascript:toggle2('disease7976277731111616787')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease7976277731111616787" style="display: none;"><a href="javascript:toggle2('disease7976277731111616787')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Rhinocort">Rhinocort</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2240017'>rs2240017</a><a href='http://www.snpedia.com/index.php/rs2240017(C;G)'>(C;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FF0A0A;'>0.0%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>respond better to steroids</div>
        <div class='boxshow' id="show-sec-0.788134555078" style="display: inline;"><a href="javascript:toggle2('sec-0.788134555078')">...more...</a></div>
        <div class='boxrstext' id="sec-0.788134555078" style="display: none;"><a href="javascript:toggle2('sec-0.788134555078')">(hide)</a>
        <div class='rstext'>This SNP encodes a variation in the 33rd amino acid of the protein encoded by the TBX21 gene. Although 95% or so of all Caucasians carry two copies of the rs2240017(G) allele, as oriented in dbSNP orientation, and are thus rs2240017(G;G) homozygotes, a few individuals are rs2240017(C;G) heterozygotes. These heterozgotes are reported to improve better over time in response to corticosteroid treatment for asthma than the rs2240017(G;G) homozygotes. So far, studies have not linked, however, this SNP to any change in the overall risk of asthma itself. Although the effect observed was strong, in that treating rs2240017(C;G) heterozygotes ultimately (over 4 years) yields average airway responsiveness in the normal range (i.e. in the same range as for nonasthmatics), the authors point out that th...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|10">Risperdal</a>

        <div class='boxshow' id="show-disease-841925005192208185" style="display: inline;"><a href="javascript:toggle2('disease-841925005192208185')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-841925005192208185" style="display: none;"><a href="javascript:toggle2('disease-841925005192208185')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Risperdal">Risperdal</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6837793'>rs6837793</a><a href='http://www.snpedia.com/index.php/rs6837793(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFF4F4;'>80.5%</span><br/>Repute:Bad<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>more likely to gain weight if taking risperidone</div>
        <div class='boxshow' id="show-sec-0.703347969605" style="display: inline;"><a href="javascript:toggle2('sec-0.703347969605')">...more...</a></div>
        <div class='boxrstext' id="sec-0.703347969605" style="display: none;"><a href="javascript:toggle2('sec-0.703347969605')">(hide)</a>
        <div class='rstext'>rs6837793 is a SNP associated with the NPY5 receptor gene, located in the single promoter region likely to be co-regulating the Y1 and Y5 receptor genes. In a study of 101 mostly Caucasian patients prescribed the atypical antipsychotic risperidone, carriers of a rs6837793(G) allele were more likely to gain significant weight compared to rs6837793(A;A) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, rs8179183 and rs705381, were also significantly associated with weight profiles in these patients.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs8179183'>rs8179183</a><a href='http://www.snpedia.com/index.php/rs8179183(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #F069F0;'>1.5%</span><br/>References:15<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.424089763762" style="display: inline;"><a href="javascript:toggle2('sec-0.424089763762')">...more...</a></div>
        <div class='boxrstext' id="sec-0.424089763762" style="display: none;"><a href="javascript:toggle2('sec-0.424089763762')">(hide)</a>
        <div class='rstext'>rs8179183 is a SNP in the leptin receptor LEPR gene. In a study of 101 mostly Caucasian patients prescribed the atypical antipsychotic risperidone, carriers of a rs8179183(G) allele were less likely to gain significant weight compared to rs8179183(C;C) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, rs6837793 and rs705381, were also significantly associated with weight profiles in these patients.  [OMIM:LEPTIN RECEPTOR POLYMORPHISM]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:8|83|8">Risperidone</a>

        <div class='boxshow' id="show-disease8907569986779335211" style="display: inline;"><a href="javascript:toggle2('disease8907569986779335211')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease8907569986779335211" style="display: none;"><a href="javascript:toggle2('disease8907569986779335211')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Risperidone">Risperidone</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1799989'>rs1799989</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1799989(A;C)'>(A;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFB7B7;'>17.7%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.656436783287" style="display: inline;"><a href="javascript:toggle2('sec-0.656436783287')">...more...</a></div>
        <div class='boxrstext' id="sec-0.656436783287" style="display: none;"><a href="javascript:toggle2('sec-0.656436783287')">(hide)</a>
        <div class='rstext'>among 120 (likely Japanese) first-episode neuroleptic-naive schizophrenics treated with risperidone genotyped for 30 variants in misc. dopamine and serotonin (receptors and otherwise) two SNPs in DRD2 (rs1799989 and rs1800497) and two SNPs in AKT1 (rs3803300 and rs2494732) were significant predictors of treatment response to risperidone</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7105881'>rs7105881</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs7105881(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDDDD;'>47.8%</span><br/>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.854477919018" style="display: inline;"><a href="javascript:toggle2('sec-0.854477919018')">...more...</a></div>
        <div class='boxrstext' id="sec-0.854477919018" style="display: none;"><a href="javascript:toggle2('sec-0.854477919018')">(hide)</a>
        <div class='rstext'>gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 3 x 10^-7 for hip circumference as a result of risperidone use</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1176713'>rs1176713</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1176713(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFE5E5;'>57.5%</span><br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.0861182306933" style="display: inline;"><a href="javascript:toggle2('sec-0.0861182306933')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0861182306933" style="display: none;"><a href="javascript:toggle2('sec-0.0861182306933')">(hide)</a>
        <div class='rstext'>rs1176713 is a SNP, also known as g.14396A&gt;G, in the 5-hydroxytryptamine (serotonin) receptor 3A HTR3A gene. rs1176713 may be a useful predictor of therapeutic response to risperidone treatment in Chinese schizophrenia patients</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs167771'>rs167771</a><a href='http://www.snpedia.com/index.php/rs167771(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 1<br/>Frequency: <span style='background-color: #FFECEC;'>67.3%</span><br/>References:9<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>Possibly more 'Insistence on Sameness' on ADI-R test.Possibly increased FTND nicotine dependence.[http://www.ncbi.nlm.nih.gov/pubmed/22309839?dopt=Abstract</div>
        <div class='boxshow' id="show-sec-0.0341969160518" style="display: inline;"><a href="javascript:toggle2('sec-0.0341969160518')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0341969160518" style="display: none;"><a href="javascript:toggle2('sec-0.0341969160518')">(hide)</a>
        <div class='rstext'>rs167771 was significantly associated with autism spectrum disorder in a study of 144 patients. G allele associated with increased extra-pyramidal symptom risk as a result of risperidone treatment in a study of 321 psychiatric inpatients (81 presenting with EPS and 189 without)  [PharmGKB:Curated Risk or phenotype-associated allele: G. Phenotype: The G variant of rs167771 was associated with increased risk for extrapyramidal symptoms in psychiatric patients receiving risperidone. Study size: 132. Study population/ethnicity: Patients with Schizophrenia or Bipolar disorder receiving antipsychotics; Caucasians; Spain; Catalonia. Significance metric(s): OR = 3.3; p = 0.00013. Type of association: PD.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3813928'>rs3813928</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs3813928(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFF0F0;'>74.1%</span><br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.266137932104" style="display: inline;"><a href="javascript:toggle2('sec-0.266137932104')">...more...</a></div>
        <div class='boxrstext' id="sec-0.266137932104" style="display: none;"><a href="javascript:toggle2('sec-0.266137932104')">(hide)</a>
        <div class='rstext'>rs3813928 (-995G&gt;A / G-995A) is a SNP upstream of HTR2C. in a small sample of 45 autistic patients taking risperidone for up to one year, HTR2A Rs6311 (-1438G&gt;A), DRD3 rs6280 (Ser9Gly), HTR2C rs3813928 (995G&gt;A) and ABCB1 rs1128503) (1236C&gt;T) were predictive of risperidone response Identification of functional SNPs in the 5-prime flanking sequences of human genes. The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia.  [PharmGKB:Curated Risk or phenotype-associated allele: A Phenotype: Carriers of the A variant of HTR2C:(-995)G&gt;A had higher Autism Treatment Evaluation Checklist (ATEC) scores, indica...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6837793'>rs6837793</a><a href='http://www.snpedia.com/index.php/rs6837793(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFF4F4;'>80.5%</span><br/>Repute:Bad<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>more likely to gain weight if taking risperidone</div>
        <div class='boxshow' id="show-sec-0.96325176709" style="display: inline;"><a href="javascript:toggle2('sec-0.96325176709')">...more...</a></div>
        <div class='boxrstext' id="sec-0.96325176709" style="display: none;"><a href="javascript:toggle2('sec-0.96325176709')">(hide)</a>
        <div class='rstext'>rs6837793 is a SNP associated with the NPY5 receptor gene, located in the single promoter region likely to be co-regulating the Y1 and Y5 receptor genes. In a study of 101 mostly Caucasian patients prescribed the atypical antipsychotic risperidone, carriers of a rs6837793(G) allele were more likely to gain significant weight compared to rs6837793(A;A) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, rs8179183 and rs705381, were also significantly associated with weight profiles in these patients.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1568679'>rs1568679</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1568679(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFF5F5;'>82.3%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.581895639977" style="display: inline;"><a href="javascript:toggle2('sec-0.581895639977')">...more...</a></div>
        <div class='boxrstext' id="sec-0.581895639977" style="display: none;"><a href="javascript:toggle2('sec-0.581895639977')">(hide)</a>
        <div class='rstext'>gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 1 x 10^-8 for hip circumference as a result of risperidone use</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4606'>rs4606</a><a href='http://www.snpedia.com/index.php/rs4606(C;G)'>(C;G)</a></div>
        <div class='boxmag'>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>complex; possible association with anxiety related behaviours</div>
        <div class='boxshow' id="show-sec-0.41603376929" style="display: inline;"><a href="javascript:toggle2('sec-0.41603376929')">...more...</a></div>
        <div class='boxrstext' id="sec-0.41603376929" style="display: none;"><a href="javascript:toggle2('sec-0.41603376929')">(hide)</a>
        <div class='rstext'>In mice, the genetic locus best correlated to anxiety-related behaviour contains the 'regulator of G protein signaling 2' gene . In humans, SNPs in the equivalent RGS2 gene have now been studied to see if they are correlated to anxiety related disorders. In the first part of one study, 119 families including children underwent standard lab-based behavioural assessments of behavioural inhibition, defined as a heritable temperamental profile characterized by a tendency to be shy, avoident, and behaviourally restrained in situations that are novel or unfamiliar. Along with some other RGS2 SNPs, carriers of a rs4606(G) allele were 3 fold more likely to exhibit behavioural inhibition (CI: 1.31-6.84, p = 0.0026). In the second part of this study, 744 college undergraduates (228 men, 516 women) w...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3803300'>rs3803300</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs3803300(A;G)'>(A;G)</a></div>
        <div class='boxmag'>References:12<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.735802101324" style="display: inline;"><a href="javascript:toggle2('sec-0.735802101324')">...more...</a></div>
        <div class='boxrstext' id="sec-0.735802101324" style="display: none;"><a href="javascript:toggle2('sec-0.735802101324')">(hide)</a>
        <div class='rstext'>G allele associated with schizophrenia among 120 (likely Japanese) first-episode neuroleptic-naive schizophrenics treated with risperidone genotyped for 30 variants in misc. dopamine and serotonin (receptors and otherwise) two SNPs in DRD2 (rs1799989 and rs1800497) and two SNPs in AKT1 (rs3803300 and rs2494732) were significant predictors of treatment response to risperidone The ancestral allele is G in the dbSNP database.  [PharmGKB:Curated This SNP is significant predictor of treatment response to risperidone in first-episode schizophrenia.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs8179183'>rs8179183</a><a href='http://www.snpedia.com/index.php/rs8179183(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #F069F0;'>1.5%</span><br/>References:15<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.411306903904" style="display: inline;"><a href="javascript:toggle2('sec-0.411306903904')">...more...</a></div>
        <div class='boxrstext' id="sec-0.411306903904" style="display: none;"><a href="javascript:toggle2('sec-0.411306903904')">(hide)</a>
        <div class='rstext'>rs8179183 is a SNP in the leptin receptor LEPR gene. In a study of 101 mostly Caucasian patients prescribed the atypical antipsychotic risperidone, carriers of a rs8179183(G) allele were less likely to gain significant weight compared to rs8179183(C;C) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, rs6837793 and rs705381, were also significantly associated with weight profiles in these patients.  [OMIM:LEPTIN RECEPTOR POLYMORPHISM]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1414334'>rs1414334</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1414334(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #F0B8F0;'>75.9%</span><br/>References:8<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.253894602079" style="display: inline;"><a href="javascript:toggle2('sec-0.253894602079')">...more...</a></div>
        <div class='boxrstext' id="sec-0.253894602079" style="display: none;"><a href="javascript:toggle2('sec-0.253894602079')">(hide)</a>
        <div class='rstext'>rs1414334(C) associated with the metabolic syndrome in patients using *clozapine (OR, 9.20; 95% CI, 1.95-43.45) *risperidone (OR, 5.35; 95% CI, 1.26-22.83)  [PharmGKB:Curated Risk or phenotype-associated allele: C. Phenotype: In a replication study, the C allele of HTR2C rs1414334 polymorphism is associated with development of the metabolic syndrome during treatment with antipsychotics. Study size: 186. Study population/ethnicity: 93% Caucasian; European; Dutch; The Netherlands. Significance metric(s): OR = 3.73; 95% CI= 1.29-10.79; P = 0.015. Type of association: CO.]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801028'>rs1801028</a><a href='http://www.snpedia.com/index.php/rs1801028(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:14<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal risk</div>
        <div class='boxshow' id="show-sec-0.722020708479" style="display: inline;"><a href="javascript:toggle2('sec-0.722020708479')">...more...</a></div>
        <div class='boxrstext' id="sec-0.722020708479" style="display: none;"><a href="javascript:toggle2('sec-0.722020708479')">(hide)</a>
        <div class='rstext'>rs1801028 is a SNP in the dopamine D2 receptor DRD2 gene. A meta-analysis comprising 27 samples and over 3,707 schizophrenia patients concluded that Cys/Ser heterozygotes, i.e. rs1801028(C;G) genotypes, were at elevated risk for schizophrenia when compared to either homozygote genotype (rs1801028(C;C) or rs1801028(G;G)). The odds ratio was 1.4 (p&lt;0.005). An earlier meta-analysis comprising over 9,000 schizophrenia patients concluded pretty much the same thing: the Cys311 (rs1801028(G)) allele frequency led to an odds ratio of 1.43 (CI: 1.16-1.78, p&lt;0.001) for this risk allele. A study of ~120 Chinese patients with schizophrenia concluded that Cys/Ser heterozygotes may not respond to risperidone treatment as well as Ser/Ser homozygotes. A paper has been published describing mistakes m...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">12 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|0|10">Rituximab</a>

        <div class='boxshow' id="show-disease938320442195194168" style="display: inline;"><a href="javascript:toggle2('disease938320442195194168')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease938320442195194168" style="display: none;"><a href="javascript:toggle2('disease938320442195194168')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Rituximab">Rituximab</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801274'>rs1801274</a><a href='http://www.snpedia.com/index.php/rs1801274(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 1.5<br/>Frequency: <span style='background-color: #FFC5C5;'>26.5%</span><br/>Repute:Bad<br/>References:56<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>complex; generally greater risk for cancer progression</div>
        <div class='boxshow' id="show-sec-0.578120829119" style="display: inline;"><a href="javascript:toggle2('sec-0.578120829119')">...more...</a></div>
        <div class='boxrstext' id="sec-0.578120829119" style="display: none;"><a href="javascript:toggle2('sec-0.578120829119')">(hide)</a>
        <div class='rstext'>rs1801274 is a SNP in the Fc fragment of IgG, low affinity IIa, receptor (CD32) FCGR2A gene. rs1801274(C) encodes the arginine (R) allele, with the (T) allele encoding the variant histidine (H). The (H) isoform is considered high-binding to IgG2 and IgG3, while the (R) isoform is considered low-binding. This SNP is known in the literature by many names, including A519C and H131R. What's the importance of this? FcgR isoforms expressed on immune system cells have been linked to the pathogenic consequences triggered by autoantibodies or immune complexes in autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as well as to the efficacy of some immunotherapeutic treatments such as rituximab. Many studies have been published about this FCGR2A SNP, roughly...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Rosiglitazone</a>

        <div class='boxshow' id="show-disease-69795708690817029" style="display: inline;"><a href="javascript:toggle2('disease-69795708690817029')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-69795708690817029" style="display: none;"><a href="javascript:toggle2('disease-69795708690817029')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Rosiglitazone">Rosiglitazone</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs10192566'>rs10192566</a><a href='http://www.snpedia.com/index.php/rs10192566(G;G)'>(G;G)</a></div>
        <div class='boxmag'>References:2<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>if diabetic, better response to rosiglitazone</div>
        <div class='boxshow' id="show-sec-0.0540590778217" style="display: inline;"><a href="javascript:toggle2('sec-0.0540590778217')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0540590778217" style="display: none;"><a href="javascript:toggle2('sec-0.0540590778217')">(hide)</a>
        <div class='rstext'>A total of 262 Korean type-2 diabetes patients were treated with 12 weeks of rosiglitazone at 4mg/day and genotyped to reveal that rs10192566(G) allele carriers responded better than (C) carriers. Patients with rs10192566(G) alleles had a larger decrease in fasting plasma glucose, 2-h postprandial glucose, and HbA1c than rs10192566(C;C) homozygotes. None of the other LPIN1 gene SNPs tested were associated with response. Note: rs11693809, rs10192566, and rs2278513 are in nearly complete linkage disequilibrium (D'&gt;0.958, r(2) &gt;0.882).  [PharmGKB:Curated A study in patients with type 2 diabetes treated with rosiglitazone showed that this SNP in the LPIN1 gene was significantly associated with rosiglitazone treatment response. rs11693809 and rs2278513 are in nearly complete linkage diseq...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|10|0">Rosuvastatin</a>

        <div class='boxshow' id="show-disease-3673331891560334691" style="display: inline;"><a href="javascript:toggle2('disease-3673331891560334691')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-3673331891560334691" style="display: none;"><a href="javascript:toggle2('disease-3673331891560334691')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Rosuvastatin">Rosuvastatin</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs20455'>rs20455</a><a href='http://www.snpedia.com/index.php/rs20455(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD3D3;'>37.2%</span><br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.472153534656" style="display: inline;"><a href="javascript:toggle2('sec-0.472153534656')">...more...</a></div>
        <div class='boxrstext' id="sec-0.472153534656" style="display: none;"><a href="javascript:toggle2('sec-0.472153534656')">(hide)</a>
        <div class='rstext'>rs20455, often called Arg719 or 719Arg, is a reasonably well studied SNP in the KIF6 gene. The risk allele (encoding the arginine at position 719) is rs20455(C). An extensive 2010 meta-analysis, including over 17,000 patients, suggests this variant does not significantly influence coronary artery disease risk. This SNP is one of the 5 used by Celera's genetic risk score (GRS) for coronary heart disease (CHD). *rs20455, in the KIF6 gene *rs3900940, in the MYH15 gene *rs7439293, in the PALLD gene *rs2298566, in the SNX19 gene *rs1010, in the VAMP8 gene For each of the five variants, the GRS was increased by 1 if the subject was homozygous for the risk variant, unchanged if heterozygous, and decreased by 1 if the individual did not carry the variant. Therefore, individuals carrying all 10 pos...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4149056'>rs4149056</a><a href='http://www.snpedia.com/index.php/rs4149056(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEEEE;'>70.8%</span><br/>Repute:Good<br/>References:60<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.134398880055" style="display: inline;"><a href="javascript:toggle2('sec-0.134398880055')">...more...</a></div>
        <div class='boxrstext' id="sec-0.134398880055" style="display: none;"><a href="javascript:toggle2('sec-0.134398880055')">(hide)</a>
        <div class='rstext'>influences statin response *rs72559745 (SLCO1B1*1)	AA	AA *rs56061388 (SLCO1B1*3)	TT	TT *rs4149056 (SLCO1B1*5)	TT	TT *rs55901008 (SLCO1B1*6)	TT	TT rs4149056, also known as 37041T&gt;C or V174A, is a SNP in the SLCO1B1 gene, which encodes the 'organic anion transporting polypeptide 1B1' (OATP1B1) protein. This protein, found primarily in the liver, regulates the uptake of numerous drugs and natural compounds. The rs4149056(C) SNP defines the SLCO1B1*5 allele. The rs4149056(C) allele gives rise to an amino acid change (from valine to alanine at residue 174) which has reduced uptake/transport activity. Therefore, drugs metabolized by OATP1B1 tend to build up to higher circulating concentrations than they would otherwise.. The drugs known (or in some cases, thought) to be transported less well ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2231142'>rs2231142</a><a href='http://www.snpedia.com/index.php/rs2231142(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF3F3;'>78.8%</span><br/>Repute:Good<br/>References:48<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.56027224154" style="display: inline;"><a href="javascript:toggle2('sec-0.56027224154')">...more...</a></div>
        <div class='boxrstext' id="sec-0.56027224154" style="display: none;"><a href="javascript:toggle2('sec-0.56027224154')">(hide)</a>
        <div class='rstext'>rs2231142, also known as Q141K and C421A, is a SNP in the ABCG2 gene, indicating a missense variant. 'Our data indicate that at least 10% of all gout cases in whites are attributable to this causal variant.' A is the risk allele. A large study totaling 7,699 participants in the Framingham cohort and 4,148 participants in the Rotterdam cohort was conducted, with genome-wide significant SNPs then replicated in 11,000+ Caucasian and ~4,000 African-American individuals who took part in the study of Atherosclerosis Risk in Communities (ARIC). This study calculated an odds ratio of 1.74 for rs2231142 (CI: 1.51-1.99, p = 3.3x10e-15). A genetic score comprised of this SNP plus 2 others may stratify risk for gout. Among non-small cell lung cancer patients treated with gefitinib, there's a 4-5x high...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Seroxat</a>

        <div class='boxshow' id="show-disease-3578371655599634825" style="display: inline;"><a href="javascript:toggle2('disease-3578371655599634825')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-3578371655599634825" style="display: none;"><a href="javascript:toggle2('disease-3578371655599634825')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Seroxat">Seroxat</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.897973131349" style="display: inline;"><a href="javascript:toggle2('sec-0.897973131349')">...more...</a></div>
        <div class='boxrstext' id="sec-0.897973131349" style="display: none;"><a href="javascript:toggle2('sec-0.897973131349')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|0|10">Sildenafil</a>

        <div class='boxshow' id="show-disease-5942993605496111411" style="display: inline;"><a href="javascript:toggle2('disease-5942993605496111411')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-5942993605496111411" style="display: none;"><a href="javascript:toggle2('disease-5942993605496111411')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Sildenafil">Sildenafil</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5443'>rs5443</a><a href='http://www.snpedia.com/index.php/rs5443(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2.1<br/>Frequency: <span style='background-color: #FFE3E3;'>55.6%</span><br/>Repute:Bad<br/>References:40<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>some risk  linked to a number of metabolic conditions including obesity, coronary artery disease, insulin resistance and therefore diabetes, left ventricular hypertrophy, and hypertension. It has also been linked to how well a patient responds to Viagra (sildenafil).</div>
        <div class='boxshow' id="show-sec-0.660569426253" style="display: inline;"><a href="javascript:toggle2('sec-0.660569426253')">...more...</a></div>
        <div class='boxrstext' id="sec-0.660569426253" style="display: none;"><a href="javascript:toggle2('sec-0.660569426253')">(hide)</a>
        <div class='rstext'>rs5443, a SNP in the G-protein beta3 subunit (GNB3) gene that is more commonly known as the C825T variant, has been linked to a number of metabolic conditions including obesity, coronary artery disease, insulin resistance and therefore diabetes, left ventricular hypertrophy, and hypertension. It has also been linked to how well a patient responds to Viagra (sildenafil). Several studies have been unable to replicate one or more of the associations in at least some populations between this SNP and these conditions. The more notable studies include: *rs5443(T) allele carriers are 2-3 fold more likely to be obese in Caucasian, Chinese, and African American populations. *rs5443(T) carriers are clearly at higher risk for hypertension, but this review indicates that whether they are also at incre...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|10|0">Simvastatin</a>

        <div class='boxshow' id="show-disease2103058382923845530" style="display: inline;"><a href="javascript:toggle2('disease2103058382923845530')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease2103058382923845530" style="display: none;"><a href="javascript:toggle2('disease2103058382923845530')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Simvastatin">Simvastatin</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs20455'>rs20455</a><a href='http://www.snpedia.com/index.php/rs20455(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD3D3;'>37.2%</span><br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.153628310995" style="display: inline;"><a href="javascript:toggle2('sec-0.153628310995')">...more...</a></div>
        <div class='boxrstext' id="sec-0.153628310995" style="display: none;"><a href="javascript:toggle2('sec-0.153628310995')">(hide)</a>
        <div class='rstext'>rs20455, often called Arg719 or 719Arg, is a reasonably well studied SNP in the KIF6 gene. The risk allele (encoding the arginine at position 719) is rs20455(C). An extensive 2010 meta-analysis, including over 17,000 patients, suggests this variant does not significantly influence coronary artery disease risk. This SNP is one of the 5 used by Celera's genetic risk score (GRS) for coronary heart disease (CHD). *rs20455, in the KIF6 gene *rs3900940, in the MYH15 gene *rs7439293, in the PALLD gene *rs2298566, in the SNX19 gene *rs1010, in the VAMP8 gene For each of the five variants, the GRS was increased by 1 if the subject was homozygous for the risk variant, unchanged if heterozygous, and decreased by 1 if the individual did not carry the variant. Therefore, individuals carrying all 10 pos...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4363657'>rs4363657</a><a href='http://www.snpedia.com/index.php/rs4363657(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFECEC;'>68.1%</span><br/>Repute:Good<br/>References:10<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.0588766515891" style="display: inline;"><a href="javascript:toggle2('sec-0.0588766515891')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0588766515891" style="display: none;"><a href="javascript:toggle2('sec-0.0588766515891')">(hide)</a>
        <div class='rstext'>rs4363657 is a SNP in the SLCO1B1 gene, a gene which encodes a protein involved in the liver's uptake of certain drugs, including the statins used to lower cholesterol levels. rs4363657 in nearly complete linkage disequilibrium with rs4149056 SNP (r&lt;sup&gt;2&lt;/sup&gt;=0.97), which has been linked to statin metabolism. rs4149056(C) odds ratio for myopathy among 20,000 individuals taking either 40 or 80mg of simvastatin daily was 4.5 (CI: 2.6-7.7) per copy of the C allele, and 16.9 (CI: 4.7-61.1) in (C;C) as compared with (T;T) homozygotes. See also rs4149056 for a more detailed description of the effect of SLCO1B1 gene SNPs on the metabolism of many drugs. SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research data...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4149056'>rs4149056</a><a href='http://www.snpedia.com/index.php/rs4149056(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEEEE;'>70.8%</span><br/>Repute:Good<br/>References:60<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.98488688542" style="display: inline;"><a href="javascript:toggle2('sec-0.98488688542')">...more...</a></div>
        <div class='boxrstext' id="sec-0.98488688542" style="display: none;"><a href="javascript:toggle2('sec-0.98488688542')">(hide)</a>
        <div class='rstext'>influences statin response *rs72559745 (SLCO1B1*1)	AA	AA *rs56061388 (SLCO1B1*3)	TT	TT *rs4149056 (SLCO1B1*5)	TT	TT *rs55901008 (SLCO1B1*6)	TT	TT rs4149056, also known as 37041T&gt;C or V174A, is a SNP in the SLCO1B1 gene, which encodes the 'organic anion transporting polypeptide 1B1' (OATP1B1) protein. This protein, found primarily in the liver, regulates the uptake of numerous drugs and natural compounds. The rs4149056(C) SNP defines the SLCO1B1*5 allele. The rs4149056(C) allele gives rise to an amino acid change (from valine to alanine at residue 174) which has reduced uptake/transport activity. Therefore, drugs metabolized by OATP1B1 tend to build up to higher circulating concentrations than they would otherwise.. The drugs known (or in some cases, thought) to be transported less well ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:26|68|5">Statins</a>

        <div class='boxshow' id="show-disease-7001199673468087607" style="display: inline;"><a href="javascript:toggle2('disease-7001199673468087607')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-7001199673468087607" style="display: none;"><a href="javascript:toggle2('disease-7001199673468087607')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Statins">Statins</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs646776'>rs646776</a><a href='http://www.snpedia.com/index.php/rs646776(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 2.1<br/>Frequency: <span style='background-color: #FFE3E3;'>54.9%</span><br/>Repute:Bad<br/>References:38<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>1.2x risk of coronary artery disease</div>
        <div class='boxshow' id="show-sec-0.553806907328" style="display: inline;"><a href="javascript:toggle2('sec-0.553806907328')">...more...</a></div>
        <div class='boxrstext' id="sec-0.553806907328" style="display: none;"><a href="javascript:toggle2('sec-0.553806907328')">(hide)</a>
        <div class='rstext'>rs599839 and rs4970834 explain about 1% of the variation in circulating LDL-cholesterol levels. 'When we look at this particular genetic variance, of all the cholesterol variation among the population, 1% of it can be attributed to this particular locus,' said Sandhu. 'This is equivalent to more established genes for LDL regulation, particularly APOE.' rs646776 also linked. Pharmacogenetic meta-analysis of genome-wide association studies of LDL &#8203;cholesterol response to statins found each minor allele to increase statin effectiveness by 1.3% (rs646776, &#946;=&#8722;0.013, s.e.=0.002, P=1.05 &#215; 10&#8722;9 and rs12740374, &#946;=&#8722;0.013, s.e.=0.002, P=1.05 &#215; 10&#8722;9). 23andMe blog coronary artery disease and heart attack SNP Risk Version Effect *rs646776 T 1.19 *rs1746...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6588480'>rs6588480</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs6588480(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC3C3;'>25.0%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.25385541339" style="display: inline;"><a href="javascript:toggle2('sec-0.25385541339')">...more...</a></div>
        <div class='boxrstext' id="sec-0.25385541339" style="display: none;"><a href="javascript:toggle2('sec-0.25385541339')">(hide)</a>
        <div class='rstext'>[GWAS:Response to statin therapy]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs541041'>rs541041</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs541041(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC5C5;'>26.5%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.173828519295" style="display: inline;"><a href="javascript:toggle2('sec-0.173828519295')">...more...</a></div>
        <div class='boxrstext' id="sec-0.173828519295" style="display: none;"><a href="javascript:toggle2('sec-0.173828519295')">(hide)</a>
        <div class='rstext'>[GWAS:Response to statin therapy]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs13390159'>rs13390159</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs13390159(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.632844394632" style="display: inline;"><a href="javascript:toggle2('sec-0.632844394632')">...more...</a></div>
        <div class='boxrstext' id="sec-0.632844394632" style="display: none;"><a href="javascript:toggle2('sec-0.632844394632')">(hide)</a>
        <div class='rstext'>[GWAS:Response to statin therapy]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2306283'>rs2306283</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs2306283(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD2D2;'>36.3%</span><br/>References:16<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.53718014482" style="display: inline;"><a href="javascript:toggle2('sec-0.53718014482')">...more...</a></div>
        <div class='boxrstext' id="sec-0.53718014482" style="display: none;"><a href="javascript:toggle2('sec-0.53718014482')">(hide)</a>
        <div class='rstext'>rs2306283 (Asn130Asp/N130D, A388G/388A&gt;G) is a SNP within SLCO1B1 (Solute carrier organic anion transporter family member 1B1). A G at this location denotes the SLCO1B1*1B allele. among 8 healthy volunteers with *1B/*1B genotypes and 16 with the *1A/*1A genotype, *1B/*1B genotype associated with reduced plasma concentrations of repaglinide (but not nateglinide) consistent with increased hepatic uptake by SLCO1B1 (but w/ limited effects on nateglinide pharmacokinetics) news rs2306283 influences statin-related myopathy risk Genotyping panel for assessing response to cancer chemotherapy. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs20455'>rs20455</a><a href='http://www.snpedia.com/index.php/rs20455(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD3D3;'>37.2%</span><br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.951672883221" style="display: inline;"><a href="javascript:toggle2('sec-0.951672883221')">...more...</a></div>
        <div class='boxrstext' id="sec-0.951672883221" style="display: none;"><a href="javascript:toggle2('sec-0.951672883221')">(hide)</a>
        <div class='rstext'>rs20455, often called Arg719 or 719Arg, is a reasonably well studied SNP in the KIF6 gene. The risk allele (encoding the arginine at position 719) is rs20455(C). An extensive 2010 meta-analysis, including over 17,000 patients, suggests this variant does not significantly influence coronary artery disease risk. This SNP is one of the 5 used by Celera's genetic risk score (GRS) for coronary heart disease (CHD). *rs20455, in the KIF6 gene *rs3900940, in the MYH15 gene *rs7439293, in the PALLD gene *rs2298566, in the SNX19 gene *rs1010, in the VAMP8 gene For each of the five variants, the GRS was increased by 1 if the subject was homozygous for the risk variant, unchanged if heterozygous, and decreased by 1 if the individual did not carry the variant. Therefore, individuals carrying all 10 pos...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs12527253'>rs12527253</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs12527253(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD4D4;'>38.9%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.584016030268" style="display: inline;"><a href="javascript:toggle2('sec-0.584016030268')">...more...</a></div>
        <div class='boxrstext' id="sec-0.584016030268" style="display: none;"><a href="javascript:toggle2('sec-0.584016030268')">(hide)</a>
        <div class='rstext'>[GWAS:Response to statin therapy]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4693596'>rs4693596</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs4693596(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD7D7;'>41.6%</span><br/>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.551964936483" style="display: inline;"><a href="javascript:toggle2('sec-0.551964936483')">...more...</a></div>
        <div class='boxrstext' id="sec-0.551964936483" style="display: none;"><a href="javascript:toggle2('sec-0.551964936483')">(hide)</a>
        <div class='rstext'>rs4693596(C;C) 2x odds of myopathy when taking statins. Statin Response</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1535'>rs1535</a><a href='http://www.snpedia.com/index.php/rs1535(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDADA;'>44.2%</span><br/>References:12<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.351263881848" style="display: inline;"><a href="javascript:toggle2('sec-0.351263881848')">...more...</a></div>
        <div class='boxrstext' id="sec-0.351263881848" style="display: none;"><a href="javascript:toggle2('sec-0.351263881848')">(hide)</a>
        <div class='rstext'>4+ IQ points for breastfeeding with the AA or AG genotypes Breastfeeding and IQ  [GWAS:Response to statin therapy]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4684585'>rs4684585</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs4684585(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDADA;'>45.1%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.385335867417" style="display: inline;"><a href="javascript:toggle2('sec-0.385335867417')">...more...</a></div>
        <div class='boxrstext' id="sec-0.385335867417" style="display: none;"><a href="javascript:toggle2('sec-0.385335867417')">(hide)</a>
        <div class='rstext'>[GWAS:Response to statin therapy]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7584099'>rs7584099</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs7584099(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFDBDB;'>46.0%</span><br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.272653838029" style="display: inline;"><a href="javascript:toggle2('sec-0.272653838029')">...more...</a></div>
        <div class='boxrstext' id="sec-0.272653838029" style="display: none;"><a href="javascript:toggle2('sec-0.272653838029')">(hide)</a>
        <div class='rstext'>[GWAS:Response to statin therapy]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs56061388'>rs56061388</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs56061388(T;T)'>(T;T)</a></div>
        <div class='boxmag'>References:0<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.258932291168" style="display: inline;"><a href="javascript:toggle2('sec-0.258932291168')">...more...</a></div>
        <div class='boxrstext' id="sec-0.258932291168" style="display: none;"><a href="javascript:toggle2('sec-0.258932291168')">(hide)</a>
        <div class='rstext'>influences statin response *rs72559745 (SLCO1B1*1)	AA	AA *rs56061388 (SLCO1B1*3)	TT	TT *rs4149056 (SLCO1B1*5)	TT	TT *rs55901008 (SLCO1B1*6)	TT	TT</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs8014194'>rs8014194</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs8014194(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #F0C9F0;'>62.2%</span><br/>References:1<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.333661663487" style="display: inline;"><a href="javascript:toggle2('sec-0.333661663487')">...more...</a></div>
        <div class='boxrstext' id="sec-0.333661663487" style="display: none;"><a href="javascript:toggle2('sec-0.333661663487')">(hide)</a>
        <div class='rstext'>[GWAS:Response to statin therapy]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs55901008'>rs55901008</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs55901008(T;T)'>(T;T)</a></div>
        <div class='boxmag'>References:0<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.117383172037" style="display: inline;"><a href="javascript:toggle2('sec-0.117383172037')">...more...</a></div>
        <div class='boxrstext' id="sec-0.117383172037" style="display: none;"><a href="javascript:toggle2('sec-0.117383172037')">(hide)</a>
        <div class='rstext'>influences statin response *rs72559745 (SLCO1B1*1)	AA	AA *rs56061388 (SLCO1B1*3)	TT	TT *rs4149056 (SLCO1B1*5)	TT	TT *rs55901008 (SLCO1B1*6)	TT	TT</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4363657'>rs4363657</a><a href='http://www.snpedia.com/index.php/rs4363657(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFECEC;'>68.1%</span><br/>Repute:Good<br/>References:10<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.797101060001" style="display: inline;"><a href="javascript:toggle2('sec-0.797101060001')">...more...</a></div>
        <div class='boxrstext' id="sec-0.797101060001" style="display: none;"><a href="javascript:toggle2('sec-0.797101060001')">(hide)</a>
        <div class='rstext'>rs4363657 is a SNP in the SLCO1B1 gene, a gene which encodes a protein involved in the liver's uptake of certain drugs, including the statins used to lower cholesterol levels. rs4363657 in nearly complete linkage disequilibrium with rs4149056 SNP (r&lt;sup&gt;2&lt;/sup&gt;=0.97), which has been linked to statin metabolism. rs4149056(C) odds ratio for myopathy among 20,000 individuals taking either 40 or 80mg of simvastatin daily was 4.5 (CI: 2.6-7.7) per copy of the C allele, and 16.9 (CI: 4.7-61.1) in (C;C) as compared with (T;T) homozygotes. See also rs4149056 for a more detailed description of the effect of SLCO1B1 gene SNPs on the metabolism of many drugs. SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research data...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4149056'>rs4149056</a><a href='http://www.snpedia.com/index.php/rs4149056(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEEEE;'>70.8%</span><br/>Repute:Good<br/>References:60<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.732459600029" style="display: inline;"><a href="javascript:toggle2('sec-0.732459600029')">...more...</a></div>
        <div class='boxrstext' id="sec-0.732459600029" style="display: none;"><a href="javascript:toggle2('sec-0.732459600029')">(hide)</a>
        <div class='rstext'>influences statin response *rs72559745 (SLCO1B1*1)	AA	AA *rs56061388 (SLCO1B1*3)	TT	TT *rs4149056 (SLCO1B1*5)	TT	TT *rs55901008 (SLCO1B1*6)	TT	TT rs4149056, also known as 37041T&gt;C or V174A, is a SNP in the SLCO1B1 gene, which encodes the 'organic anion transporting polypeptide 1B1' (OATP1B1) protein. This protein, found primarily in the liver, regulates the uptake of numerous drugs and natural compounds. The rs4149056(C) SNP defines the SLCO1B1*5 allele. The rs4149056(C) allele gives rise to an amino acid change (from valine to alanine at residue 174) which has reduced uptake/transport activity. Therefore, drugs metabolized by OATP1B1 tend to build up to higher circulating concentrations than they would otherwise.. The drugs known (or in some cases, thought) to be transported less well ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7900909'>rs7900909</a><a href='http://www.snpedia.com/index.php/rs7900909(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF0F0;'>73.9%</span><br/>Repute:Good<br/>References:1<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.660450607181" style="display: inline;"><a href="javascript:toggle2('sec-0.660450607181')">...more...</a></div>
        <div class='boxrstext' id="sec-0.660450607181" style="display: none;"><a href="javascript:toggle2('sec-0.660450607181')">(hide)</a>
        <div class='rstext'>[GWAS:Response to statin therapy]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs17238540'>rs17238540</a><a href='http://www.snpedia.com/index.php/rs17238540(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:5<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common</div>
        <div class='boxshow' id="show-sec-0.135652013757" style="display: inline;"><a href="javascript:toggle2('sec-0.135652013757')">...more...</a></div>
        <div class='boxrstext' id="sec-0.135652013757" style="display: none;"><a href="javascript:toggle2('sec-0.135652013757')">(hide)</a>
        <div class='rstext'>rs17238540, also known as SNP 29, is located in the HMG-CoA reductase HMGCR gene. The protein encoded by this gene is the target for drugs designed to inhibit its action, in order to lower cholesterol levels. SNPs in the HMGCR gene may affect how well such drugs (typically statins) work. In a study of ~1,500 patients treated with 40mg/d of pravastatin, rs17238540(G;T) heterozgyotes had a mean decrease in total cholesterol of 32.5 mg/dL (0.85 mmol/L), while the mean change for rs17238540(T;T) homozygotes was 41.8 mg/dL (1.09 mmol/L), a reduction in overall efficacy of 22.3% (absolute difference, 9.3 mg/dL, CI: 3.8-14.7 mg/dL, p&lt;.001). The drop in total cholesterol was almost completely due to the decrease in LDL cholesterol, as there was no significant difference in the change in HDL cho...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs17244841'>rs17244841</a><a href='http://www.snpedia.com/index.php/rs17244841(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:4<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>more responsive to statin treatment</div>
        <div class='boxshow' id="show-sec-0.210278483989" style="display: inline;"><a href="javascript:toggle2('sec-0.210278483989')">...more...</a></div>
        <div class='boxrstext' id="sec-0.210278483989" style="display: none;"><a href="javascript:toggle2('sec-0.210278483989')">(hide)</a>
        <div class='rstext'>rs17244841, also known as SNP 12, is located in the HMG-CoA reductase HMGCR gene. The protein encoded by this gene is the target for drugs designed to inhibit its action, in order to lower cholesterol levels. SNPs in the HMGCR gene may affect how well such drugs (typically statins) work. In a study of ~1,500 patients treated with 40mg/d of pravastatin, rs17244841(A;T) heterozgyotes had a mean decrease in total cholesterol of &#226;&#8364;&#8220;32.8 mg/dL (&#226;&#8364;&#8220;0.85 mmol/L), while the mean change for rs17244841(A;A) homozygotes was &#226;&#8364;&#8220;42.0 mg/dL (&#226;&#8364;&#8220;1.09 mmol/L), a reduction in overall efficacy of 21.8% (absolute difference, 9.2 mg/dL, CI: 3.8-14.6 mg/dL, p=.001). The drop in total cholesterol was almost completely due to the decrease in LDL...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">19 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|10">Tacrolimus</a>

        <div class='boxshow' id="show-disease8937500156034048335" style="display: inline;"><a href="javascript:toggle2('disease8937500156034048335')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease8937500156034048335" style="display: none;"><a href="javascript:toggle2('disease8937500156034048335')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Tacrolimus">Tacrolimus</a>
  <div id="gs155"  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs155'>gs155</a></div></div>
        <div class='boxmag'>Magnitude: 2.5</div>
        <div class='boxrep'>Repute: Bad</div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>CYP3A5 non-expressor</div>
        <div class='gsboxeffect'>This is common for Caucasians, but rare for African populations. As a CYP3A5 non-expressor you are unable to metabolize some common medications. This influences the synthesis of cholesterol, steroids and other lipids. The enzyme metabolizes drugs such as olanzapine, tacrolimus, nifedipine and cyclosporine as well as the steroid hormones testosterone, progesterone and androstenedione.</div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs776746'>rs776746</a><a href='http://www.snpedia.com/index.php/rs776746(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FF9A9A;'>7.2%</span><br/>References:34<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>carrier of 1 nonfunctional CYP3A5 allele; drug metabolism affects</div>
        <div class='boxshow' id="show-sec-0.983797152685" style="display: inline;"><a href="javascript:toggle2('sec-0.983797152685')">...more...</a></div>
        <div class='boxrstext' id="sec-0.983797152685" style="display: none;"><a href="javascript:toggle2('sec-0.983797152685')">(hide)</a>
        <div class='rstext'>rs776746, also known as 6986A&gt;G, is a SNP encoding the (nonfunctional) CYP3A5*3 allele of the CYP3A5 gene. CYP3A5*3 has been studied especially in connection with the metabolism of tacrolimus, an immunosuppressive drug used in organ transplantation. The optimal therapeutic dose is in a relatively narrow window, so blood concentration monitoring is recommended. CYP3A5*3 carriers tend to build up higher levels of tacrolimus than CYP3A5*1 carriers, unless their tacrolimus intake is reduced. Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. Prevalence of common dis...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 genoset 1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:30|20|0">Tamoxifen</a>

        <div class='boxshow' id="show-disease2245627048929029354" style="display: inline;"><a href="javascript:toggle2('disease2245627048929029354')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease2245627048929029354" style="display: none;"><a href="javascript:toggle2('disease2245627048929029354')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Tamoxifen">Tamoxifen</a>
  <div id="gs161"  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs161'>gs161</a></div></div>
        <div class='boxmag'>Magnitude: 2.5</div>
        <div class='boxrep'></div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>CYP2C9 Intermediate Metabolizers</div>
        <div class='gsboxeffect'>CYP2C9 intermediate metabolizers are 30% of the population. May require slightly different dosages for drugs such as tamoxifen, warfarin, fluvastin, and many nonsteroidal anti-inflammatory agents such as aspirin, ibuprofen and naproxen.</div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3740065'>rs3740065</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs3740065(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFF6F6;'>83.2%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.0121878608378" style="display: inline;"><a href="javascript:toggle2('sec-0.0121878608378')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0121878608378" style="display: none;"><a href="javascript:toggle2('sec-0.0121878608378')">(hide)</a>
        <div class='rstext'>rs3740065 is a SNP in the ATP-binding cassette, sub-family C (CFTR/MRP), member 2 ABCC2 gene. A study of 282 hormone receptor-positive, invasive breast cancer Japanese patients receiving tamoxifen found a significant association with shorter recurrence-free survival (p = .00017; hazard ratio 10.64, CI: 1.44 - 78.88) in rs3740065(T;T) patients; the hazard ratio for carriers of one (T) allele was 3.5 (CI: 0.5-26). Curiously, no significant difference in plasma levels of the tamoxifen metabolites endoxifen or 4-hydroxytamoxifen were seen. This same study of tamoxifen users concluded that rs3740065(T;T) patients who also had two CYP2D6 risk alleles had a 45 fold higher risk of recurrence than patients with zero or one (out of the possible four) risk alleles. The overall average recurrence risk...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs12248560'>rs12248560</a><a href='http://www.snpedia.com/index.php/rs12248560(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFE3E3;'>55.4%</span><br/>Repute:Good<br/>References:13<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.485435298247" style="display: inline;"><a href="javascript:toggle2('sec-0.485435298247')">...more...</a></div>
        <div class='boxrstext' id="sec-0.485435298247" style="display: none;"><a href="javascript:toggle2('sec-0.485435298247')">(hide)</a>
        <div class='rstext'>rs12248560(T) defines the CYP2C19*17 allele, an ultra fast metabolizer phenotype of the CYP2C19 gene. CYP2C19*17 is likely to lead to less effective drug treatment by, for example, proton pump inhibitors (such as omeprazole) and antidepressants. On the other hand, cancer patients who are CYP2C19*17 carriers are more likely to benefit from tamoxifen treatment, presumably because they break it down more rapidly into the antiestrogenic metabolites endoxifen and 4-hydroxytamoxifen. A study of 1,000+ breast cancer patients showed a 0.77x decreased risk of breast cancer for carriers of a CYP2C19*17 allele (CI: 0.65-0.93, p = 0.005). Analysis of a subgroup of such carriers who were using hormone therapy for ten years or longer showed an even stronger effect (odds ratio 0.57, CI: 0.39-0.83, p = 0....</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs6025'>rs6025</a><a href='http://www.snpedia.com/index.php/rs6025(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFDFD;'>96.5%</span><br/>Repute:Good<br/>References:26<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal/common</div>
        <div class='boxshow' id="show-sec-0.0238304740651" style="display: inline;"><a href="javascript:toggle2('sec-0.0238304740651')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0238304740651" style="display: none;"><a href="javascript:toggle2('sec-0.0238304740651')">(hide)</a>
        <div class='rstext'>rs6025 represents a SNP in the Factor V F5 gene, encoding a change in the protein from an arginine at position 506 to a glutamine. The resulting rs6025(A) allele encodes a mutation known as the Leiden mutation, R506Q, found in perhaps 3 to 5% of the individuals in most populations. About 1 in 10 individuals harboring the R506Q will experience clinically significant venous thromboembolism in their lifetimes (according to OMIM). Overall, the rs6025(A) allele appears to be necessary but not sufficient for the development of venous thromboembolism. Patients who are rs6025(A;G) heterozygotes but lack other risk-enhancing SNPs have a risk of recurrent deep venous thrombosis equal to patients with no such SNPs. In contrast, patients who are heterozygotes for both rs6025 and the prothrombin rs1799...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.842675896585" style="display: inline;"><a href="javascript:toggle2('sec-0.842675896585')">...more...</a></div>
        <div class='boxrstext' id="sec-0.842675896585" style="display: none;"><a href="javascript:toggle2('sec-0.842675896585')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 genoset 4 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Taxotere</a>

        <div class='boxshow' id="show-disease9064971105055766668" style="display: inline;"><a href="javascript:toggle2('disease9064971105055766668')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease9064971105055766668" style="display: none;"><a href="javascript:toggle2('disease9064971105055766668')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Taxotere">Taxotere</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs11045585'>rs11045585</a><a href='http://www.snpedia.com/index.php/rs11045585(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFEFEF;'>72.3%</span><br/>Repute:Good<br/>References:7<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>24% chance (lower than average) of docetaxel-induced leukopenia/neutropenia</div>
        <div class='boxshow' id="show-sec-0.782737595326" style="display: inline;"><a href="javascript:toggle2('sec-0.782737595326')">...more...</a></div>
        <div class='boxrstext' id="sec-0.782737595326" style="display: none;"><a href="javascript:toggle2('sec-0.782737595326')">(hide)</a>
        <div class='rstext'>rs12762549 and rs11045585 can be used to predict whether docetaxel will induce leukopenia/neutropenia, according to a study of ~100 Japanese patients. When patients were classified into three groups by the scoring system based on the genotypes of these two SNPs, patients with a score of 1 or 2 were shown to have a significantly higher risk of docetaxel-induced leukopenia/neutropenia as compared to those with a score of 0 (P = 0.0000057; odds ratio [OR], 7.00; 95% CI [confidence interval], 2.95-16.59). This prediction system correctly classified 69.2% of severe leukopenia/neutropenia and 75.7% of non-leukopenia/neutropenia into the respective categories. [Effect percentages provided in table are raw population fractions taken from the referenced study based on rs11045585 only. Total populat...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Tofranil</a>

        <div class='boxshow' id="show-disease-7521850314195917343" style="display: inline;"><a href="javascript:toggle2('disease-7521850314195917343')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-7521850314195917343" style="display: none;"><a href="javascript:toggle2('disease-7521850314195917343')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Tofranil">Tofranil</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs3892097'>rs3892097</a><a href='http://www.snpedia.com/index.php/rs3892097(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:18<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>extensive metabolizer</div>
        <div class='boxshow' id="show-sec-0.218556290693" style="display: inline;"><a href="javascript:toggle2('sec-0.218556290693')">...more...</a></div>
        <div class='boxrstext' id="sec-0.218556290693" style="display: none;"><a href="javascript:toggle2('sec-0.218556290693')">(hide)</a>
        <div class='rstext'>The normal (or wild type) form of this SNP is a (G). The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6*4. The CYP2D6*4 allele is the most common nonfunctioning variant of CYP2D6. If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug. ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|0|0">Topiramate</a>

        <div class='boxshow' id="show-disease-75411805210408140" style="display: inline;"><a href="javascript:toggle2('disease-75411805210408140')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-75411805210408140" style="display: none;"><a href="javascript:toggle2('disease-75411805210408140')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Topiramate">Topiramate</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2832407'>rs2832407</a><a href='http://www.snpedia.com/index.php/rs2832407(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFD1D1;'>35.4%</span><br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>topiramate may work to reduce heavy drinking best for this genotype   Research by Dr. H. Kranzler's group has found that the drug topiramate was more effective in reducing heavy drinking in individuals with this rs2832407(C;C) genotype.</div>
        <div class='boxshow' id="show-sec-0.465443586368" style="display: inline;"><a href="javascript:toggle2('sec-0.465443586368')">...more...</a></div>
        <div class='boxrstext' id="sec-0.465443586368" style="display: none;"><a href="javascript:toggle2('sec-0.465443586368')">(hide)</a>
        <div class='rstext'>The rs2832407(C) allele has inconsistently been linked to alcoholism and its treatment. Nonetheless, a 2014 report based on 138 patients concludes that rs2832407(C;C) individuals show a greater decrease than non-carriers (of a rs2832407(C) allele) in the number of heavy drinking days per week when taking topiramate at a dose of 200 mg/daily. A follow-up study done 3 and 6 months after treatment seemed to mostly confirm the topiramate benefit preferentially to rs2832407(C;C) individuals.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Trepiline</a>

        <div class='boxshow' id="show-disease6383790163373941601" style="display: inline;"><a href="javascript:toggle2('disease6383790163373941601')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease6383790163373941601" style="display: none;"><a href="javascript:toggle2('disease6383790163373941601')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Trepiline">Trepiline</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.970643255609" style="display: inline;"><a href="javascript:toggle2('sec-0.970643255609')">...more...</a></div>
        <div class='boxrstext' id="sec-0.970643255609" style="display: none;"><a href="javascript:toggle2('sec-0.970643255609')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|0|20">Triptans</a>

        <div class='boxshow' id="show-disease3292596185121113845" style="display: inline;"><a href="javascript:toggle2('disease3292596185121113845')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease3292596185121113845" style="display: none;"><a href="javascript:toggle2('disease3292596185121113845')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Triptans">Triptans</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5443'>rs5443</a><a href='http://www.snpedia.com/index.php/rs5443(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2.1<br/>Frequency: <span style='background-color: #FFE3E3;'>55.6%</span><br/>Repute:Bad<br/>References:40<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>some risk  linked to a number of metabolic conditions including obesity, coronary artery disease, insulin resistance and therefore diabetes, left ventricular hypertrophy, and hypertension. It has also been linked to how well a patient responds to Viagra (sildenafil).</div>
        <div class='boxshow' id="show-sec-0.176671737509" style="display: inline;"><a href="javascript:toggle2('sec-0.176671737509')">...more...</a></div>
        <div class='boxrstext' id="sec-0.176671737509" style="display: none;"><a href="javascript:toggle2('sec-0.176671737509')">(hide)</a>
        <div class='rstext'>rs5443, a SNP in the G-protein beta3 subunit (GNB3) gene that is more commonly known as the C825T variant, has been linked to a number of metabolic conditions including obesity, coronary artery disease, insulin resistance and therefore diabetes, left ventricular hypertrophy, and hypertension. It has also been linked to how well a patient responds to Viagra (sildenafil). Several studies have been unable to replicate one or more of the associations in at least some populations between this SNP and these conditions. The more notable studies include: *rs5443(T) allele carriers are 2-3 fold more likely to be obese in Caucasian, Chinese, and African American populations. *rs5443(T) carriers are clearly at higher risk for hypertension, but this review indicates that whether they are also at incre...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2653349'>rs2653349</a><a href='http://www.snpedia.com/index.php/rs2653349(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 1.1<br/>Frequency: <span style='background-color: #FFEEEE;'>70.5%</span><br/>Repute:Bad<br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>2-6x increased risk for cluster headaches</div>
        <div class='boxshow' id="show-sec-0.712938084149" style="display: inline;"><a href="javascript:toggle2('sec-0.712938084149')">...more...</a></div>
        <div class='boxrstext' id="sec-0.712938084149" style="display: none;"><a href="javascript:toggle2('sec-0.712938084149')">(hide)</a>
        <div class='rstext'>rs2653349, also known as G1246A, is a SNP in the HCRTR2 hypocretin-orexin gene. It has been linked primarily to cluster headaches. The more common allele (G) has been linked to increased risk; alternatively, this could be seen as implying that the less common (A) allele reduces cluster headache risk. In the (first) study, 100+ Italian patients were analyzed to reveal that rs2653349(G;G) genotypes were at 5x increased risk for the disorder, compared with (A;G) and (A;A) genotypes. A study of 200+ German patients indicated that (G;G) homozygotes were at 2x increased risk (CI: 1.32-2.92, p = 0.0007) for cluster headaches. A meta-analysis of 3 pooled studies concluded that the rs2653349(G;G) genotype showed a higher disease risk compared to the remaining genotypes (odds ratio 1.69, CI:1.11-2.5...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Tryptanol</a>

        <div class='boxshow' id="show-disease400072037191283734" style="display: inline;"><a href="javascript:toggle2('disease400072037191283734')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease400072037191283734" style="display: none;"><a href="javascript:toggle2('disease400072037191283734')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Tryptanol">Tryptanol</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.0994855998348" style="display: inline;"><a href="javascript:toggle2('sec-0.0994855998348')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0994855998348" style="display: none;"><a href="javascript:toggle2('sec-0.0994855998348')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Tryptizol</a>

        <div class='boxshow' id="show-disease-7599931962400715038" style="display: inline;"><a href="javascript:toggle2('disease-7599931962400715038')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-7599931962400715038" style="display: none;"><a href="javascript:toggle2('disease-7599931962400715038')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Tryptizol">Tryptizol</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.849243881981" style="display: inline;"><a href="javascript:toggle2('sec-0.849243881981')">...more...</a></div>
        <div class='boxrstext' id="sec-0.849243881981" style="display: none;"><a href="javascript:toggle2('sec-0.849243881981')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|10|0">Tylenol</a>

        <div class='boxshow' id="show-disease6156815428945021304" style="display: inline;"><a href="javascript:toggle2('disease6156815428945021304')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease6156815428945021304" style="display: none;"><a href="javascript:toggle2('disease6156815428945021304')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Tylenol">Tylenol</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1467558'>rs1467558</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs1467558(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCCCC;'>31.9%</span><br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.344110935354" style="display: inline;"><a href="javascript:toggle2('sec-0.344110935354')">...more...</a></div>
        <div class='boxrstext' id="sec-0.344110935354" style="display: none;"><a href="javascript:toggle2('sec-0.344110935354')">(hide)</a>
        <div class='rstext'>After taking Acetaminophen (Tylenol&#174;), rs1467558(A;G) individuals have higher alanine aminotransferase (ALT) levels, a sign of liver toxicity, than do (G;G) homozygotes. More studies are needed; there was only 1 (A;A) individual, and he didn't show elevated ALT levels; furthermore, the ALT increases were 'modest' anyway for (A;G) individuals compared to (G;G). see also: 23andMe blog '''Note:''' the orientation of this SNP in SNPedia is as detailed in dbSNP, but in publications (including 23andMe's blog) the orientation is 'flipped', so what's (A;A) in dbSNP is (T;T) as discussed by the 23andMe blog.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:50|0|0">Venlafaxine</a>

        <div class='boxshow' id="show-disease-7762616173043894600" style="display: inline;"><a href="javascript:toggle2('disease-7762616173043894600')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-7762616173043894600" style="display: none;"><a href="javascript:toggle2('disease-7762616173043894600')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Venlafaxine">Venlafaxine</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2032583'>rs2032583</a><a href='http://www.snpedia.com/index.php/rs2032583(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 1.9<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants.  This version of a blood brain barrier protein allows many common antidepressants to enter the brain, including: amitriptyline (Elavil), citalopram (Celexa), paroxetine (Paxil), and venlafaxine (Effexor). That makes those antidepressants 7 times more effective.</div>
        <div class='boxshow' id="show-sec-0.577282104717" style="display: inline;"><a href="javascript:toggle2('sec-0.577282104717')">...more...</a></div>
        <div class='boxrstext' id="sec-0.577282104717" style="display: none;"><a href="javascript:toggle2('sec-0.577282104717')">(hide)</a>
        <div class='rstext'>rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2032583 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs12720067'>rs12720067</a><a href='http://www.snpedia.com/index.php/rs12720067(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.952606980336" style="display: inline;"><a href="javascript:toggle2('sec-0.952606980336')">...more...</a></div>
        <div class='boxrstext' id="sec-0.952606980336" style="display: none;"><a href="javascript:toggle2('sec-0.952606980336')">(hide)</a>
        <div class='rstext'>rs12720067 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs12720067 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are kn...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2235040'>rs2235040</a><a href='http://www.snpedia.com/index.php/rs2235040(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Magnitude: 1<br/>Frequency: <span style='background-color: #FFC7C7;'>27.4%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.658188780602" style="display: inline;"><a href="javascript:toggle2('sec-0.658188780602')">...more...</a></div>
        <div class='boxrstext' id="sec-0.658188780602" style="display: none;"><a href="javascript:toggle2('sec-0.658188780602')">(hide)</a>
        <div class='rstext'>rs2235040 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs2235040 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs7787082'>rs7787082</a><a href='http://www.snpedia.com/index.php/rs7787082(A;G)'>(A;G)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCDCD;'>32.3%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>7x more likely to respond to certain antidepressants</div>
        <div class='boxshow' id="show-sec-0.49060746222" style="display: inline;"><a href="javascript:toggle2('sec-0.49060746222')">...more...</a></div>
        <div class='boxrstext' id="sec-0.49060746222" style="display: none;"><a href="javascript:toggle2('sec-0.49060746222')">(hide)</a>
        <div class='rstext'>rs7787082 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and thus their efficacy or potential for adverse side effects. rs7787082 is one of 9 SNPs found within a tight linkage block (r&lt;sup&gt;2&lt;/sup&gt; &gt;= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. When treated for depression with substrates of the protein encoded by ABCB1, carriers of one or two minor alleles at these ABCB1 SNPs have been reported to respond better than non-carriers. The antidepressant drugs that are know...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5030655'>rs5030655</a><a href='http://www.snpedia.com/index.php/rs5030655(I;I)'>(I;I)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.191356386561" style="display: inline;"><a href="javascript:toggle2('sec-0.191356386561')">...more...</a></div>
        <div class='boxrstext' id="sec-0.191356386561" style="display: none;"><a href="javascript:toggle2('sec-0.191356386561')">(hide)</a>
        <div class='rstext'>The (-) form of this SNP, representing a deletion of one nucleotide, causes a frameshift such that the resulting CYP2D6 protein is nonfunctional. The associated allele is also known as CYP2D6*6, and there are several subtypes but they are all nonfunctional. If two copies of this (or similar) changes are inherited, CYP2D6 poor metabolism ('PM') is observed. CYP2D6 poor metabolism may affect the efficacy or degree of side effects of drugs metabolized by CYP2D6, such as dextromorphan, sparteine, nortriptyline, venlafaxine and codeine. Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms.  [PharmGKB:Curated This variant is part of the CYP2D6*6 PM haplotype. Plasma concentrations of metoprolol were shown to be were 4.9-fold higher in the PMs, with gr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">5 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:0|0|10">Viagra</a>

        <div class='boxshow' id="show-disease-3800624258796433774" style="display: inline;"><a href="javascript:toggle2('disease-3800624258796433774')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-3800624258796433774" style="display: none;"><a href="javascript:toggle2('disease-3800624258796433774')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Viagra">Viagra</a>

  <div  class='boxbadresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs5443'>rs5443</a><a href='http://www.snpedia.com/index.php/rs5443(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Magnitude: 2.1<br/>Frequency: <span style='background-color: #FFE3E3;'>55.6%</span><br/>Repute:Bad<br/>References:40<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>some risk  linked to a number of metabolic conditions including obesity, coronary artery disease, insulin resistance and therefore diabetes, left ventricular hypertrophy, and hypertension. It has also been linked to how well a patient responds to Viagra (sildenafil).</div>
        <div class='boxshow' id="show-sec-0.645979613902" style="display: inline;"><a href="javascript:toggle2('sec-0.645979613902')">...more...</a></div>
        <div class='boxrstext' id="sec-0.645979613902" style="display: none;"><a href="javascript:toggle2('sec-0.645979613902')">(hide)</a>
        <div class='rstext'>rs5443, a SNP in the G-protein beta3 subunit (GNB3) gene that is more commonly known as the C825T variant, has been linked to a number of metabolic conditions including obesity, coronary artery disease, insulin resistance and therefore diabetes, left ventricular hypertrophy, and hypertension. It has also been linked to how well a patient responds to Viagra (sildenafil). Several studies have been unable to replicate one or more of the associations in at least some populations between this SNP and these conditions. The more notable studies include: *rs5443(T) allele carriers are 2-3 fold more likely to be obese in Caucasian, Chinese, and African American populations. *rs5443(T) carriers are clearly at higher risk for hypertension, but this review indicates that whether they are also at incre...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:33|66|0">Warfarin</a>

        <div class='boxshow' id="show-disease-4787796365539979508" style="display: inline;"><a href="javascript:toggle2('disease-4787796365539979508')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-4787796365539979508" style="display: none;"><a href="javascript:toggle2('disease-4787796365539979508')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Warfarin">Warfarin</a>
  <div id="gs127"  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs127'>gs127</a></div></div>
        <div class='boxmag'>Magnitude: 3</div>
        <div class='boxrep'></div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>Intermediate warfarin metabolizer</div>
        <div class='gsboxeffect'>Approximately 30% of people are intermediate metabolizers of the popular anticoagulant Warfarin and would probably need a decreased dosage. This due to rs1799853 or rs1057910 respectively leading to the CYP2C9*2 or CYP2C9*3 alleles. For prodrugs that require activation by CYP2C9, an alternative treatment or increased dose should be considered. See also gs126</div>
      </div>
      <div class="boxfooter"></div>
  </div>


  <div id="gs161"  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxfreq'><div class='boxlink'><a href='http://www.snpedia.com/index.php/gs161'>gs161</a></div></div>
        <div class='boxmag'>Magnitude: 2.5</div>
        <div class='boxrep'></div>
      </div>
      <div class='boxresultcol2'>
        <div class='gsboxsummary'>CYP2C9 Intermediate Metabolizers</div>
        <div class='gsboxeffect'>CYP2C9 intermediate metabolizers are 30% of the population. May require slightly different dosages for drugs such as tamoxifen, warfarin, fluvastin, and many nonsteroidal anti-inflammatory agents such as aspirin, ibuprofen and naproxen.</div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs8050894'>rs8050894</a><a href='http://www.snpedia.com/index.php/rs8050894(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 2.1<br/>Frequency: <span style='background-color: #F0D0F0;'>44.6%</span><br/>References:6<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>warfarin sensitivity (~2.5 mg/day)</div>
        <div class='boxshow' id="show-sec-0.704870365354" style="display: inline;"><a href="javascript:toggle2('sec-0.704870365354')">...more...</a></div>
        <div class='boxrstext' id="sec-0.704870365354" style="display: none;"><a href="javascript:toggle2('sec-0.704870365354')">(hide)</a>
        <div class='rstext'>rs8050894, is located on chromosome 16 in the gene VKORC1. VKORC1 is the primary target of the drug warfarin (Coumadin), a commonly used oral anticoagulant. rs8050894 is one of several polymorphisms found in VKORC1 that is associated with specific warfarin doses (). Other polymorphisms in VKORC1 (rs7196161, rs9923231, rs9934438, rs2359612) are equally predictive of warfarin dose requirement in both European and Asian-descent individuals. Other polymorphisms found in the gene cytochrome P450 2C9 (CYP2C9) influence the metabolism of warfarin and have a smaller effect on warfarin dose. These polymorphisms are rs1799853 (CYP2C9*2) and rs1057910 (CYP2C9*3). In several hundred Europeans, no association was found between rs8050894 and risk for ischemic stroke. Genetic-based dosing in orthopedic p...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2108622'>rs2108622</a><a href='http://www.snpedia.com/index.php/rs2108622(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 2<br/>Frequency: <span style='background-color: #FFE7E7;'>60.7%</span><br/>References:51<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>lower warfarin dosing</div>
        <div class='boxshow' id="show-sec-0.995367126255" style="display: inline;"><a href="javascript:toggle2('sec-0.995367126255')">...more...</a></div>
        <div class='boxrstext' id="sec-0.995367126255" style="display: none;"><a href="javascript:toggle2('sec-0.995367126255')">(hide)</a>
        <div class='rstext'>rs2108622 is a SNP in the cytochrome P450, family 4, subfamily F, polypeptide 2 CYP4F2 gene. In the males rs2108622(G) was significantly higher in cerebral infarction patients (P = 0.025) A study of Italian patients concluded that rs2108622(T;T) patients require 5.49 mg/day of warfarin versus 2.93 mg/day for (C;C) patients. Analysis of variance indicates that about 7% of mean weekly warfarin dose variance is explained by CYP4F2 genotype. A study of 370 Brazilian ('admixed') patients concludes that prospective CYP4F2 genotyping is of little value to these patients, presumably due to ethnic-based differences.  [PharmGKB:Curated Risk or phenotype-associated allele: no allelic association. Phenotype: Improved pharmacogenetic algorithm-based warfarin dosing. Study size: 370. Study population/et...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1799853'>rs1799853</a><a href='http://www.snpedia.com/index.php/rs1799853(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFB9B9;'>19.0%</span><br/>References:22<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>CYP2C9*2 carrier; average 20% reduction in warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.380828410031" style="display: inline;"><a href="javascript:toggle2('sec-0.380828410031')">...more...</a></div>
        <div class='boxrstext' id="sec-0.380828410031" style="display: none;"><a href="javascript:toggle2('sec-0.380828410031')">(hide)</a>
        <div class='rstext'>rs1799853 is a SNP in the CYP2C9 gene and is linked to poor warfarin metabolism. Advanced knowledge of this may influence initial warfarin dosing by physicians. Warfarin is monitored through INR (international normalized ratio) and proper dosing is influenced by a variety of factors including warfarin metabolism and diet. rs1799853 is a SNP in the CYP2C9 gene. The rs1799853(T) allele encodes a variant amino acid, cysteine, which has been linked to poor metabolism of warfarin and thus sensitivity . The common nomenclature for this polymorphism is CYP2C9*2 (Cys amino acid, T allele; the SNP is also known as C430T or Cys144Arg). The CYP2C9*2 allele is also associated with higher sensitivity to the anti-epileptic drug phenytoin. The effect of CYP2C9 variants on drug metabolism should not be pr...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4086116'>rs4086116</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs4086116(C;T)'>(C;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFCBCB;'>30.4%</span><br/>References:4<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.267536420294" style="display: inline;"><a href="javascript:toggle2('sec-0.267536420294')">...more...</a></div>
        <div class='boxrstext' id="sec-0.267536420294" style="display: none;"><a href="javascript:toggle2('sec-0.267536420294')">(hide)</a>
        <div class='rstext'>A genome-wide association study of acenocoumarol maintenance dosage.  [PharmGKB:Curated In a GWAS study, this SNP was modestly associated with warfarin dose, accounting for ~9% of the variance in dose. This SNP was in perfect linkage disequilibrium with rs4917639.] [GWAS:Warfarin maintenance dose]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs10871454'>rs10871454</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs10871454(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD5D5;'>39.8%</span><br/>References:6<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.451945749308" style="display: inline;"><a href="javascript:toggle2('sec-0.451945749308')">...more...</a></div>
        <div class='boxrstext' id="sec-0.451945749308" style="display: none;"><a href="javascript:toggle2('sec-0.451945749308')">(hide)</a>
        <div class='rstext'>[PharmGKB:Curated In a GWAS study, this SNP accounted for ~25% of the variance in log-transformed stabilized warfarin dose, and was in perfect linkage disequilibrium with rs9923231 (VKORC1:-1639).] [GWAS:Warfarin maintenance dose]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs216013'>rs216013</a><a href='http://www.snpedia.com/index.php/Special:AddData/Genotype/rs216013(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFEFEF;'>72.6%</span><br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.822176886134" style="display: inline;"><a href="javascript:toggle2('sec-0.822176886134')">...more...</a></div>
        <div class='boxrstext' id="sec-0.822176886134" style="display: none;"><a href="javascript:toggle2('sec-0.822176886134')">(hide)</a>
        <div class='rstext'>influences warfarin dose  [PharmGKB:Non-Curated This intronic variant in the membrane calcium-channel gene CACNA1C was correlated with warfarin dose (p = 9.2 &#215; 10&#8722;5) in the index population (n = 181) from a GWAS study of white patients undergoing anticoagulation therapy. Combined analysis of the index and replication populations (n = 374) yielded a p value of 8.6 &#215; 10&#8722;7. &quot;However, this variant did not reach established significance threshold independently in the replication population (P = .002), nor did it achieve significance after multiple testing correction in multivariate modeling (uncorrected P = .003)&quot;.] [GWAS:Warfarin maintenance dose]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1057910'>rs1057910</a><a href='http://www.snpedia.com/index.php/rs1057910(A;A)'>(A;A)</a></div>
        <div class='boxmag'>Magnitude: 0.1<br/>Frequency: <span style='background-color: #FFF9F9;'>88.5%</span><br/>Repute:Good<br/>References:65<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal; no effect on warfarin metabolism</div>
        <div class='boxshow' id="show-sec-0.850402026588" style="display: inline;"><a href="javascript:toggle2('sec-0.850402026588')">...more...</a></div>
        <div class='boxrstext' id="sec-0.850402026588" style="display: none;"><a href="javascript:toggle2('sec-0.850402026588')">(hide)</a>
        <div class='rstext'>SNP rs1057910(A), located in the cytochrome p450 CYP2C9 gene, most commonly encodes the amino acid isoleucine at position 359, and the resulting allele is also known as CYP2C9*1. rs1057910(C) encodes a leucine at this same position, and the resulting allele is called CYP2C9*3. This SNP is also known as Ile359Leu or A1075C. The effect of CYP2C9 variants on drug metabolism should not be predicted without also considering CYP2C9*2, defined as the common loss of function variant rs1799853(T) (NM_000771:c.430C&gt;T, NP_000762:p.144R&gt;C) Studies of the effects of these alleles include: * rs1057910(C;C)] genotypes may clear drugs like celecoxib (trade name Celebrex) twice as slowly as rs1057910(A;A) genotypes; the rs1057910(A;C) genotypes are in-between clearance rates. Lower clearance rates wi...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs9923231'>rs9923231</a><a href='http://www.snpedia.com/index.php/rs9923231(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFD5D5;'>39.8%</span><br/>Repute:Good<br/>References:53<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.365559326242" style="display: inline;"><a href="javascript:toggle2('sec-0.365559326242')">...more...</a></div>
        <div class='boxrstext' id="sec-0.365559326242" style="display: none;"><a href="javascript:toggle2('sec-0.365559326242')">(hide)</a>
        <div class='rstext'>Several SNPs in the VKORC1 gene have been linked to warfarin sensitivity, with perhaps the most common being this SNP rs9923231. Note that the orientation as published in scientific articles is often on the opposite strand compared to the orientation in dbSNP, so you will sometimes see it as a G&gt;T snp. It is also known as *-1639G&gt;A with the minus indicating that this is in an upstream promoter *3673 based on its position in GenBank accession number AY587020. *VKORC1*2. The main findings related to the treatment of venous thromboembolism (aka VTE; from hypercoagulability) with the blood thinner warfarin for this SNP are that carriers of the rs9923231(T) allele require significantly reduced doses of warfarin, and are (otherwise) at a higher risk of serious bleeding. Clinical studies de...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs9934438'>rs9934438</a><a href='http://www.snpedia.com/index.php/rs9934438(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFD5D5;'>39.8%</span><br/>References:33<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.673736011785" style="display: inline;"><a href="javascript:toggle2('sec-0.673736011785')">...more...</a></div>
        <div class='boxrstext' id="sec-0.673736011785" style="display: none;"><a href="javascript:toggle2('sec-0.673736011785')">(hide)</a>
        <div class='rstext'>risk of aortic calcification was calculated, adjusted for potential confounders. The T allele frequency of the VKORC1 1173C&gt;T polymorphism was 38.8%. 1185 (37.2%) persons were homozygous CC, 1529 (48,0%) were heterozygous CT and 473 (14.8%) were homozygous TT. Persons with at least one T-allele had a statistically significant 19% (95% CI 2 to 40%) risk increase of calcification of the aortic far wall compared to CC homozygous persons  [PharmGKB:Curated Double homozygous VKORC1 1173T/T, CYP4F2 433Val/Val (n = 5) showed the highest INR (3.1; 2.0-4.7) and required the lowest acenocoumarol dose (11 &#177; 3 mg/week) The addition of the V433M genotype to the VKORC1 genotype raised the R2 from 8% to 14% for INR, and from 12% to 19% for acenocoumarol dose requirements.] [OMIM:VITAMIN K EPOXIDE...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs10509680'>rs10509680</a><a href='http://www.snpedia.com/index.php/rs10509680(G;G)'>(G;G)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF8F8;'>86.6%</span><br/>Repute:Good<br/>References:3<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common on affy axiom data</div>
        <div class='boxshow' id="show-sec-0.741751761301" style="display: inline;"><a href="javascript:toggle2('sec-0.741751761301')">...more...</a></div>
        <div class='boxrstext' id="sec-0.741751761301" style="display: none;"><a href="javascript:toggle2('sec-0.741751761301')">(hide)</a>
        <div class='rstext'>Warfarin  [GWAS:None]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs339097'>rs339097</a><a href='http://www.snpedia.com/index.php/rs339097(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFFFFF;'>100.0%</span><br/>Repute:Good<br/>References:2<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in complete genomics</div>
        <div class='boxshow' id="show-sec-0.238025293919" style="display: inline;"><a href="javascript:toggle2('sec-0.238025293919')">...more...</a></div>
        <div class='boxrstext' id="sec-0.238025293919" style="display: none;"><a href="javascript:toggle2('sec-0.238025293919')">(hide)</a>
        <div class='rstext'>PharmGKB indicates that this SNP is relevant to Warfarin dosing. rs339097(G) is associated with 14.5% higher therapeutic warfarin dose in African Americans. This variant is also more common in African Americans with minor allele frequencies of 11&#8211;14% , but only 0.2% in Caucasians. Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.  [PharmGKB:Curated Risk or phenotype-associated allele: G allele was associated with higher required warfarin dose. Phenotype: The G allele of this SNP was associated with a 14.5% (SD +/- 7%) higher therapeutic warfarin dose in African Americans. Study size/population/ethnicity: Discovery cohort was 108 outliers(53 patients in the low dose group and 55 in the high dose group) selected from patients who attended a...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs11676382'>rs11676382</a><a href='http://www.snpedia.com/index.php/rs11676382(C;C)'>(C;C)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #F0B4F0;'>78.5%</span><br/>References:3<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.403448028566" style="display: inline;"><a href="javascript:toggle2('sec-0.403448028566')">...more...</a></div>
        <div class='boxrstext' id="sec-0.403448028566" style="display: none;"><a href="javascript:toggle2('sec-0.403448028566')">(hide)</a>
        <div class='rstext'>rs11676382 was associated with a warfarin maintenance dose across all analysis methods. the effects of GGCX are potentially population/treatment-dependent and will not have broad utility for determining warfarin dosing.</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs1801272'>rs1801272</a><a href='http://www.snpedia.com/index.php/rs1801272(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #F098F0;'>90.8%</span><br/>Repute:Good<br/>References:10<br/><a href='http://www.snpedia.com/index.php/Ambiguous_flip'>ambig</a><br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common in clinvar</div>
        <div class='boxshow' id="show-sec-0.638513907445" style="display: inline;"><a href="javascript:toggle2('sec-0.638513907445')">...more...</a></div>
        <div class='boxrstext' id="sec-0.638513907445" style="display: none;"><a href="javascript:toggle2('sec-0.638513907445')">(hide)</a>
        <div class='rstext'>minor form is a slow metaboliser according to pharmgkb  [PharmGKB:In-Depth This variant results in enzyme inactivity and is considered to be part of the %22slow metabolizer%22 group; part of the CYP2A6*2 haplotype.] [OMIM:?] [GWAS:Smoking behavior]</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">2 genosets 13 snps </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:10|0|0">Ziagen</a>

        <div class='boxshow' id="show-disease-8086336580519411340" style="display: inline;"><a href="javascript:toggle2('disease-8086336580519411340')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-8086336580519411340" style="display: none;"><a href="javascript:toggle2('disease-8086336580519411340')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Ziagen">Ziagen</a>

  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs2395029'>rs2395029</a><a href='http://www.snpedia.com/index.php/rs2395029(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFF9F9;'>88.5%</span><br/>Repute:Good<br/>References:32<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>common  The rs2395029(T;T) genotype is the common genotype for this SNP, against which the rs2395029(T;G) and rs2395029(G;G) genotypes that are associated with reduced HIV viral load in HIV carriers are compared. See also rs9264942 and HIV.</div>
        <div class='boxshow' id="show-sec-0.989413366244" style="display: inline;"><a href="javascript:toggle2('sec-0.989413366244')">...more...</a></div>
        <div class='boxrstext' id="sec-0.989413366244" style="display: none;"><a href="javascript:toggle2('sec-0.989413366244')">(hide)</a>
        <div class='rstext'>rs2395029 is a SNP in the major histocompatibility complex (MHC) region, and several studies have shown that the rs2395029(G) allele is 99.9% predictive of the presence of an HLA-B*5701 allele. This HLA allele, in turn, has been associated with several conditions. A study of 51 cases of flucloxacillin drug-induced liver injury (DILI), an important cause of serious liver disease, along with a replication study of another 23 cases, found that the rs2395029(G) carriers were at highly increased risk (odds ratio 80, p=8.7x10(-33)). * see also: 23andMe blog rs2395029(G;G) increases the odds of drug-induced liver injury in response to flucloxacillin by 45x This SNP is thought to be involved in determining the HIV viral load set point during the asymptomatic period of infection. This SNP is estima...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">1 snp </div>
</div>
  <div class='adiseasebox'>

  <a class='diseasebutton'><img src="http://chart.googleapis.com/chart?chbh=a&chs=100x10&cht=bhs&chco=80FF90,DADADA,FF8080&chd=t:20|10|0">Zocor</a>

        <div class='boxshow' id="show-disease-2567356673340097542" style="display: inline;"><a href="javascript:toggle2('disease-2567356673340097542')">...more...</a></div>
        <div class='member-is-a-medicine' id="disease-2567356673340097542" style="display: none;"><a href="javascript:toggle2('disease-2567356673340097542')">(hide)</a>        <a class="diseaselink" href="http://www.snpedia.com/index.php?title=Zocor">Zocor</a>

  <div  class='boxresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs20455'>rs20455</a><a href='http://www.snpedia.com/index.php/rs20455(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Frequency: <span style='background-color: #FFD3D3;'>37.2%</span><br/>References:11<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'></div>
        <div class='boxshow' id="show-sec-0.242800888379" style="display: inline;"><a href="javascript:toggle2('sec-0.242800888379')">...more...</a></div>
        <div class='boxrstext' id="sec-0.242800888379" style="display: none;"><a href="javascript:toggle2('sec-0.242800888379')">(hide)</a>
        <div class='rstext'>rs20455, often called Arg719 or 719Arg, is a reasonably well studied SNP in the KIF6 gene. The risk allele (encoding the arginine at position 719) is rs20455(C). An extensive 2010 meta-analysis, including over 17,000 patients, suggests this variant does not significantly influence coronary artery disease risk. This SNP is one of the 5 used by Celera's genetic risk score (GRS) for coronary heart disease (CHD). *rs20455, in the KIF6 gene *rs3900940, in the MYH15 gene *rs7439293, in the PALLD gene *rs2298566, in the SNX19 gene *rs1010, in the VAMP8 gene For each of the five variants, the GRS was increased by 1 if the subject was homozygous for the risk variant, unchanged if heterozygous, and decreased by 1 if the individual did not carry the variant. Therefore, individuals carrying all 10 pos...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4363657'>rs4363657</a><a href='http://www.snpedia.com/index.php/rs4363657(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFECEC;'>68.1%</span><br/>Repute:Good<br/>References:10<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.415804421424" style="display: inline;"><a href="javascript:toggle2('sec-0.415804421424')">...more...</a></div>
        <div class='boxrstext' id="sec-0.415804421424" style="display: none;"><a href="javascript:toggle2('sec-0.415804421424')">(hide)</a>
        <div class='rstext'>rs4363657 is a SNP in the SLCO1B1 gene, a gene which encodes a protein involved in the liver's uptake of certain drugs, including the statins used to lower cholesterol levels. rs4363657 in nearly complete linkage disequilibrium with rs4149056 SNP (r&lt;sup&gt;2&lt;/sup&gt;=0.97), which has been linked to statin metabolism. rs4149056(C) odds ratio for myopathy among 20,000 individuals taking either 40 or 80mg of simvastatin daily was 4.5 (CI: 2.6-7.7) per copy of the C allele, and 16.9 (CI: 4.7-61.1) in (C;C) as compared with (T;T) homozygotes. See also rs4149056 for a more detailed description of the effect of SLCO1B1 gene SNPs on the metabolism of many drugs. SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research data...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>



  <div  class='boxgoodresult'>
      <div class='boxresultcol1'>
        <div class='boxlink'><a href='http://www.snpedia.com/index.php/rs4149056'>rs4149056</a><a href='http://www.snpedia.com/index.php/rs4149056(T;T)'>(T;T)</a></div>
        <div class='boxmag'>Magnitude: 0<br/>Frequency: <span style='background-color: #FFEEEE;'>70.8%</span><br/>Repute:Good<br/>References:60<br/></div>
      </div>
      <div class='boxresultcol2'>
        <div class='boxeffect'>normal</div>
        <div class='boxshow' id="show-sec-0.0621478924072" style="display: inline;"><a href="javascript:toggle2('sec-0.0621478924072')">...more...</a></div>
        <div class='boxrstext' id="sec-0.0621478924072" style="display: none;"><a href="javascript:toggle2('sec-0.0621478924072')">(hide)</a>
        <div class='rstext'>influences statin response *rs72559745 (SLCO1B1*1)	AA	AA *rs56061388 (SLCO1B1*3)	TT	TT *rs4149056 (SLCO1B1*5)	TT	TT *rs55901008 (SLCO1B1*6)	TT	TT rs4149056, also known as 37041T&gt;C or V174A, is a SNP in the SLCO1B1 gene, which encodes the 'organic anion transporting polypeptide 1B1' (OATP1B1) protein. This protein, found primarily in the liver, regulates the uptake of numerous drugs and natural compounds. The rs4149056(C) SNP defines the SLCO1B1*5 allele. The rs4149056(C) allele gives rise to an amino acid change (from valine to alanine at residue 174) which has reduced uptake/transport activity. Therefore, drugs metabolized by OATP1B1 tend to build up to higher circulating concentrations than they would otherwise.. The drugs known (or in some cases, thought) to be transported less well ...</div>
      </div>
      </div>
      <div class="boxfooter"></div>
  </div>

  </div>

  <div class="diseaseinfo">3 snps </div>
</div>
</div>
</div>
     <div class="boxfooter"></div>
     </div>
<p><br/></p></body></html>